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FUNCTIONAL CHARACTERIZATION OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS QSEBC: A 
BACTERIAL ADRENERGIC RECEPTOR AND GLOBAL REGULATOR OF VIRULENCE 
Whitney Weigel 
October 29, 2015 
In order for a pathogen to successfully colonize the host, it must be able to acquire 
essential nutrients and regulate gene expression to respond to environmental fluctuations. One 
mechanism bacteria have evolved in order to detect these fluctuations and respond is the two 
component signal transduction systems (TCS). Aggregatibacter actinomycetemcomitans, a 
dental commensal associated with localized aggressive periodontitis, contains a TCS designated 
QseBC that was previously shown to regulate expression of several iron acquisition genes, 
biofilm formation and virulence, but the activating signal was unknown []. QseBC is a conserved 
TCS in the Enterobacteriaceae and Pasteurellaceae, but the activating signal for QseC varies for 
each species [125]. The QseC in Escherichia coli responds to catecholamines whereas the QseC 
homolog (FirS) in Haemophilus influenzae responds to ferrous iron. Here we show that the 
activating signal for the A. actinomycetemcomitans QseC is a combination of iron and 
catecholamines (CAT-Fe). The sensing of the CAT-Fe complex leads to a significant stimulation of 
biofilm and planktonic growth, as well as induction of genes involved in anaerobic metabolism, 
electron transport and oxidative stress while down-regulating expression of genes involved in 
iron acquisition and fatty acid and LPS biosynthesis.  Using a combination of RNA analysis and 
metabolomics, we identified an increased flux through the TCA cycle to pyruvate and then to 
anaerobic respiration and metabolism with exposure to CAT-Fe. Cells exposed to Cat-Fe also 





 Finally, QseB also appears to play a role in regulating the general stress response in A. 
actinomycetemcomitans since a ΔqseB mutant exhibits increased transcription of several stress 
response genes, including the Lon protease. Ectopic expression of lon resulted in an increase in 
transcription of ygiW-qseBC. Lon is involved in activating type II toxin/anti-toxin (TA) systems, 
one of which (D11S_2133-2134) was shown to be highly up-regulated during iron starvation.  
Further, it was found that ectopic expression of the putative anti-toxin D11S_2134 resulted in a 
significant increase in transcription of qseBC. Based on this data, it is likely that D11S_2133-2134 
regulates expression of qseBC allowing QseBC and D11S_2133-2134 to tightly control iron 
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CHAPTER ONE: INTRODUCTION 
As awareness of germ theory gained acceptance in the early 1900's, the idea that 
systemic and chronic diseases, such as atherosclerosis, mental illness and cancer, were caused by 
the systemic spread of microbes and their toxins through the body also gained traction. The idea 
behind the theory of focal infection was that the root cause of these systemic diseases could 
eventually be traced back to some sort of infectious origin  [1]. In the 1890’s W.D. Miller and 
later in 1911 William Hunter, were the earliest to make the link between oral infections and 
systemic health issues [2, 3]. As a result, one of the methods that was employed to treat and 
prevent systemic disease included the therapeutic extraction of teeth, sometimes even healthy 
teeth [1]. One piece of evidence given to support this therapy is the claim that Hippocrates 
cured arthritis in 400 B.C. by extracting infected teeth [2]. This lead to widespread extraction of 
infected and sometimes even healthy teeth as a way to treat and prevent disease although much 
of the evidence given in support of the theory was anecdotal [4]. The theory was discredited as 
additional studies were conducted that showed the extraction of teeth did not on a whole lead 
to or prevent disease and there was no proof of a direct cause and effect between oral infections 
and some systemic diseases [2, 4]. The problem of cause and effect was difficult to solve at this 
time since the molecular technology was not advanced enough to prove pathogens isolated 
from other sites had an oral origin [3]. Recently, some of the ideas of focal infection have started 
to regain popularity as people have done epidemiological studies looking at the association 
between periodontal disease and systemic inflammatory diseases such as atherosclerosis [5], 
diabetes [1], and rheumatoid arthritis [6]. Numerous case studies have shown systemic issues 
such as urinary tract infections [7], brain abscesses [8] and pneumonia [8] can occur from oral 
infections or after routine dental procedures. One of the strongest links is data suggesting a 
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strong correlation to periodontal disease and endocarditis [9]. Evidence exists of the presence of 
oral pathogens in numerous extra-oral tissues including the heart [10] and brain [11] suggesting 
that oral bacteria can use the oral cavity as a reservoir from which to disperse, most likely after 
dental procedures were small cuts in the gum allow the bacteria access to the bloodstream [2]. 
It has also been suggested that depending on the oral hygiene, activities as innocuous as 
chewing could cause cuts from which the bacteria can enter the blood stream and travel 
throughout the body [3]. From there, depending on the health of the patient, the bacteria can 
travel and potentially colonize other sites in the body. 
Periodontal Diseases 
There are two types of periodontal diseases: periodontitis, a chronic inflammatory 
disease of the periodontium characterized by massive soft tissue destruction, irreparable bone 
and tooth loss, and bleeding upon probing.  Gingivitis is a milder inflammation of the gingiva 
that with proper treatment can be reversed, but if left untreated can result in periodontitis [12]. 
In clinical terms, gingivitis is characterized as a subgingival pocket depth of 4-5 mm with bleeding 
of the gums, while periodontitis is characterized by a subgingival pocket depth greater than 6 
mm, and severe periodontitis giving a subgingival pocket depth greater than 7mm [12]. 
Forty six percent of the adult population of the United States have some form of 
periodontitis and 8.9% have severe periodontitis, making it the most common chronic 
inflammatory disease [13]. The prevalence of periodontitis varies with race with Hispanics 
having the highest percentage (63.5%) and non-Hispanic whites having the lowest percentage 
(40.8%) [13]. $14.3 billion was spent on treating periodontal disease in the US alone in 1999 
[14]. This amount has undoubtedly increased since then.  In addition, research correlating 
periodontal disease to the development of other potentially life-threatening and costly diseases 
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such as atherosclerosis [5], arthritis, diabetes, pulmonary disease and adverse pregnancy 
outcomes means that the cost of periodontal disease in terms of dollar amounts and in terms of 
morbidity/mortality is much higher. This suggests that there is a high need for innovative 
treatments and preventative therapies. 
Numerous risk factors can influence the onset of periodontitis including age, race, 
gender, oral hygiene, diet, socio-economic status, education status, smoking, and stress [13, 15]. 
Hispanics, males, people over the age of 30, and smokers are much more likely to develop 
disease, with 63% of current smokers having periodontal disease and 18.9% of current smokers 
having severe periodontal disease compared to 5.5% of non-smokers with severe periodontal 
disease [13]. The bias towards males developing periodontal disease is interesting since more 
often it is females that are more likely to develop inflammatory diseases, which is thought to be 
due to the influence of hormones on immune cell development [16]. The reasons for the 
increase incidence of periodontal disease in males is still not well known, since female mice in 
lab settings are more likely to develop periodontal disease [17]. This could be explained by 
differences in oral hygiene between males and females since when age and oral hygiene are 
taking into account, incidence of disease between males and females, females are more likely to 
have periodontal disease [117]. The impact of socio-economic and education status can be 
explained in these populations due to reduced access to oral healthcare. In addition, the 
association between race, in particular Hispanics, with the development of periodontal disease 
could have a two-fold explanation. One explanation is that Hispanics may be less likely to receive 
proper oral healthcare [18].  Several of these risk factors (i.e. smoking and diet) are due to the 
direct impact on the microbiome, whereas other risk factors (i.e. smoking, age, sex and stress) 
may have indirect influences on the microbiome by modulating the immune response. These 
impacts on the microbiome can cause significant population shifts resulting in the presence of 
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more pathogenic bacteria. For example, several studies have shown an increase in the 
prevalence of pathogenic bacteria such as Tannerella forsythia, Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis, and Treponema denticola in the oral cavity 
of smokers [19, 20]. In addition, smoking has been shown to cause a dampening of the immune 
response and causes also changes in the oral biofilm [21] by increasing the incidence of 
pathogenic bacteria such as F. nucleatum, P. intermedia, and Actinomyces spp [22]. It can also 
promote colonization by P. gingivalis by causing an increase in fimbriae expression which 
augments the immune response [23]. 
In healthy gums, the teeth are connected to the soft tissue via gingival fibers and the 
alveolar bone via the periodontal ligament fibers. Colonization with pathogenic bacteria triggers 
inflammation resulting in a massive influx of infiltrating neutrophils, macrophages, and 
lymphocytes and eventually leads to deterioration of the supporting soft tissue around the 
teeth, destruction of the periodontal ligaments and gingival fibers, and loss of attachment to the 
tooth. Ultimately the activation of bone-resorbing osteoclasts, over the bone-forming 
osteoblasts, results in alveolar bone loss that causes a reduction in the height of the alveolar 
bone crest and an increase in vertical bone loss.  The pro-inflammatory cytokines released by 
invading immune cells and leading to the activation of osteoclasts include IL-1B, IL-6, TNF-α, IL-8, 
and RANKL [24]. Osteoclast activation leads to bone resorption and alveolar bone loss [24]. In 
addition, infiltrating neutrophils can release a whole host of chemicals from their granules (e.g. 
defensins, proteases, lactoferrin, and catecholamines [25]) when triggered by pro-inflammatory 
signals. 
A second form of periodontitis differs from the typical chronic periodontitis. Localized 
aggressive periodontitis (LAP) is a rapid onset periodontal disease, and when left untreated 
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results in rapid alveolar bone loss and destruction of the supporting tissues around the teeth, 
particularly in the incisors and first molars. LAP has significant differences in geographic burden 
with people from Moroccan descent more likely to have LAP suggesting that geographic location, 
socio-economic factors and race play an important role in its development [26].   It is more often 
seen in juveniles compared to chronic periodontitis and is strongly associated with colonization 
with A. actinomycetemcomitans [26], and in particular, a hyper-leukotoxic strain of the organism 
[37]. 
Biofilms 
 Periodontitis is an inflammatory response triggered by certain oral bacteria that form 
biofilms, structured communities of bacteria in a self-generated matrix of proteins, nucleic acids, 
and carbohydrates, in the subgingival pocket. The plaque deposited on the teeth (hard tissue) 
and in the subgingival pocket (soft tissue) is comprised of a microbial biofilm. The presence of 
plaque is the most important risk factor for the development of periodontitis. The development 
of biofilms is advantageous to the bacteria since the structured community allow them to more 
tightly adhere to the salivary pellicle or each other, making them more difficult to remove by 
chemical or physical means. Biofilms also help bacteria to resist antibiotic mediated killing and 
can promote slow-growing persister cell formation [122]. These are cells that are physiologically 
dormant and more resistant to anti-bacterial treatment. The oral biofilm is extremely complex, 
containing both pathogens and commensals, and usually exists in homeostasis with the host.  
However, a variety of environmental stimuli can induce populational changes in the biofilm that 
disrupt homeostasis and initiate disease.  Development of biofilms on the teeth starts within 
hours of tooth eruption from the gingiva [123]. In addition, routine cleanings can clear the 
biofilm, but it will start to reform soon after [123]. Formation begins with the deposition of the 
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salivary pellicle and initial colonizers such as Streptococci spp. and Actinomycetes spp. attaching 
to these immobilized salivary components [27]. Early (i.e. Neisseria, Prevotella, Eikenella, Rothia, 
Porphyromonas, and Veillonella), middle (i.e. Fusobacterium nucleatum) and late colonizers (i.e. 
those most associated with disease, such as P. gingivalis, T. denticola, T. forsythia, and A. 
actinomycetemcomitans [28]) will then attach to the established biofilm making it more complex 
and diverse. 
 The oral biofilm consists of around 700 species, but only some of these bacteria have 
been associated with the progression from health to disease. A shift of mostly Gram-positive 
aerobes to Gram-negative anaerobes is associated with the development of disease [27]. Some 
of the better characterized bacteria that have been associated with periodontitis include 
bacteria of the “red complex” (T. denticola, T. forsythia, and P. gingivalis), Filifactor alocis, 
Prevotella intermedia, and A. actinomycetemcomitans [26, 28]. The colonization of the 
subgingiva by these pathogens is aided by several virulence factors that help in evading the 
immune response. Biofilm development depends on the interaction of not only bacteria to the 
surface of the tissues of the host, but also on bacteria-bacteria interactions [27]. 
Aggregatibacter actinomycetemcomitans 
A. actinomycetemcomitans is gram-negative, non-motile, facultative anaerobe of the 
Pasteurellaceae family. Other members of the Pasteurellaceae family include Haemophilus 
influenzae and Actinobacillus pleuropneumoniae.  There are five serotypes (a-e), with variation 
in the global population in serotype burden, with a, b, and c being globally dominant, while d 
and e are rare [29, 30]. This study utilizes the smooth strain D11S c seroptype of A. 
actinomycetemcomitans due to its role in pathogenesis of localized aggressive periodontitis. 
 Although A. actinomycetemcomitans is now considered to be an oral opportunistic 
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pathogen, it wasn't recognized as being a member of the oral microbiota until 1975, 63 years 
after it was first isolated [31]. It is associated with a particular type of periodontitis called 
localized aggressive periodontitis (LAP) [26].  Geographic and race disparities have been 
reported in terms of incidence of LAP, but A. actinomycetemcomitans remains prevalent in the 
overall population and is commonly present in the subgingival plaque. A. 
actinomycetemcomitans has also been shown to cause extra-oral infections and complications 
such as infective endocarditis [10], soft-tissue abscesses [8], reactive arthritis [32], urinary tract 
infections [7], pneumonia [8] and has been associated with atherosclerosis [33]. 
A. actinomycetemcomitans has a variety of virulence factors including a 116 kDa 
leukotoxin, a member of the repeats-in-toxin (RTX) family of pore-forming toxins that specifically 
kills polymorphonuclear leukocytes, monocytes and T-cells in humans, apes and Old-World 
monkeys [34, 35].  Previous studies have shown that people harboring an A. 
actinomycetemcomitans strain JP2 that expresses higher levels of leukotoxin due to a deletion in 
the toxin promoter have earlier onset of periodontitis than patients colonized with a non-JP2 
strains [36, 37]. In addition, A. actinomycetemcomitans produces other virulence factors such as 
a cytolethal distending toxin that causes apoptosis of lymphocytes [38], lipopolysaccharide (LPS) 
[39], collagenase [39], a capsular polysaccharide that has been shown to inhibit IL-6 and IL-8 
production [40], an IgA protease [41], an adhesin associated with infective endocarditis EmaA 
[42] , and fimbriae that allows it to form robust biofilms [43]. The fimbriae play an important role 
in the ability of A. actinomycetemcomitans to attach to itself or to other surfaces and resist 
salivary flow when forming biofilms [44].   
A. actinomycetemcomitans is also resistant to complement mediated phagocytosis and 
killing by neutrophils [45] although the exact mechanism by which it resists neutrophil killing is 
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unknown. The b serotype of A. actinomycetemcomitans is capable of resisting phagocytosis via 
serotype b-specific polysaccharide antigen [46]. However, it’s also able to invade epithelial [47] 
and endothelial cells [48].  The ability to invade into these cells may be an important mechanism 
by which the bacteria shields itself from immune killing or a way for the bacteria to disseminate 
through the host [39]. 
Since a virulence factor can be defined as anything that helps a pathogen to successfully 
colonize a host, the definition of virulence factors has started to be expanded to include things 
that would have been considered house-keeping genes before, such as essential metabolic 
genes. Recent research now suggests that metabolites and changes in metabolism itself can be 
considered a virulence factor since many virulence factors and quorum sensing systems are 
under metabolite control, for example, the regulation of carbon metabolism via the cAMP 
regulatory protein [49-51]. Further, successful colonization of the host requires correct 
expression of metabolic pathways. For example, Jorth et al showed that when A. 
actinomycetemcomitans grown in in vitro biofilms was compared to A. actinomycetemcomitans 
cultured in a mouse abscess model, the largest changes in gene transcription revolved around 
genes involved in anaerobic respiration and metabolism [52]. In addition, deletion mutants of 
some of the genes that were up-regulated in in vivo conditions (e.g. fumarate reductase and 
formate dehydrogenase) were attenuated compared to wild type strains [52]. 
Two-component Regulatory Systems and QseBC 
Successfully colonizing a host requires that a pathogen respond quickly to environmental 
fluctuations. One way that bacteria respond to changes in their environments is through the 
activity of two component signal transduction systems. These systems have evolved to respond 
to a variety of stimuli including pH, temperature, salinity, and concentrations of ions such as zinc 
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and iron [59, 62, 60]. They are usually comprised of a membrane bound histidine kinase sensor 
and a cytosolic, DNA-binding response regulator that are often co-transcribed in an operon. 
When the inner membrane bound sensor senses its cognate stimulus, it becomes activated and 
auto-phosphorylates at a highly conserved histidine residue. The histidine kinase sensor will 
then transfer the phosphate to the cognate response regulator causing it to change 
conformation and become activated. The activated response regulator can then bind to DNA to 
either promote or repress expression of certain genes, sometimes including its own operon [60, 
101]. There has also been evidence that some sensors can activate response regulators other 
than its own cognate response regulator [60]. This suggests that a large and complex signaling 
cascade can occur in order to change gene transcription in response to environmental stimuli. 
QseBC is a two-component system that is highly conserved in the Enterobacteriaceae 
and the Pasteuerellaceae. In A. actinomycetemcomitans, the operon is transcribed with a gene 
encoding a small putative periplasmic solute binding protein of the OB-fold family designated 
ygiW [53]. The ygiW gene is present in Escherichia coli, but it is divergently transcribed from the 
qseBC operon. 
Work done in E. coli and Salmonella enterica have shown that this two component 
system responds to catecholamines in iron-limiting environments [54-57]. This response is also 
dependent on the presence of a functional synthesis and transport system for the enterobactin 
siderophore [58]. The E. coli QseBC can also become activated with increased levels of ferric 
iron, but it is not directly activated by the iron. Iron activates another TCS, PmrAB [59], and PmrA 
binds to the promoter region of qseBC to induce its expression [60].  Further, PmrB will 
phosphorylate QseB which in turn auto-regulates expression of the qseBC operon [60]. In 
addition, the E. coli QseBC is able to respond to a quorum sensing molecule designated as AI-3 
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[55, 61]. It was shown that exposure to catecholamines regulates the production of AI-3 by the 
bacteria, and AI-3 goes on to further activate QseBC on its own. Contrary to this, the QseBC 
homolog in H. influenzae (FirRS) did not appear to respond to catecholamines, and instead 
responded to ferrous, and not ferric, iron [62]. This response to iron was dependent on an iron-
responsive motif in FirS, DYRED [62].  
Some of the reported changes in response to QseC activation by catecholamines in E. 
coli include the activation of genes involved in the formation of the attaching and effacing lesion 
[63], the Type Three Secretion System (TTSS) contained on the locus of enterocyte effacement 
(LEE) [54], and flagella and motility genes [64, 65]. Other effects of catecholamine exposure 
include increase in planktonic growth [66], biofilm formation [65], as well as virulence [65]. This 
effect has also been seen in P. gingivalis and A. plueropneumoniae, where catecholamines have 
been shown to cause an up-regulation of certain virulence factors [67, 68]. It is not known if 
catecholamines cause changes in gene transcription and growth in A. actinomycetemcomitans, 
but since the A. actinomycetemcomitans genome lacks many of the QseBC-regulated gene of E. 
coli, the potential impact of catecholamines on A. actinomycetemcomitans will likely be novel 
and species specific. 
Although the activating signal for the A. actinomycetemcomitans QseBC has not been 
identified, previous work has shown that QseC plays an essential role in two important and 
complex phenotypes. The first phenotype is virulence, since a ΔqseC mutant is attenuated in a 
mouse model of periodontitis, and a qseC complemented strain restores the virulence 
phenotype, as measured by alveolar bone loss [44]. The other phenotype that QseBC plays a role 
in is biofilm formation [44, 53].  
 The ability of A. actinomycetemcomitans to form biofilms is contingent on its ability to 
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sense the quorum sensing molecule AI-2 by the receptors LsrB and RbsB [70]. In an AI-2 synthase 
mutant (ΔluxS) biofilm formation is reduced. QseBC is activated downstream of AI-2 detection, 
but QseBC is not directly activated by AI-2 [44]. The mechanism linking AI-2 detection to QseBC 
activation is unknown, but in E. coli it was shown that qseBC is regulated by the toxin MqsR, 
which is activated by AI-2 [71]. Biofilm formation was significantly reduced in a MqsR deletion 
mutant in the presence of AI-2 and MqsR was found to positively regulate qseBC expression [71]. 
Microbial Endocrinology 
Microbial endocrinology refers to the rapidly growing field dedicated to understanding 
the impact of host hormones on pathogens in terms of virulence and growth. Hormones play an 
important and varied role within the host. One process that is controlled by hormones in 
humans is the stress response.  High catecholamine (i.e. norepinephrine, epineprhine and 
dopamine) hormones are associated with stress [15, 72]. When the host encounters some sort 
of stressor, the sympathetic nervous system becomes activated causing signaling through the 
hypothalamic-pituitary-adrenal axis [73]. This activation triggers the response of the 
catecholamine neurotransmitters in order to put the body into a “fight-or-flight” response mode. 
Effects of catecholamines include increased heart rate, blood pressure, and glucose levels [73]. 
Catecholamines are mainly produced in the adrenal glands by chromaffin cells and in the 
post-ganglionic fibers of the sympathetic nervous system. Recent research has shown that 
norepinephrine can also be produced and released by activated phagocytes (including activated 
neutrophils which migrate into the tissue during periodontitis) in response to inflammatory 
signals [25, 74].  The concentration of released catecholamines can reach up to millimolar 
amounts and work to activate other immune cells, ramping up the immune response [25, 57].  
The synthesis of catecholamines begins with L-phenylalanine, which is converted into L-
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tyrosine by aromatic amino acid hydroxylase (AAAH). Using the same enzyme, L-tyrosine is 
converted into L-DOPA with tetrahydrobiopterin, O2, and ferrous iron acting as cofactors. L-DOPA 
is converted by aromatic L-amino acid decarboxylase (AADC) to dopamine with pyridoxal 
phosphate as the cofactor. Dopamine can then act as a precursor for the synthesis of the other 
catecholamines: epineprhine and norepinephrine. Dopamine is first converted to 
norepinephrine by dopamine β-hydroxylase (DBH) using O2 and L-ascorbic acid as cofactors and 
is then converted into epinephrine by phenylethanolamine N-methyltransferase (PMNT) with S-
adenosyl-L-methionine acting as the cofactor [75]. There are two enzymes which can degrade 
catecholamines: catechol-O-methyltransferase (COMT) and by monoamine oxidases (MAO) [75]. 
The original studies done on the effect of catecholamines on bacteria began with work 
on E. coli and S. enterica. It had been widely reported that animals exposed to stressful 
conditions were more susceptible to disease [57, 76]. These reports contradict evidence showing 
that catecholamine stress hormones can activate immune cells [25] which would be expected to 
decrease susceptibility to disease. It was hypothesized that catecholamines had a direct impact 
on pathogens leading to an increase in virulence. This was confirmed with work showing that 
catecholamines result in increased growth in minimal, iron-restricted media [57]. 
Catecholamines can also act as pseudo-siderophores and can scavenge iron from host iron-
binding proteins [77]. This ability of catecholamines to scavenge iron was suggested to 
contribute to the growth phenotype in response to catecholamines, suggesting that bacteria can 
exploit the production of host hormones to acquire the essential nutrient iron. Catecholamines 
have been shown to scavenge iron through their catechol moeity by forming a complex with the 
iron-loaded lactoferrin [77]. This complex causes reduction of the iron, which destabilizes the 
bond between the iron and lactoferrin, allowing iron to be released [77]. Both catecholamines 
and lactoferrin can be released by neutrophils in response to pro-inflammatory signals [78, 79], 
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so the bacteria may not only exploit the systemic production of hormones, but also the 
inflammatory response designed to combat infection. 
Normally, free iron is very limited in the host due to host iron-binding proteins that 
ensure bacteria cannot easily acquire this essential nutrient [124]. Bacteria have in turn evolved 
mechanisms to counter iron sequestration, most notably through the secretion of siderophores 
such as enterobactin, which is able to bind iron via a catechol moiety [58]. However, in bacteria 
that do not produce siderophores, e.g., A. actinomycetemcomitans, the use of catecholamines to 
scavenge iron may represent a novel mechanism for nutrient acquisition [57].  Several different 
proteins have been suggested to function as bacterial adrenergic receptors and interact with 
catecholamines but the best characterized protein is QseC [55]. The ability of bacteria to sense 
catecholamines through bacterial adrenergic receptors like QseC demonstrates the ability of 
these organisms to take part in inter-kingdom signaling. 
As previously mentioned, stress is a risk factor for the development of periodontitis [15]. 
In addition, it has been shown that activated polymorphonuclear cells can release up to 
millimolar concentrations of catecholamine stress hormones in response to inflammatory signals 
[78, 79]. Although macrophages have been shown to release higher amounts of catecholamines, 
infiltrating neutrophils are in a higher abundance during periodontitis [95, 96] and are more 
likely to have an effect on periodontal microbes like A. actinomycetemcomitans due to their 
release of catecholamines. Therefore, a better understanding of how oral bacteria, specifically A. 
actinomycetemcomitans, respond to catecholamines and the impact on virulence may provide 
insight for understanding the connection between stress and pathogenesis. Understanding the 
impact of catecholamines on the pathogenesis of A. actinomycetemcomitans may allow us to 
use different therapies to block the recognition of catecholamines by A. 
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actinomycetemcomitans. There are already drugs on the market (i.e. alpha blockers and beta 
blockers) that block the recognition of catecholamine hormones by adrenergic receptors [80]. If 
QseC is functioning as an adrenergic receptor, then these receptor antagonists could potentially 
block the recognition of catecholamines by the bacteria and therefore could modulate 
pathogenesis and reduce the damage caused by periodontitis. In addition, understanding the 
link between catecholamines and periodontitis and the effect on A. actinomycetemcomitans 
may allow dentists in the clinical setting to look at which patients will need to be targeted for 
more aggressive treatment.   Ultimately, this information could also be used to determine 
patients that are at higher risk to develop more virulent bacterial infections leading to 
periodontitis due to increased catecholamines and target them with more aggressive dental care 
and potentially therapeutic agents such as adrenergic receptor antagonists. 
Toxin/Anti-toxin (TA) Systems: 
Previous work done on E. coli has shown that QseBC activation is directly controlled by 
the toxin MqsR, which is directly downstream of AI-2 detection [71]. MqsR is the toxin in the 
mqsRA type II toxin/anti-toxin (TA) system. Type II TA systems are comprised of a labile protein 
anti-toxin that is co-transcribed in a small operon with its cognate protein toxin [81]. Under 
normal conditions, the anti-toxin binds to the toxin to negate its effects. TA systems can be 
activated by the Lon [82] or Clp [83] proteases which more readily degrades the labile anti-toxin, 
releasing the toxin [85, 83]. Most toxins act as endoribonucleases [84], but some toxins can 
target other factors such as DNA gyrase, elongation factors, or uridine diphosphate-N-
acetylglucosamine [81]. TA systems are activated by a signaling mechanism involving RelA/SpoT, 
the signaling nucleotide (p)ppGpp, and polyphosphate (PolyP) [85]. RelA/SpoT synthesizes 
ppGpp which causes an inhibition of exopolyphosphatase (PPX), which is an enzyme that 
15 
 
degrades PolyP [85]. PolyP is produced by polyphosphate kinase (PPK), and since PPX is 
inhibited, the concentration of PolyP within the cell increases, which activates Lon [85]. This 
signaling mechanism can be activated stochastically at very low levels [85], or conversely, when 
the bacterium is stressed or goes through metabolic transitions [86]. In addition, the Clp 
protease can also degrade anti-toxins [83], but it has not been determined if it responds to the 
same mechanisms as Lon. A. actinomycetemcomitans contains both the Lon (D11S_1522) and 
Clp (D11S_2042-2043) proteases. The activation of TA systems through this signaling mechanism 
is hypothesized to be a way for the bacterium to form a persister state in response to stress [81, 
84]. TA systems can respond to a variety of stressors, and they can be functionally redundant. 
For E.coli, all 10 TA systems had to be knocked out in order to see a phenotype of decreased 
persistence [84]. 
As mentioned previously, qseBC is part of the AI-2 regulon in A. actinomycetemcomitans, 
but it is not directly activated by AI-2 detection [44]. The mechanism that links AI-2 and qseBC 
remains unknown. There are 10 putative TA systems in A. actinomycetemcomitans, and it is 
possible that one of these TA systems plays a role in qseBC expression. The stimuli that activates 
these TA systems in A. actinomycetemcomitans, their mechanism of action, and their targets for 
regulation are unknown. Previous work done in E. coli has shown that certain TA systems can 
have a wide range of targets, for example, the MazF toxin acts as an endoribonuclease that 
targets the sequence ACA, which is present in almost all mRNA's [87]. The targets for TA systems 
allow the bacteria to down-regulate processes such as transcription and translation, processes 
that require a significant amount of energy and are required for a metabolically active cell. By 
down-regulating these processes, the cell can go into a persister state and persist under 
conditions of environmental stress [125]. Therefore, understanding how TA systems regulate cell 
activities could elucidate targets for therapeutics that could be employed as a way to prevent 
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persister cell formation and make the bacteria more susceptible to antibiotics. 
Significance 
QseBC has been previously shown to be essential for the pathogenesis of A. 
actinomycetemcomitans and from these studies seem to regulate many key cellular processes 
like metabolism, biofilm formation and the stress response. The data presented in this 
dissertation demonstrates that the A. actinomycetemcomitans QseBC responds to both iron and 
catecholamines (CAT-Fe) and to high concentrations of the adrenergic receptor antagonists 
propranolol and phentolamine. CAT-Fe stimulates both planktonic growth and biofilm formation 
in a TonB dependent manner.  In addition, CAT-Fe significantly alters the metabolic flux of A. 
actinomycetemcomitans and results in an up-regulation of genes involved in oxidative stress 
which protects the bacteria after exposure to H2O2. The ability of A. actinomycetemcomitans to 
respond to CAT-Fe and exploit it as a nutritional niche may provide insight about the connection 
between stress and periodontitis. Further, the loss of QseB results in an up-regulation of the 
stress response. Ectopic expression of lon, one of the proteases involved in the stress response, 
induces increased transcription of ygiW-qseBC. In addition, ectopic expression of the iron-
responsive D11S_2133-2134 TA system was shown to modulate expression of ygiW-qseBC. These 
results suggest that the D11S_2133-2134 TA system and QseB might be involved in a regulatory 
circuit that fine-tunes the response of A. actinomycetemcomitans to changes in iron in the 
environment and might represent a target for therapeutics. In addition, our results potentially 







CHAPTER TWO: MATERIALS AND METHODS 
Bacterial strains and culture conditions: All strains used are listed in Table 1. LB (Luria–Bertani) 
broth, LB agar (LB broth with 1.5 % agar) and brain–heart infusion (BHI) broth, BHI agar, and a 
chemically defined media (CDM) was used to propagate and plate bacteria.  A. 
actinomycetemcomitans 652 serotype c was grown at 37oC in 5.0% CO2 in either Brain Heart 
Infusion (BHI) supplemented with 40 mg of NaHCO3  per liter or CDM supplemented when 
required with 100uM of ferrous or ferric iron or 50uM of epinephrine or norepinephrine or 50-
400uM of phentolamine or propranolol. The components of CDM are essentially described by 
Socransky et al [88] listed in Table 2. Cultures grown in CDM for CAT-Fe studies were first 
inoculated into BHI and cultured overnight to an O.D.600nm of 0.3-0.4. The overnight culture was 
then passaged into fresh BHI at a 1:30 dilution until growth reached an O.D.600nm of 0.5-0.6. The 
culture was then passaged into CDM at a 1:30 dilution. The ΔqseC complemented strain and 
strains carrying the pDJR29 plasmid were grown as described above but supplemented with 
kanamycin (25ug/mL).  The A. actinomycetemcomitans strain carrying pWAW28 was grown in 
BHI supplemented with kanamycin while the strains carrying pWAW17, pWAW19, pWAW20, and 
pWAW31 were grown with kanamycin in BHI with or without 1mM IPTG supplementation. The 
A. actinomycetemcomitans strains carrying pWAW14 or pWAW16 were grown in LB with 
kanamycin with or without supplementation with 0.2% glucose.  XL Blue Escherichia coli cultures 
containing the plasmids pWAW17, pWAW19, and pWAW21 were cultured in Luria Broth (LB) 
supplemented with tetracyline (50ug/mL), kanamycin (25ug/mL) or with 1mM IPTG. XL Blue 
Escherichia coli strains carrying pWAW14 and pWAW16 were grown in LB supplemented with 
tetracycline and kanamycin. A.actinomycetemcomitans cultures harboring the suicide plasmid 
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pWAW23 were grown in BHI with spectinomycin (25ug/mL) or TYE with 1mM IPTG and 10% 
sucrose.  
Growth Kinetics: For determining the effect of CAT-Fe on growth, a frozen glycerol stock of A. 
actinomycetemcomitans was inoculated into BHI and allowed to grow to an O.D.600nm of 0.3-0.4. 
Cells were then transferred to fresh BHI at a dilution of 1:30 until an O.D.600nm of 0.5-0.6 was 
achieved. The cells were then inoculated into fresh CDM at 1:30 dilution with or without CAT-Fe 
supplementation or adrenergic receptor antagonist supplementation.  At various time points, 
aliquots were removed from triplicate cultures and the O.D.600nm measured using a BioRad 
SmartSpec Plus UV-vis spectrophotometer. Growth kinetics for XL strains or A. 
actinomycetemcomitans strains containing plasmids for the ectopic expression of the Lon 
protease or the TA systems were done in triplicate using aliquots taken a various times and the 
O.D.600nm measured.  For all other growth curves, cultures were inoculated from an overnight 
stock at a 1:30 dilution into fresh media with the appropriate supplementations. At various time 
points, aliquots were removed from triplicate cultures and measured for the O.D.600nm.
 
Table 1: Strains and plasmids    
Strain or plasmid 
Derived, relevant genotype or 
characteristics  Source or reference 
Escherichia coli     
XL1-Blue MRF’ 
∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 
endA1 supE44 thi-1 recA1 gyrA96 relA1 lac 
[F´ proAB. lacIqZ∆M15 Tn10 (Tcr)] Stratagene 
   
Aggregatibacter actinomycetemcomitans   
652 WT Wild type, serotype c Laboratory stock 
652-JR23 652 qseCΔp Juárez-Rodríguez et al. (2013a) 
652-JR36 652 ΔygiW Juárez-Rodríguez et al. (2013a) 
652-JR37 652 ΔqseB Juárez-Rodríguez et al. (2013a) 
652-JR38 652 ΔqseC  Juárez-Rodríguez et al. (2013a) 
652-JR39 652 ΔqseBC  Juárez-Rodríguez et al. (2013a) 
652-JR39-46 652 ΔqseBC::46 (YgiW QseBQseC) Juárez-Rodríguez et al.  (2014) 
652-JR39-61 652 ΔqseBC::61 (YgiW QseBQseCY155A, R156A) Weigel et al. (2015) 
652-WW1 652 ΔD11S_1352 This study 
   
Plasmids   
pJT1 Spr, suicide vector Juárez-Rodríguez et al. (2013b)  






Strain or plasmid Derived, relevant genotype or characteristics  Source or reference 
Derived from pJT1   
pWAW4 Spr, D11S_1352 This study 
   
Derived from pJT3   
pWAW17 Kmr, pTRC promoter -1 to -87, Lon -87 to -2505 This study 
pWAW19 
 
Kmr, pTRC promoter -1 to -87, D11S_2134 -87 to -
2505 This study 
pWAW20 
 
Kmr, pTRC promoter -1 to -87, D11S_2133 -87 to -









Kmr, ygiW-qseBC promoter -1 to -372-lacZ 
Kmr, pTRC promoter -1 to -87, D11S_1354-1352 -
87 to-2305 
Kmr, lsrA promoter -441 to +182 D11S_2134 +182 to 
+338 
Kmr, lsrA promoter -441 to +182 D11S_2133 +182 to 
+464 
Kmr, lsrA promoter -441 to +182 lacZ 













Construction of TA system and Lon ectopic expression plasmids: pWAW17, pWAW19, and 
pWAW20, were constructed from the lacZ-reporter strain pJT3. Using A. actinomycetemcomitans 
chromosomal DNA as a template, fragments representing lon, D11S_2133, or D11S_2134 were 
PCR amplified using a high fidelity Taq polymerase (Invitrogen) and primer sets: WW64&WW75, 
WW76&WW68, and WW70&WW77, respectively. The primers were flanked with restriction 
sites as shown in Table 3. The 2.4kb, 156bp, or 282 bp products were digested with BamHI-Xbal 
and ligated into the BamHI-Xbal digested pJT3 to make pWAW17A, pWAW19A, and pWAW20A. 
Using pJT1 plasmid DNA, primer set WW86&WW87 was used to PCR amplify the pTRC promoter. 
The 150 bp product was then digested with BamHI-KpnI and ligated together with BamHI-KpnI 
digested pWAW17A, pWAW19A, or pWAW20A to create pWAW17, pWAW19, or pWAW20, 
respectively. To make pWAW14 or pWAW16, the reporter plasmid containing the lsrA promoter, 
pATE33 [49] was digested with KpnI/BamHI and ligated together with KpnI/BamHI digested 
products from the PCR amplification of WW76&WW68 and WW70&WW77, respectively.  The 
ligation reaction was then transformed into E.coli XL gold electrocompetent cells. Electroporated 
cells were incubated for 1 hour in SOC (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM 
KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) media with shaking then plated on LB 
plates supplemented with 50ug/mL of tetracycline and 25ug/mL kanamycin and incubated 
overnight. Colonies were chosen and grown in LB with tetracycline and kanamycin overnight. 
Plasmid was extracted from cultures using the Plasmid Miniprep Kit (Qiagen) and confirmed by 
sequencing using the University of Louisville Sequencing Core to confirm correct insertion. 25ug 
of plasmid was then used to transform A. actinomycetemcomitans by electroporation. 
Transformed cells were then cultured on BHI plates supplemented with kanamycin and resulting 




Table 2: Composition of CDM  
1L CDM 
10mL CaCl2 (10mg/mL) 
50mL Amino Acid Stock 
50mL Inorganic Salt Stock 
1mL Vitamin Stock 
50mL NaHCO3 (20mg/mL) 
10mL Cysteine (65mg/mL) 
10mL MgSO4 (70mg/mL) 
1mL Pimelic acid/Biotin 
10mL Riboflavin (0.1mg/mL) 
1mL Lipoamide 
1mL Folic Acid 
    
Amino Acid Stock 
Hydrophilic Amino Acids 
10mL H2O 
2.5mL 2M NaOH 




200mg L-lysine hydrochloride 
242mg L-arginine hydrochloride 




200mg L-aspartic acid 














Hydrophobic Amino Acids 
15mL H2O 












1.25mL 2M NaOH 
25mg Adenine 
20mg Guanine 







0.625mL 2M NaOH 
10mg L-cystine 
  
Combine hydrophobic, hydrophilic, 
purine & pyrimidine and cystine to make 

























0.5mg Boric Acid 
0.7mg ZnSO4:7H2O 












20mg Nicotinic Acid 





2mg p-aminobenzoic acid 
.00005mg Vitamin B12 























β-Galactosidase Assay: A. actinomycetemcomitans containing the lacZ reporter plasmid pDJR29 
were grown in CDM with or without supplementation of catecholamines, iron, and/or adrenergic 
receptor antagonists. Quantitative evaluation of β-galactosidase was carried out using 
permeabilized cells incubated with o-nitrophenyl-β-d-galactopyranoside (ONPG) substrate 
(Sigma-Aldrich) as previously described by Miller. Briefly, at 24 hours, 1mL of culture was taken 
to measure the O.D.600nm and 100uL of culture was taken for a β-Galactosidase assay. 700uL of 
Buffer Z (0.06M Na2PO4.7H2O, 0.04M NaH2PO4.H2O, 0.01M KCl, 0.001M MgSO4.7H2O, 0.05M 2-
mercaptoethanol, pH7.0) was added to the 100uL of culture. Cells were then permeabilized 
using 20µL of chloroform and 0.5% SDS. 200uL of o-nitrophenyl-β-galactoside (ONPG) (4ug/mL) 
in Buffer Z was added to initiate the reaction. The reaction was stopped by the addition of 500uL 
of Na2CO3 after a color change was observed. The absorbance at 420nm and 550nm was read 
using a BioRad SmartSpec Plus UV-vis spectrophotometer. 
Formate Assay: Formate concentration was calculated by the conversion of formate and NAD+ to 
bicarbonate and NADH via formate dehydrogenase using a Formic Acid Kit (r-Biopharm).  A. 
actinomycetemcomitans was grown in CDM with or without supplementation with 
catecholamines and/or iron until 16 hours. Cells were then pelleted and the supernatant was 
harvested. The supernatant was then treated with 30mM trichloroacetic acid (TCA) at a 2:1 ratio 
of TCA to supernatant. The solution was then neutralized with 2M sodium hydroxide and filtered 
to remove all proteins. The filtered product added to the assay was adjusted based on growth 
rates of the bacteria and used in the Formic Acid Assay (r-Biopharm) as per manufacturer's 
instructions.  
Oxidative Stress: A. actinomycetemcomitans was cultured in CDM with or without 
supplementation with iron and/or Ne for 16 hours. At this time, the growth was measured at 
O.D.600nm and the culture was split into two equal volumes in separate conical tubes. One half of 
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the culture was incubated at 37oC for 15 minutes while the other half of the culture was then 
stressed for 15 minutes using 0.3% H2O2 at 37oC. The hydrogen peroxide was quenched after 15 
minutes with 50mM sodium pyruvate. Growth was measured 5 hours after culture at 37oC and 
compared to the pre-stress levels of growth.  
RNA Isolation: Total RNA was harvested from mid-log growing cells using the RNA Lipid Tissue 
Minikit (Qiagen) as per manufacturer's instructions. To ensure that the RNA was free from any 
contaminating genomic DNA, the sample was digested by the Rnase-Free Dnase Set. The 
concentration and purity of each RNA sample were measured via spectrophotometry (ND-1000 
Spectrophotometer, NanoDrop Technologies, Inc, Wilmington, DE). The RNA was tested for any 
genomic DNA contamination using qRT-PCR with primers specific for the 5S rRNA (Table 3) of A. 
actinomycetemcomitans and the SYBR Green FastMix (Quanta). RNA samples were considered 
free of significant genomic DNA if no amplification product was detected by qRT-PCR after at 
least 30 cycles of amplification. 
 
 
Table 3 Primers  
Primer Description Sequence 
5sF 5s GCGGGATCCTGGCGGTGACCTACT 
5sR 5s GCGATCTAGACCACCTGAAACCATACC 
MDJR-
263F     pJT1 sequencing GTTAGCAGTTCGTAGTTATCTTGGAGAGAATATTGAATGGAC  
ww 26 D11S_2135 real-time GGTATGCGCGAAAAAGCCACCAACGCG 
ww 27 D11S_2135 real-time CGCCTTTGATTTTATCGACCACATCCATGCC 
ww 28 2134-2135 intergenic real-time CCGAATGAGGATGTGGTGATTACTTCGGTTAC 
ww 29 2134-2135 intergenic real-time CTTTAGCTTTTACCGCCGCTTGAATCACGC 
ww 36 D11S_2134 real-time GATGACACAGGAATATAAGCAGTTTTTGCAACAAAAAG 
ww 37 D11S_2134 real-time CATTCCTTCTTTAGCTTTTACCGC 
ww 38 D11S_2133 real-tome CGAATATGCCGGATTTAGCAGTGC 
ww 39 D11s_2133 real-time CAATTCGATAGCCTCTGACATAAATTTCA 
ww 42 D11S_2134 5'RACE CATTCCTTCTTTAGCTTTTACCGCCGCTTGAATCAC 
ww 64 Lon R pjt4 GCTTTTGAAAAACACTGAA TCTAGA TTAATTGACCGCAC 
ww 65 Lon real-time GGATGTTACAAGTGCCTTGGCACAAACGTAGTAAAG 
ww 66 Lon real-time CGCCACAAACATTACGTCGGATAAATCATAATCC 
ww 68 2134 pWAW19 CTGAATAAATAATT TCTAGA TTATGCAACGTCCTTCATTCC 
ww 70 2133 pWAW20 GGTATCAAAAAAAGGCATGA TCTAGA TTAGAAATTGG 
ww 75 lon pWAW17 GGAATTTAGATAAGAGAGTACATG GGATCC ATGAGAGC 
ww 76  2134 pWAW19 GGAGGTTATGATG GGATCC   ATGACACAGG 
ww 77 2133 pWAW20 GAAGGACGTTG GGATCC CATAAAATTATTTATTCAG  
ww 80 qseC real-time GATAATTTAACCCAAGGTATCGACCGTGCGACG 
ww 81 qseC real-time CATGAAAATACAGGTCGCCGATAAGGGACGGAAC 
ww 82 qseB real-time GAAATTGCCCTGACCACCCGTGAATATAAACTG 
ww 83 qseB real-time CACTTCCAGCGCGTTACTGCTCACTTC 








   
 
ww 85 ygiW real-time CGCGCCAGGCTTTGCGTTCGATTTC 
ww 86 pTrc  GCGCTTATTGCT GGTACC ATTCTG AAATGAGCTG  
ww 87 pTrc CATAGATCT GGATCC CATTTTCCTGTGTGAAATTGTTATCC 
ww142 Formate Dehydrogenase real-time GGACACTATTCCTGCCGTTCTATGACAG 
ww143 Formate Dehydrogenase real-time CAAACCAAGTCGTTGTTTTTAATACCCAGTGC 
ww138 Formate Acetyltransferase real-time GCAATGAATATGATCAATTGTTCTCCGGCG 
ww139 Formate Acetyltransferase real-time CGGAAGCTGTTTTTGGTCACGAGAGTAC 
ww 149 focA real-time CATTATGGTAGTGGTGTGCGGCTCC 
ww 150 focA real-time CTAAAACAATAAAAATTGCGCCGACGAAATTACCAC 
ww123 Nitrate Reductase real-time GCGTGCCGAAAGATGTGTTGGAAAATTTGG 
ww124 Nitrate Reductase real-time GGTCAGCAAATGGATGTTATAAATGAGGTGG 
ww109 Nitrite Reductase nrfD real-time GACAAAAAATGGTCGCCATGCACAACGCCCTAAG 
ww110 Nitrite Reductase nrfD real-time CGGGATGAGGATGCCGATAAGCATGAC 
ww113 hypF real-time GTGTTACACCACCACGCCCACATCGTCAG 
ww114 hypF real-time CCTAAATAGTACGCGGCTTTTTCATCTGCCAGC 
ww 147 Catalase real-time GGTCATAAATTTTTAACCAACGCAGAAGCGG 
ww 148 Catalase real-time GATTTGAATTCGCACGTTCCAACGGGG 
ww129 arcA real-time GAGTTCCGCGCCATGTTACATTTCTG 
ww130 arcA real-time CGTGATGATCTTCAAAATGTTTACGAATTCGAC 
ww131 arcB real-time GCAGACAGCAGAGGAAGAATTTGCGTTG 
ww132 arcB real-time CACTTCGCTACTGACGGTTAAATCGCC 





ww134  oxyR real-time CGGTACGGACGCTACAATAGCACAATC 
ww127 ahpD real-time GAGGTCGCCGCCGCACTTGCTATG 
ww128 ahpD real-time GTCTTTTTGTGTATTGTAAGCTTCTAATGCGCGTAATG 




ww 152 Ferritin real-time GCATATGTTGCATTTCTTCACCTGCGTG 
ww88 fepA real-time GGAAAATTAATGATCATTGGGACATTAATACG 
ww89 fepA real-time CTGCATTACGATAAATACGTTTATCTAAAATATTATTCACACCC 
ww96 FecCD family permease real-time GGCGTTTAAATTTGCTTTCTTTAGAGGAAGAAG 
ww97 FecCD family permease real-time CAATAAGCCGACCCAACCGATAATGC 
ww111 ccmF real-time GGGTATCGGACCGCTGGTAAAGTGGCG 
ww112 ccmF real-time CGACATCATGGTGCCGAGTACGGCGC 
ww117 Fumarate Reductase real-time GGTGTTGCTTTACGGTGTGATTTGTTTGGG 
ww118 Fumarate Reductase real-time CGGTCATGTCAAATAATGTCACGGCGTGC 
ww119 Fumarate Hydratase real-time GGTGAAAATCGGTCGTACGCATTTAATGG 
ww120 Fumarate Hydratase real-time GCCGAGGGCTAATTGACGCAAATG 
ww121 Oxaloacetate Decarboxylase real-time CCATCGTGGCAACTTTGCAAGGCAC 
ww122 Oxaloacetate Decarboxylase real-time GCACTTGCGCCACCAAAATTCGGCTG 
ww125 Ammonia Aspartate Lyase real-time GGCGCACCCAATTGCAAGATGCGG 
ww126 Ammonia Aspartate Lyase real-time CGGTCGCACCTAAGTTCACTTCAAGC 
ww136 2133 reverse sequencing GAAATTGGGATAAAGTCTTTTACAATGAATGATGG 
ww137 2134 reverse sequencing GCAACGTCCTTCATTCCTTCTTTAGC 
ww 154 D11S_1352 mutant upstream fragment 5' GATTTATTTG GCGGCCGC CACCTACCCATTTATG  
ww 155 D11S_1352 mutant upstream fragment 3' GGCATCATCC CTCGAG AAGAATGGCAAG 
ww 156 D11S_1352 mutant downstream  fragment 5' GCTAATCTGAAATACAGTTTCTAA CTCGAG TGAATGATATAAGAAAG 
ww 157 D11S_1352 mutant downstream fragment 3' GCGCGCTGTTTT CTGCAG TTACCTGCCTAG 
ww 158 D11S_1352 deletion confirmation  CCGTTTACCTTGGGCAGTACCGGCC 





ww175 TonB dependent receptor complement 5' CAAGGACGTACCATGGGATCCAAAAAACTC 





Microarray: A custom A. actinomycetemcomitans gene expression microarray (GE 8 X 15k per 
slide, 60-mer oligonucleotide probes) was printed by Agilent Technologies using oligonucleotide 
probes obtained from the OligoArray Database for A. actinomycetemcomitans D11S-1 at the 
University of Michigan 
(http://berry.engin.umich.edu/oligoarraydb/organismPage.php?ORG=Aggregatibacter%20actino
mycetemcomitans%20D11S-1).  This database comprises 5638 oligonucleotides representing 
2062 transcripts encoded by the A. actinomycetemcomitans D11S-1 genome.  Of the 2062 
transcripts, 1552 are represented by three independent oligonucleotide probes, 215 are 
represented by two probes and 221 by a single specific oligonucleotide.  Each oligonucleotide 
was printed twice on the array; thus the majority of genes are represented by six separate spots 
on the array and no transcript is represented by fewer than two spots.  Seventy two putative 
transcripts of A. actinomycetemcomitans D11S-1 are not represented in the oligonucleotide 
database; these mostly comprise hypothetical proteins (37) and transposases/integrases of 
mobile genetic elements (11).   
A. actinomycetemcomitans 652 was cultured in CDM or in CDM supplemented with 50 
uM Ne and 100 uM FeCl2 to mid-log phase (roughly 16 hours after inoculation) as described 
previously.  Labeling of RNA, microarray hybridization, array scanning and data analysis was 
carried out by the MicroArray Core Facility at the University of Louisville.  Briefly, RNA was 
isolated using the Lipid Tissue Minikit (Qiagen) following the protocols supplied by the 
manufacturer.  The quality of the isolated RNA was assessed using an Agilent 2100 Bioanalyzer 
(Agilent Technologies, Inc.).  RNA samples were considered to have little or no degradation if 
they exhibited an RNA integrity number (RIN) greater than 9 [89]. Total RNA (100ng) was labeled 
with Cyanine 3-CTP using the Low Input Quick Amplification WT Labeling Kit for one color 
(Agilent Technologies).  This kit uses random nucleotide-based T7 promoter primers to first 
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synthesize cDNA which is then reacted with T7 RNA polymerase in the presence of NTPs and 
Cyanine 3-CTP to generate labeled cRNA.  The labeled cRNA was purified using the RNeasy Mini 
Elute kit (Qiagen) and total yield and Cy3 incorporation efficiency was determined using a 
NanoDrop Technologies spectrophotometer. 
Array hybridizations were carried out using the Agilent Gene Expression Hybridization kit 
as described by the manufacturer.  Briefly, 600ng of each labeled cRNA sample was incubated at 
600C for 30 min and then hybridized to the custom A. actinomycetemcomitans gene expression 
array at 650C for 17 hours.  After hybridization, the microarray slides were washed with Agilent 
gene expression wash buffer 1 at 370C for 5 minutes followed by wash buffer 2 at 370C for 1 
minute.  After hybridization and washing, the slides were scanned using an Agilent microarray 
scanner (Model G2505C) set for one-color using the green channel and 5 µm resolution. The 
one-color microarray images (.tif) were extracted with the aid of Feature Extraction software (v 
9.5.1, Agilent Technologies).  The raw data files (.txt) were imported into GeneSpring (GX 11.1) 
and the data were transformed to bring any negative or value <0.01 to 0.01.  Normalization was 
then performed using a per-chip 75 percentile method that normalizes each chip on its 75 
percentile to facilitate comparison among chips.  A per-gene on median normalization was then 
performed to normalize the expression of every gene on its median among samples.  An 
expression threshold of ≥2-fold was applied and the differentially expressed genes were 
evaluated using a pair-wise t-test and genes with p-values <0.05 were considered to be 
significantly up- or down-regulated. 
cDNA synthesis & qRT-PCR: cDNA synthesis was carried out using the cDNA Synthesis Kit 
(Quanta) as per manufacturer's instructions. qRT-PCR was then carried out with the Applied 
Bioscience using 50ng of cDNA, 250nM specific primer (Table 3) and PerfeCTa SYBR Green 
Fastmix Low Rox (Quanta). The protocol was as follows: 95oC for 3 minutes for 1 cycle, 95oC for 
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15 seconds and 60oC for 30 seconds for 45 cycles, with extension and annealing occurring at 
60oC. The threshold cycle for each qRT-PCR was determined from a second derivative plot of 
total fluorescence as a function of cycle number by using the software package supplied with 
the. All gene-specific threshold values were normalized against the values measured from 
primers specific to the 5S rRNA. qRT-PCR was carried out in triplicate with two independent 
measurements. 
 cDNA RACE: The Rapid Amplification of cDNA Ends (RACE) allows for the amplification of 
messenger RNA and its subsequent sequencing. Primers were designed to specifically amplify 
the 5' end of cDNA for identification of the promoter region of the TA system, D11S_2133-2134. 
The GeneRacer kit (Invitrogen) was used as per manufacturer's instructions. Briefly, RNA from 
the ΔqseB mutant was harvested as previously described and the 5' phosphate of truncated 
mRNA's or non-mRNA's was removed using calf intestinal phosphatase (CIP). The mRNA's were 
then treated with tobacco acid pyrophosphatase to remove the 5' cap. An RNA oligo of known 
sequence was then ligated on to the 5' end of the mRNA's and the mRNA is reverse transcribed. 
Primers specific for the ligated cDNA oligo and the gene of interest are then used to amplify a 
specific product. The resulting product is then gel purified and cloned into the pCR4-TOPO vector 
and transformed into Top10 competent cells. Transformed cells were then plated on LB agar 
plates supplemented with ampicillin (50ug/mL). Ten colonies were chosen and plasmid was 
purified using the Qiagen Plasmid Miniprep kit. The plasmids were digested with EcoRI to 
confirm insertion and also sequenced to determine the promoter region of the genes of interest. 
Biofilms: A. actinomycetemcomitans was grown on saliva-coated coverglass in a polycarbonate 
flow chamber (model FC81; Biosurface Technologies Corp., Bozeman, MT). Chamber dimensions 
are 50.5 mm by 12.7 mm by 2.54 mm) at 25°C. Saliva was harvested, diluted 1:2 with ddH2O, and 
filter sterilized. 50uL was then incubated for 30 min at 37oC on a coverglass (60 mm by 24 mm). 
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The saliva-coated coverglass was then washed with 1X phosphate-buffered saline (PBS) for 10 
min at a flow rate of 5.8mL per hr using a multichannel peristaltic pump (ManoStat Sarah 
cassette; Fisher Scientific Co.). The flow cells were inoculated with a 40mL culture of A. 
actinomycetemcomitans (O.D.600nm 0.5-0.6) then allowed to incubate for one hour. Biofilms were 
fed with fresh media for 62 hours and then stained with 40mL of 0.2 mg/ml fluorescein 
isothiocyanate (FITC) in the dark and then washed with 1X PBS for 2 hours. Biofilms were 
visualized by using a Leica TCS SP8. Confocal images were captured from 5 randomly chosen 
frames from each flow chamber with each biofilm done in triplicate independently. Biofilm 
depth was determined by performing z-plane scans from 0 to 100 μm above the glass surface, 
and total biomass was determined by integrating fluorescence intensity across the z-stack using 
the Volocity software. 
Metabolomics: Each cell sample was mixed in a glass vial with 500 µL CH3CN, 375 µL H2O and 
250 µL CHCl3. The mixture was grounded with 2 beads at 30 Hz for 2 min, followed by 
centrifugation at 4 °C and 13,000 rpm for 20 min. The bottom layer (lipid layer) was dried in 
speedvac after removing the liquid layer. Each dried sample was re-dissolved in 100 µL solution 
of chloroform:methanol (2:1, v:v) containing 1 mM butylated hydroxytoluene (BHT). The mixture 
was then split into two aliquots. One aliquot was diluted 10-fold using a methanol solution 
containing 0.1% acetate, 1 mM BHT and 1 µg/mL reserpine. This diluted sample was then 
analyzed on FTIRC-MS in positive mode. The other aliquot was also diluted 10 times using a 
methanol solution containing 5 mM ammonium acetate, 1 mM BHT and 1 µg/mL reserpine. This 
sample was analyzed on FTICR-MS in negative mode. 
FTICR-MS experiment was performed on an FT-MS instrument (LTQ-FT; Thermo Electron 
Corporation, Bremen, Germany) equipped with a chip-based nanoelectrospray ionization (nESI) 
ion source (Triversa NanoMate) (Advion Biosciences, Ithaca, NY, USA). Each sample was 
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measured for 15 min and covered the m/z = 150-1,600 range. The mass spectra were recorded 
using Fourier Transform Ion Cyclotron Resonance (FTICR) in the profile mode, and the resolving 
power (RP) was set at 400,000 at m/z = 400. The maximum ion accumulation time was set at 
1,000 ms. The ion optics was tuned for a typical precursor ion mass (taurocholic, m/z 514) in 
MS/MS mode with a normalized collision energy of 34 using the linear ion trap (LIT). The two 
most important nESI parameters were as follows: the spray voltage = -1.6 kV and the nitrogen 
gas pressure = 0.7 psi. 
The FTICR-MS data was processed with a software package MetSign. For the metabolite 
quantification, the instrument data was first reduced into a peak list using second-order 
polynomial fitting (SPF) and Gaussian mixture model (GMM). For metabolite identification, each 
peak detected in the FTICR-MS data was first assigned to metabolite(s) recorded in LIPID MAPS, 
by matching the experimentally measured metabolite ion m/z value and the profile of the 
isotopic peaks with the corresponding theoretical data calculated from the chemical formula of 
database metabolites. The threshold for m/z variation was set as ≤ 3 ppm. After cross sample 
alignment, contrast normalization was performed to make the abundance of metabolites in all 
samples comparable. Pairwise two-tail t-test with up to 1,000 sample permutation was used to 
recognize metabolites with significant abundance difference between sample groups by setting 
p-value ≤ 0.05. 
Catalase Assay: Catalase activity was measured using the Catalase Assay Kit (Cayman Chemical, 
707002). Briefly, A. actinomycetemcomitans was cultured in 35mLs of CDM with or without Ne, 
ferrous iron, or both for 24 hours. Cells were pelleted at 4,000g for 10 minutes at 4°C. Pelleted 
cells were homogenized by sonication in 800 ml of 1X Sample Buffer and then centrifuged at 
16,000xg for 5 min at 4°C. A standard curve was constructed using the Catalase Formaldehyde 
Standard provided with the kit for different concentrations (0, 5, 15, 30, 45, 60, 75 mM) diluted 
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in 1X Sample Buffer. Assays were performed in a 96 well plate and the catalase positive control, 
standards, and samples were done in triplicates. Each well contained 1X Assay Buffer, methanol, 
and one of the following: catalase positive control, standard or sample of interest. The catalase 
reaction was initiated by the addition of 0.035 M hydrogen peroxide, followed by incubation and 
shaking at room temperature for 20 minutes. The reaction was terminated by the addition of 10 
M Potassium Hydroxide and Catalase Purpald. Covered plates were incubated with shaking at 
room temperature for 10 minutes. Finally, Catalase Potassium Periodate was added, and the 
covered plates were incubated shaking at room temperature for 5 minutes. Absorbance was 
read at 570 nm. 
Protein Gels: At 8 hours post-inoculation, 1mL aliquots of A. actinomycetemcomitans cultures 
were used to measure the O.D.600nm. 30mL cultures were diluted to similar densities and then 
pelleted by centrifugation. The cell pellet was re-suspended in 1mL of phosphate buffer (0.5M 
KH2PO4) pH 8 and homogenized by sonication. The cell lysate was centrifuged at 4oC for 5 
minutes at 13,000xg to separate the soluble and non-soluble fractions. The soluble fraction was 
removed to a clean tube and the non-soluble fraction was re-suspended in 1mL of phosphate 
buffer containing 8M urea. Protein concentration of cell extracts was determined using a BCA 
assay. 1X of LDS 5X Sample Buffer (141mM Trizma base, 2% lithium dodecyl sulfate, 10% 
glycerol, 0.51mM EDTA, 0.22M Serva Blue G, 0.175mM Phenol Red, pH 8.5) (LifeTechnologies) 
was added to roughly 1ug of protein and then loaded on a NuPAGE Novex 4-12% Bis-Tris Protein 
gel (LifeTechnologies). The gel was run for 50 minutes at 200V. The gel was stained for one hour 
with shaking with AquaStain (Bulldog Bio) and then washed with water and visualized. 
Construction of TonB Dependent Receptor Mutant: A. actinomycetemcomitans 652 deletion 
mutants (Table 1) used in this study were constructed by allelic replacement of the target gene 
by double homologous recombination using a suicide vector pJT1 [90]. Briefly, the flanking 
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regions of a fragment of the TonB dependent receptor were amplified by PCR using A. 
actinomycetemcomitans chromosomal DNA as a template with two primer sets: ww154/155 & 
ww156/157. Each primer was flanked with a restriction site as stated above (Table 1). The 1.8kb 
and the 393 base pair PCR products were digested with NotI−XhoI and XhoI−PstI respectively, 
and both PCR fragments were cloned adjacent to each other (joined by the XhoI restriction site) 
into NotI−PstI-digested pJT1 suicide vector to create pWAW23. The recombinant suicide plasmid 
was introduced into A. actinomycetemcomitans by electroporation. The cells were incubated for 
5 h at 37 °C and plated onto BHI agar containing 50 µg spectinomycin (Sp) ml−1 to select for cells 
with single recombinant crossover events. Sp-resistant (Spr) colonies were selected and grown 
statically in BHI broth for 24 hr at 37 °C. On the next day, each culture was diluted 1: 200 in 
tryptone–yeast-extract (TYE) broth and grown for 24 h at 37 °C. This step was repeated for 3 
consecutive days, except that the cultures on day 3 were grown in the presence of 1 mM IPTG. 
Afterwards, to select bacteria with a second recombination event resulting in the deletion of the 
target gene, cells were diluted 10-fold and spread onto TYE agar supplemented with 1 mM IPTG 
and 10 % sucrose and grown for 24 h at 37 °C. Sucrose-resistant (Sucr) colonies were selected 
and replica plated onto TYE agar supplemented with sucrose and onto BHI agar supplemented 
with spectinomycin. Spectinomycin-sensitive (SpS) colonies were selected to perform PCR to 
confirm the deletion of the target gene. SpS colonies that were PCR-positive for the appropriate 
gene deletion were chosen for further analysis. Primer sets used to verify by PCR amplification 
the expected fragment and nucleotide sequence for each isogenic mutant were: ww158 & 
ww159. 
Construction of TonB Dependent Receptor Complemented Strains: 
For construction of the TonB dependent receptor, complement primers amplifying the entire 
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TonB dependent receptor were PCR-amplified from A. actinomycetemcomitans chromosomal 
DNA using the primer set: ww175 & ww176. The resulting 2.1kb base pair PCR product was 
digested with BamHI-XbaI and cloned with BamHI-Xbal digested pWAW17 resulting in pWAW31.  
Statistics: 
All experiments were conducted in triplicates for at least three independent experiments. Data 
was analyzed by either two-tailed t-test or ANOVA using the InStat program (Graphpad). 





















CHAPTER THREE: A. ACTINOMYCETEMCOMITANS QSEBC IS ACTIVATED BY CATECHOLAMINES 
STRESS HORMONES AND IRON 
Introduction: 
Bacteria have evolved a specialized signaling transduction mechanism called the two-
component regulatory system (TCS) as a way to quickly sense changes to the environment and 
adapt by changing gene transcription. QseBC is a TCS that is conserved in the Enterobacteriaceae 
and the Pasteurellaceae [126].  The A. actinomycetemcomitans QseC sensor kinase contains a 
highly conserved acidic motif (EYRDD) [69] and a similar motif (DYRED) in the H. influenzae QseC 
homolog (FirS) was shown to be essential for the response to ferrous iron [62]. A. 
actinomycetemcomitans QseBC shares 70% sequence similarity to the E.coli QseBC, but differs in 
the organization of the operon. In many of the Enterobacteriaceae and Pasteurellaceae, the 
qseBC locus is associated with a gene, designated ygiW, that encodes a putative periplasmic 
protein in the OB fold family [91], but transcription and genetic organization of ygiW relative to 
the qseBC operon varies. In many of the Pasteurellaceae, including A. actinomycetemcomitans, 
ygiW is co-transcribed with qseBC but there exists an attenuator region between them [53, 62].  
ygiW also resides upstream of qseBC in many of the available Enterobacteriaceae sequences but 
in these organisms, it is transcribed from the opposite strand. 
The signal that activates the QseC in A. actinomycetemcomitans has not yet been 
determined, but it has been shown that QseC regulates virulence and biofilm formation [44, 53]. 
The expression of qseBC is also regulated by AI-2, but the sensor is not directly activated by AI-2 
[44]. qseBC is also part of the AI-2 regulon in E.coli, but quorum sensing-mediated regulation 
requires the toxin MqsR of the MqsAR TA system [71]. 
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In this chapter we show that QseBC is activated by the combination of both 
catecholamines and iron (CAT-Fe).  In addition, adrenergic receptor antagonists that functioned 
to block catecholamine mediated growth responses and QseC activation in E. coli are inactive 
against QseC in A. actinomycetemcomitans and at higher concentrations may function as QseC 
agonists.  These results suggest that there may be significant differences in the structure of the 
A. actinomycetemcomitans QseC compared to either eukaryotic adrenergic receptors or the 
QseC in E. coli. 
Results: 
QseC is Not Activated by Catecholamines, Iron, Zinc, or Cold Temperatures 
 In order to determine the activating signal for QseBC, a lacZ reporter plasmid was 
constructed to take advantage of the fact that QseB auto-regulates the operon. The reporter 
plasmid, pDJR29, was created by fusing the promoter region for ygiW-qseBC to the lacZ gene. 
The strain was then tested in a chemically defined media (CDM) with a variety of conditions that 
were reported to activate the QseBC in other bacterial species.   Increasing concentrations of 
the catecholamine norepinephrine (0-300µM) (Figure 1A), ZnCl2 (Figure 1B), as well as 
temperatures down to 4oC (Figure 1C) failed to significantly stimulate QseC compared to the 
control condition of A. actinomycetemcomitans grown in CDM at 37oC. Supplementation of 
100µM of ferrous or ferric iron failed to significantly stimulate the operon (Figure 2A). In 
addition, previous attempts to isolate AI-3 from A. actinomycetemcomitans failed suggesting 
that the bacteria does not make that particular quorum sensing molecule [69]. 
QseC is Activated by a Combination of Iron and Catecholamines 
 The combination of both ferrous and ferric iron and different catecholamines (i.e. 
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norepineprhine or epinephrine) were then tested for the ability to stimulate the QseBC operon 
since the individual components failed to do so (Figure 2A).  Chemically Defined Media (CDM) 
supplemented with either 100 uM ferrous or ferric chloride, 50 uM of norepinephrine (Ne) or 
epinephrine (Ep), or a combination of both (CAT-Fe). Supplementation with either single 
component, iron or catecholamines, resulted in no significant induction of the operon as shown 
previously (Figure 2A). 
 In contrast, the combination of CAT-Fe resulted in a robust, significant induction of 
operon expression suggesting that both signals are required in activating QseBC in A. 
actinomycetemcomitans (Figure 2A). The activation of QseC occurred with either 
norepinephrine or epinephrine and with either ferrous or ferric iron, in contrast to the qseBC 
homolog in H. influenza which responds only to ferrous iron. 
 To determine if CAT-Fe activation of the QseC sensor was autoinduced and dependent 
on a functional QseBC, pJDR29 was transformed into non-polar gene deletion mutants of A. 
actinomycetemcomitans that lacked ygiW, qseC or qseB (ΔygiW, ΔqseC and ΔqseB, respectively), 
or into a strain in which qseC was replaced by a copy of the qseC gene that did not encode the 
periplasmic region of the sensor kinase (qseCΔp).  As shown in Figure 2B, lacZ expression in CDM 
alone was reduced by approximately 4-fold in the ΔygiW, ΔqseC and ΔqseB strains and no 
induction of lacZ expression occurred in the presence of Ep/FeCl2.  These results are consistent 
with our previous finding that ygiW-qseBC is auto-regulated by QseC-mediated activation of 
QseB [53].  Importantly, no Ep/FeCl2-dependent induction of lacZ occurred in A. 
actinomycetemcomitans that expressed a QseC protein that lacked the periplasmic domain 
(Figure 2B).  These results suggest that Ep and Fe+2 function as signals that activate the QseC 
sensor and require its periplasmic domain. 
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 To confirm that Ep/FeCl2-dependent induction of lacZ was mediated by QseB, a family of 
reporter plasmids containing a nested series of ygiW-qseBC promoter deletions were tested 
(Figure 3A).  These constructs were previously described and were used to map the -10, -35 and 
QseB binding sites in the ygiW-qseBC promoter [53].  As shown in Figure 3B, ygiW-qseBC 
promoter activity was reduced by approximately 35% when nucleotides -94 to -138 were 
deleted (compare pDJR63, pDJR57 and pDJR56).  However, Ep/FeCl2-dependent induction of 
lacZ expression still occurred in each of these constructs.  Ep/FeCl2-dependent induction of lacZ 
was significantly reduced only after deletion (pDJR58) or site specific mutation (pDJR86) of the 
QseB binding site (Figure 3B.  This indicates that the interaction of QseB with its binding site is 
essential for Ep/FeCl2-dependent induction of the operon and is consistent with a model where 
catecholamines and iron represent signals that are recognized by and activate QseC, which in 
turn activates the QseB response regulator. 
The periplasmic region of A. actinomycetemcomitans QseC contains a sequence (EYRDD, 
residues 154-157) that resembles the DYRED motif previously shown to be important for the 
sensing of iron by the QseC paralogs of H. influenzae [62]. To determine if this motif in A. 
actinomycetemcomitans is important for Ep/FeCl2-dependent activation of QseC, EYRDD was 
altered to EAADD by site-directed mutagenesis and the mutant (encoding QseCY155A, R156A) or wild 
type qseC alleles together with qseB were integrated by homologous recombination into the 
chromosome of A. actinomycetemcomitans ΔqseBC to generate strains ΔqseBC::61 and 
ΔqseBC::46, respectively.  As shown in Figure 4, lacZ expression from pDJR29 in ΔqseBC::61 was 
not significantly induced when cells were cultured in CDM supplemented with Ep and FeCl2.  In 
contrast, ΔqseBC::46 exhibited a ~5-fold increase in lacZ activity, similar to the wild type (Figure 
4).  However, lacZ expression in ΔqseBC::61 was approximately 90-fold higher than in the wild 
type strain even when cultured in CDM alone (Figure 4).  These results suggest that QseCY155A, 
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R156A cannot sense Ep/FeCl2 but may be locked in an activated conformation that results in 
constitutive activation of QseB and high expression of the ygiW-qseBC operon. 
Adrenergic Receptor Antagonists Fail to Block CAT-Fe Activation of QseC  
 QseC has been shown to play an essential role in both virulence and biofilm formation. 
Therefore, it can be considered a target for any potential therapeutics as a way to modulate the 
course of infection. Based on the ability of QseC to sense catecholamines in E. coli, it was 
suggested that the sensor acts as a bacterial adrenergic receptor, the eukaryotic receptors that 
recognize and respond to catecholamines [55, 102]. Adrenergic receptor antagonists function to 
block the recognition of catecholamines by adrenergic receptors in eukaryotes. In E. coli, these 
same drugs have been shown to block catecholamine mediated stimulation of growth [80]. 
Therefore, both the alpha adrenergic receptor antagonist, phentolamine, and the beta 
adrenergic receptor antagonist, propranolol, were tested to determine if they could block CAT-
Fe activation of QseC.  
Both the alpha-blocker phentolamine and the beta blocker propranolol were tested 
from 0 µM to 400 µM to determine if they were able to block ygiW- qseBC activation and also 
induction of the operon in response to CAT-Fe. At concentrations below 400 µM, both 
adrenergic receptor antagonists were unable to block CAT-Fe mediated activation of QseC 
(Figure 5A & B). Interestingly, both receptor antagonists alone were able to activate qseBC at 
400 µM (Figure 5 C) suggesting that at higher concentrations both drugs might act as QseC 
agonists. Activation by propranolol or phentolamine was dependent on the QseC periplasmic 
domain since a mutant lacking the periplasmic domain had no significant induction of the 




The QseBC TCS has been shown previously to play a vital role in pathogenesis of 
periodontitis by regulating both biofilm formation and virulence , but little was known about 
how it controls these two complex phenotypes or the genes that are regulated by this TCS. In E. 
coli and S. enterica, catecholamines and a quorum sensing molecule designated AI-3 have been 
shown to activate Qse [61]. Previous work has shown no evidence for the production of AI-3 in 
A. actinomycetemcomitans, nor is QseC activated by reduced temperatures or zinc. Instead, our 
results show that a combination of iron, either ferrous or ferric, and catecholamines, e.g. 
epinephrine or norepinephrine, results in significant induction of the operon and the response 
to CAT-Fe is dependent on having a functional periplasmic sensory domain. Thus, the response 
of the A. actinomycetemcomitans QseC differs from H. influenzae in that it occurs with either 
ferrous or ferric iron and from its E. coli counterpart since activation of A. 
actinomycetemcomitans QseBC requires both catecholamines and iron. Ferric iron does cause 
an activation of qseBC in E. coli, but not directly [60]. The iron activates the PmrB sensor which 
in turn activates the PmrA response regulator which in turn binds to the qseBC promoter and 
induces qseBC expression [60].  Interestingly, the QseB binding site of the ygiW-qseBC promoter 
region in A. actinomycetemcomitans is identical to the consensus PmrA binding sequence of E. 
coli suggesting that in A. actinomycetemcomitans these two TCS might have integrated into one 
that responds to both catecholamines and iron. 
 It remains unclear as to how CAT-Fe is binding QseC: whether both the catecholamine 
and iron bind as a complex or if there are separate binding sites for both catecholamine and iron 
and activation of QseC only occurs when both sites are occupied. When comparing the amino 
acid sequence between eukaryotic adrenergic receptors and QseC there is no striking structural 
similarity that would allow for identification of the catecholamine binding pocket. The 
differences between eukaryotic adrenergic receptors and QseC is also evident from the data 
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that in A. actinomycetemcomitans, drugs that are used as adrenergic receptor antagonists in 
eukaryotes do not antagonize Cat-Fe binding and may even function as QseC agonists at higher 
concentrations. In addition the inhibition of growth in the presence of high concentrations of 
adrenergic receptor antagonists has not been previously observed in E.coli or Salmonella.  This 
result suggests that these drugs might be toxic to A. actinomycetemcomitans at high 
concentration. Although it has been previously reported that some beta adrenergic receptor 
antagonists can act simultaneously as agonists and antagonists at high concentration, this has 
never been observed for propranolol or any of the alpha blockers [127].  
Based on the results from the β-galactosidase assay, YgiW may play a role in QseC 
activation by CAT-Fe since the ΔygiW mutant did not show significant induction of the operon in 
the presence of Ne/FeCl2. It is possible that YgiW may play a role in delivering catecholamines, 
iron, or both to QseC since it is a putative periplasmic solute binding protein. One other possible 
explanation for the failure of Ne/FeCl2 to induce qseBC expression is that the overall level of 
transcription of the operon may be blocked in the ΔygiW strain. This might occur since a 
transcriptional attenuator exists between ygiW and qseB and transcription of qseBC could be 
significantly reduced due to the proximity of the transcriptional attenuator to the qseB start 
codon in the ΔygiW strain.  Therefore, further experiments are needed to determine if YgiW can 




Figure 1: Expression of the ygiW-qseBC operon in A. actinomycetemcomitans cultures exposed to increasing various 
stimuli. β-galactosidase activity was determined after 24 hours of growth.  Significant differences (p < 0.05) are indicated 
by asterisks and calculated from two independent triplicate experiments by ANOVA.  A. A. actinomycetemcomitans 652 
harboring the ygiW-qseBC promoter-lacZ reporter plasmid pDJR29 was grown in CDM broth and compared to those 
grown in CDM supplemented with increasing concentrations of catecholamine (norepinephrine Ne).  B. A. 
actinomycetemcomitans harboring pDJ29 grown in CDM broth and compared to a culture grown in CDM supplemented 
with 15µM ZnCl2. C. A. actinomycetemcomitans harboring pDJ29 grown in CDM broth at 37oC then shocked for 15 




Figure 2: Expression of the ygiW-qseBC operon in A. actinomycetemcomitans cultures exposed to increasing 
various stimuli. β-galactosidase activity was determined after 24 hours of growth.  Significant differences (p < 0.05) 
are indicated by asterisks and calculated from two independent triplicate experiments by ANOVA.  A.Expression of 
the ygiW-qseBC operon in A. actinomycetemcomitans cultures exposed to catecholamines and iron.  A. 
actinomycetemcomitans 652 harboring the ygiW-qseBC promoter-lacZ reporter plasmid pDJR29 was grown in CDM 
broth and compared to those grown in CDM supplemented with either ferrous or ferric chloride (Fe2+ or Fe3+; 
100uM), epinephrine (Ep; 50uM), norepinephrine (Ne; 50uM, or a combination of both catecholamine (50uM) and 
iron (100uM). B.1 Expression of ygiW-qseBC in either the Wt strain, ΔqseC, a strain lacking the periplasmic domain of 
QseC (qseCΔp), ΔygiW, or ΔqseB grown in CDM broth or CDM supplemented with Ep/FeCl2 
 
                                                 
1 Experiments performed in Figure 2B for the ΔqseC, ΔqseB, and qseCΔp mutant were performed by Drs. 




Figure 32: CAT-Fe-dependent induction of ygiW-qseBC requires a functional QseB binding site.  (A) Schematic diagram 
of the ygiW-qseBC promoter region and transcriptional fusion constructs pDJR29, pDJR55, pDJR56, pDJR57, pDJR63, 
pDJR58, pDJR85 and pDJR86 [53, 101]showing the binding regions for QseB (white boxes), the -10 and -35 promoter 
elements (black boxes) and the primary transcriptional start site (bent arrow).  Site specific mutations in the QseB 
binding site are indicated with the  symbol. The numbering of the nucleotides is relative to the ygiW translational 
start codon.  (B) β-galactosidase activity in A. actinomycetemcomitans 652 transformed individually with each 
reporter plasmid.  Cultures were grown in CDM or CDM supplemented with Ep (50µM) and FeCl2 (100µM) and β-
galactosidase activity was determined after 24 h of growth.  Values are means of results from three independent 
experiments ± standard deviations. Statistical analysis was performed by using one-way analysis of variance (ANOVA) 
followed by Tukey’s multiple-comparison test.  Significant differences (p < 0.05) are indicated by asterisks; n.s., not 
significant. 
                                                 







Figure 43: The CAT-Fe induction of ygiW-qseBC is dependent on a putative conserved iron responsive motif, EYRDD. 
Point mutations were constructed in the EYRDD motif resulting in QseC Y155A, R156A, which was designated as 
ΔqseBC::46. The complemented strain with a fully functional EYRDD motif was designated ΔqseBC::61. Each strain 
was tested for QseC activation through the use of the pDJR29 reporter plasmid in a β-galactosidase assay and 
compared to that same strain grown in CDM without any supplementation.(n.s. not significant) 
                                                 





Figure 5: QseC is activated by adrenergic receptor antagonists. A & B. lacZ activity of a strain of A. 
actinomycetemcomitans harboring the pDJR29 reporter plasmid cultured in CDM supplemented with ferrous iron or 
Ne/Fe2+ with 50µM of propranolol (A) or 200µM (B). C. Increasing concentrations of the beta adrenergic receptor 
antagonist propranolol (0-400µM) was added to A. actinomycetemcomtians harboring the reporter plasmid pDJR29 
and grown in CDM. D. Wt A. actinomycetemcomtians or a strain lacking the periplasmic domain of QseC (qseCΔp) 
cultured in CDM with 400µM of phentolamine or propranolol. All experiments were done in triplicate with two 








CHAPTER FOUR: QSEBC IS A GLOBAL REGULATOR OF A. ACTINOMYCETEMCOMITANS 
METABOLISM, OXIDATIVE STRESS RESPONSE, AND IRON ACQUISITION 
Introduction: 
QseC has been previously shown to be essential for biofilm formation since a mutant 
lacking a functional QseC had significant reduction of biofilm formation in A. 
actinomycetemcomtians [44, 53]. This same strain was also significantly attenuated in a mouse 
model of periodontitis [44].  In addition, QseC has also been suggested to act as a global 
regulator of metabolism in E. coli [50]. Together this suggests that QseC plays a vital role in 
several essential pathogenesis mechanisms.  
In the previous chapter, we showed that the QseC responds to the combination of 
catecholamines and iron, suggesting that it acts as a bacterial adrenergic receptor. The field of 
microbial endocrinology has evolved in order to characterize the functional outcomes of 
catecholamine and other hormone exposure on microbes [57]. The downstream outcomes of 
CAT-Fe exposure on A. actinomycetemcomitans was unknown. Although the regulon that is 
under the control of QseBC that is differentially regulated in the presence of catecholamines in 
E. coli is known, many of these genes do not exist in A. actinomycetemcomitans. For example, 
catecholamines have been shown to result in an up-regulation of motility associated genes, but 
A. actinomycetemcomitans is non-motile [119]. This suggests that the regulons for E. coli and A. 
actinomycetemcomitans evolved in a species specific manner. 
Catecholamines are also thought to be used as a vector for the acquisition of an 
essential nutrient, iron [57].  Free iron is normally limited in the body, therefore bacteria have 
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evolved a wide range of mechanism to acquire it. The use of siderophores, such as enterobactin, 
vibriobactin, and yersiniabactin, is often a common tactic employed by bacteria to acquire iron. 
Siderophores work by sequestering iron at a higher affinity than host iron-binding proteins. The 
siderophores are then recognized by the bacteria and taken up via specific receptors and 
transport machinery. The ligands siderophores use to capture iron can vary, such as hydroxamate 
in ferrichrome or catecholates in enterobactin, which uses the same mechanism by which 
catecholamines can scavenge iron [57]. A variety of iron acquisition and regulatory mechanisms 
have been associated with virulence as well as biofilm and growth stimulation [128]. 
A. actinomycetemcomitans employs a wide-variety of mechanism by which to acquire 
iron. It can directly bind heme, and hemoglobin and lactoferrin [97-100], but so far no evidence 
has been found to suggest that it can synthesize any kind of siderophore.  However, 
A.actinomycetemcomitans encodes a putative enterobactin transporter and receptor 
(D11S_1352-1357). One possible function of this operon in A. actinomycetemcomitans is that it 
imports enterobactin made by other oral pathogens, but it is also possible that it might function 
in catecholamine mediated iron acquisition. The catecholamine mediated growth induction seen 
in E. coli was dependent on a functional enterobactin biosynthesis and transport system, 
suggesting that it plays a vital role in the acquisition of catecholamines [58]. Taken together this 
evidence could explain the role of stress in the development of periodontitis since stress is 
associated with the development and exacerbation of periodontitis. 
In this chapter, we characterize the QseBC regulon and show that exposure to CAT-Fe 
results in an up-regulation of genes encoding proteins involved in anaerobic respiration and 
metabolism. In addition, exposure to CAT-Fe up-regulates genes involved in the oxidative stress 
while down-regulating genes involved in iron acquisition, fatty acid, lipid and LPS biosynthesis.  
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Finally, we also show that QseBC stimulates biofilm formation and planktonic growth, which is 
contingent on having a functional QseC periplasmic domain and a functional TonB dependent 
receptor.   
Results: 
CAT-Fe exposure Induces Genes Involved in Anaerobic Respiration and Metabolism and 
Increases the Flux through the TCA Cycle 
To characterize the QseBC regulon, a custom microarray was designed using 
oligonucleotide probes from the OligoArray Database for A. actinomycetemcomitans D11S at the 
University of Michigan. cDNA from Wt cultures grown in either CDM or CDM supplemented with 
Ne/FeCl2 was hybridized to the array. There were 235 genes (roughly 11.5% of the A. 
actinomycetemcomitans genome) that were differentially regulated by 2-fold or greater when 
exposed to Ne/FeCl2 compared to cells grown in just CDM (Appendix Table 1). Of these 235 
genes, 135 genes were down-regulated and 99 genes were up-regulated and for many of these 
genes, the array results were confirmed by qRT-PCR (Appendix Table 1). In confirmation with the 
previous β-galactosidase assays, one of the most highly up-regulated operons with 
norepinephrine and iron treatment was ygiW-qseBC, and this was also confirmed with qRT-PCR. 
Interestingly, there was no significant change in expression of many of the well-characterized 
virulence factors:   tad fimbriae and the collagen adhesin, EmaA. Other virulence determinants 
such as the cytolethal distending toxin was down-regulated around 1.5 fold and the biofilm 
lipoprotein pgaB and the leukotoxin (ltxA and ltxC) were down-regulated around 2.1 fold. 
Leukotoxin expression was also confirmed on a SDS-PAGE gel where the band correlating to the 
leukotoxin (116kDa) was reduced in CAT-Fe exposed cells (Figure 6).  
Of the 99 genes up-regulated with Ne/FeCl2 treatment, 56 of those genes encoded 
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proteins associated with anaerobic respiration and metabolism (Table 4). The differentially 
regulated genes included genes encoding proteins for a hydrogenase complex, metabolism of 
aspartate, fumarate, malate, oxaloacetate, pyruvate and formate, and reduction of nitrate, 
DMSO, trimethylamine-N-oxide, fumarate and formate. Six differentially expressed operons 
encoded components associated with anaerobic electron transport, e.g., the nap operon 
(D11S_0205–0210), an operon involved in the biogenesis of c-type cytochromes (D11S_2000–
1990), the hydrogenase-4 complex and hydN (D11S_1735–1747 and D11S_1092-1093) involved 
in electron transport from formate to hydrogen and the oxidation of hydrogen, D11S_1412-1413 
involved in trimethylamine N-oxide anaerobic respiration, and D11S_0493-0494 encoding a 
dimethylsulfoxide terminal reductase.  
 At least four additional induced operons and several other singlet genes encode 
proteins that may also be associated with anaerobic metabolism.  D11S_0303 and D11S_1771 
each encode a C4 dicarboxylate transporter involved in the utilization of aspartate and fumarate.  
Consistent with this, D11S_0597 encodes aspartate ammonia lyase which converts aspartate to 
fumarate, D11S_0810–0812 encodes a fumarate reductase, and D11S_1061 encodes fumarate 
hydratase.  Other up-regulated operons code for oxaloacetate decarboxylase (D11S_1379-1381) 
which converts oxaloacetate to pyruvate.  Other genes associated with anaerobic metabolism 
included D11S_1748-1749 and D11S_1986-1989 which encode formate dehydrogenase and 
catalyze the formate dependent reduction of nitrite to ammonia, respectively.  
Since several of the genes that were differentially regulated were involved in formate 
metabolism, an extracellular formate assay was performed using supernatants from cultures 
grown in CDM with or without Ne/FeCl2. Formate levels were significantly increased in 
supernatants from cultures supplemented with Ne/FeCl2 compared to CDM (Figure 7) confirming 
56 
 
predictions based on observations from the microarray. 
Since the microarray results and the formate assay suggested that significant changes to the 
metabolic profile of A. actinomycetemcomitans occur upon activation of QseBC, a metabolomics 
approach was used to confirm changes in metabolites suggested by the changes in gene 
expression and to further examine the overall global metabolic changes that occur in response 
to CAT-Fe. Water soluble and lipid soluble fractions were isolated from A. 
actinomycetemcomitans cultured in CDM with or without supplementation Ne/FeCl2 and were 
analyzed by mass spectroscopy as described in Materials and Methods (Chapter 2). The first 
group of metabolites that were significantly changed were metabolites involved in carbon 
metabolism. Data from the water soluble fraction (Table 5) were consistent with changes 
suggested by the microarray as there were significant increases in fumarate, malate, aspartate, 
and mannose. Combining the data from both the microarray and the metabolomics approaches 
suggest that there may be an increase in flux through glycolysis from the import of mannose and 
increase in Glucose-6-phosphate, as well as an increase in activity of the TCA cycle since many of 
the enzymes and intermediates of the TCA cycle are induced or increased  (Figure 8). However, 
succinate levels were decreased most likely due to efficient conversion to fumarate. These 
pathways converge into the formation of pyruvate which can then be channeled to energy 
forming pathways such as fermentation or anaerobic respiration via the electron transport chain 
(Figure 8).  
Treatment with Ne/FeCl2 also resulted in an increase of gluconic acid, 6-
phosphocgluconate, and glucose-6-phosphate compared to cells grown in CDM alone (Table 5). 
These metabolites are associated with the Entner–Doudoroff pathway that catabolizes glucose 
to pyruvate and suggest that Ne/FeCl2 treatment results in stimulation of part of this pathway. A. 
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actinomycetemcomitans does not have a complete Entner-Duodoroff pathway but does possess 
the genes of the pathway that result in the production of pyruvate and glyceraldehyde 3-
phosphate, which is eventually converted to pyruvate. This represents one of many pathways, 
including oxaloacetate decarboxylase that is up-regulated in A. actinomycetemcomitans and 
leads increased pyruvate levels.   
The metabolism of several amino acids was also significantly altered. The most striking is 
the increase in the levels of aspartate.  This amino acid can feed into the TCA cycle through its 
conversion to fumarate and the gene encoding the enzyme that carries out this reaction, 
aspartate ammonia lyase was also significantly induced.  In contrast, treatment with Ne/FeCl2 
resulted in a significant decrease of cysteine and tyrosine and consistent with this, the 
microarray data showed down-regulation of the tyrosine-specific transport protein (D11S_1053) 
and the cysteine synthase subunit alpha (D11S_1533).  
CAT-Fe Results in an Up-Regulation of the Oxidative Stress Response 
In addition to inducing genes involved in anaerobic metabolism, Ne/FeCl2 treatment also 
up-regulates genes involved in the oxidative stress response.  The up-regulated genes associated 
with oxidative stress included quinol peroxidase (5-fold; D11S_1676), alkylhydroperoxidase ahpD 
(4-fold; D11S_0383), catalase (1.4-fold; D11S_2121), and the oxidative stress response regulator 
arcA (1.8-fold; D11S_1888). In order to confirm changes in catalase activity, a catalase activity 
assay was performed with cell lysates from cultures grown in CDM alone or CDM supplemented 
with either Ne, FeCl2, or Ne/FeCl2.  As shown in Figure 9B, catalase activity was significantly 
increased in cells grown with Ne/FeCl2 supplementation compared to cells grown in CDM alone. 
 In order to determine if the changes in gene expression and catalase activity correlated 
with changes in the ability of the bacteria to respond to oxidative stress, an assay was performed 
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to measure growth of A. actinomycetemcomitans after exposure to H2O2 stress. Cells were 
cultured in CDM with or without supplementation with Ne, FeCl2, or Ne/FeCl2.  . At mid-log, the 
cultures were split into two aliquots.  One aliquot was then exposed to the H2O2 stress for 15 
minutes and the other served as a control.  Growth was then assessed 5 hours and 12 hours later 
(only 5 hours shown). Cells exposed to Ne/FeCl2 had a significant increase in survival after 
exposure to H2O2 compared to cells grown in CDM, norepinephrine or ferrous iron suggesting that 
CAT-Fe exposure results in a greater resistance to oxidative stress (Figure 9A). 
It has been reported previously that high iron levels can lead to the formation of hydroxyl 
radicals [115, 116] which may explain the up-regulation of genes involved in oxidative stress. In 
addition, the up-regulation of ferritin also suggests high intracellular iron levels. Therefore, we 
determined if the up-regulation in oxidative stress genes and catalase activity in Ne/FeCl2 treated 
cells could be explained by a significant increase in intracellular iron. An intracellular iron assay 
was performed with cell lysate from cells grown in CDM supplemented with either FeCl2 or 
Ne/FeCl2. Surprisingly, there was no significant differences in intracellular iron content for cells 
grown in CDM or cells grown in Ne/FeCl2 (Figure 9C), although only cells grown in CDM with 
Ne/FeCl2 showed significant up-regulation of oxidative stress genes, catalase activity, and had a 
significant reduction of inhibition of growth in the presence of H2O2 stress.  
CAT-Fe Results in a Down-Regulation of High Affinity Iron Acquisition Genes and Up-
Regulation of Ferritin 
 The genes that were down-regulated with Ne/FeCl2 exposure were more diverse 
in their putative functions.  However, twenty of the 135 down-regulated genes (~15%) encode 
proteins associated with high affinity iron transport (Table 6).  Within this group, four operons 
encode putative ABC-type iron transporters (e.g., D11S_0621-0622, D11S_815-818, D11S_1128-
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1131 and D11S_1557-1558).  Other down-regulated genes encode putative outer membrane 
iron receptors (D11S_1630 and D11S_1864) and consistent with this, the expression of tonB 
components (D11S_487-489) are also reduced by approximately 5-fold.  This suggests that CDM 
supplemented with Ne/FeCl2 may represent an iron replete environment and consistent with 
this, the iron storage protein ferritin was induced by over 10-fold in the array experiment.  
Together these results suggest that Ne/FeCl2 exposure increases intracellular iron storage 
capacity and decreases high affinity iron acquisition transporters. 
CAT-Fe Exposure Down-Regulates Fatty Acid, Lipid and LPS Biosynthesis and Dramatically 
Changes the Lipid Profile in A. actinomycetemcomitans. 
The most notable group of metabolites that were decreased in the water soluble group 
after treatment with Ne/FeCl2 were fatty acids including myristic acid, palmitelaidic acid, 
palmitic acid, nonanoic acid, and hydroxymyrisitc acid. Using a 2-fold cutoff in the microarray 
experiment, there was not a notable change in the transcription of genes encoding enzymes 
involved in fatty acid biosynthesis.  However, using a 1.5-fold cutoff showed a consistent down-
regulation of genes involved in fatty acid, lipid and LPS biosynthesis (see Table 7). Some notable 
examples include acyl coA thioesterase (D11S_0833) which converts palmityl-coA to palimitic 
acid, an operon involved in forming long chain fatty acids from acetyl coA (D11S_0525-0526), 
rfaL (D11S_0359), and a gene encoding a lipopolysaccharide heptosyltransferase rfaF 
(D11S_0203). In addition, several genes encoding various lipoproteins were down-regulated 
such as D11S_1952, the lipoprotein vacJ (D11S_0144), D11S_0631, and D11S_0745. There was 
also a significant up-regulation of 2.2-fold of D11S_2125, the gene encoding a putative long-
chain-fatty-acid--CoA ligase-like, which is involved in fatty acid degradation. 
Together these data suggest that there may be a substantial alteration of the plasma 
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membrane in response to CAT-Fe. Consistent with this, the lipid soluble data from the 
metabolomics approach identified numerous lipid species that were increased or decreased in 
response to CAT-Fe exposure (see Table 8).  While many of these metabolites could not be 
specifically identified by mass spectroscopy, the results suggest that for cells exposed to CAT-Fe, 
there may be a decrease of long-chained fatty acids (Table 8).  Treatment with Ne/FeCl2 also 
resulted in a significant up-regulation of an isoprenoid, which is a class of molecules that include 
the quinones and hydroquinones.  These molecules can function in electron transport which is 
consistent with the induction of electron transport systems observed in the microarray results.  
Discussion: 
Although the QseBC regulon and downstream functional outcomes of catecholamine 
exposure have begun to be characterized for E.coli and Salmonella spp., little was known about 
the response of A. actinomycetemcomitans. However, give that many of the QseBC-regulated 
genes of E. coli are not present in the A. actinomycetemcomitans genome, it is likely that the 
QseBC regulon differs significantly.  Indeed in E.coli, catecholamines induce a variety of virulence 
factors, but using a custom genomic microarray, we showed that under conditions in which 
QseBC is activated (i.e., CAT-Fe exposure) the expression of many of the well-characterized A. 
actinomycetemcomitans virulence factors, e.g., tad fimbriae, autotransporter epithelial cell 
adhesins, and EmaA were unchanged or decreased slightly (e.g., the leukotoxin, pgaB, and the 
cytolethal distending toxin).  Approximately 11% of the A. actinomycetemcomitans genome was 
differentially expressed upon exposure to CAT-Fe and 63% of these genes were organized into 
operons where at least one other gene in the operon was also differentially regulated.  
 The most striking result was the induction of associated with anaerobic respiration and 
metabolism, which suggests that a primary function of QseBC is to prime the cell for growth in 
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an anaerobic environment.  These results were further confirmed using a metabolomics 
approach and together, our results suggest that the activation of QseBC increases metabolism 
and energy production through glycolysis and the TCA cycle to generate pyruvate, which can 
subsequently feed into various fermentation pathways and/or anaerobic electron transport 
mechanisms. 
 Interestingly, many of the QseBC-regulated genes identified in this study were also 
shown to be induced using RNA-seq in an in vivo abscess model of A. actinomycetemcomitans 
virulence but not when A. actinomycetemcomitans was grown as an in vitro biofilm [52]. In that 
study, Jorth et al reported that 14% of the genome was differentially regulated by 2-fold or 
greater when A. actinomycetemcomitans grown in vivo, and many of the differentially regulated 
genes encoded proteins and enzymes that were involved in anaerobic respiration and 
metabolism [52].  Thus, we can speculate that in Jorth et al. [52], QseBC may sense 
catecholamines released by neutrophils responding to the infection [25, 74] and may be 
essential for priming cellular metabolism for the host environment, e.g., the anaerobic 
environment of the subgingival pocket.  Furthermore, A. actinomycetemcomitans may be 
exploiting this aspect of the host response via QseBC to detect catecholamines and iron in order 
to acquire this essential nutrient.  Finally, since QseBC does not significantly regulate the 
expression of A. actinomycetemcomitans virulence factors, the shift in metabolism that occurs 
upon activation of the TCS may represent the primary role of QseC in virulence.  
Surprisingly, there was also an up-regulation of genes associated with the oxidative stress 
response along with an increase in catalase activity.  The induction of oxidative stress genes was 
unexpected given the apparent metabolic shift towards anaerobic metabolism and respiration. 
One possibility is that A. actinomycetemcomitans is often exposed to H2O2 in the oral cavity, 
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produced either from the neutrophil respiratory burst or by other oral organisms such as 
Streptococcus gordonii. Therefore, an increase in expression of oxidative stress genes and 
resistance to H2O2 may be required to both persist in a complex microbial community and evade 
the host response.  Alternatively, it has been reported that high iron levels can induce oxidative 
stress via hydroxyl radical formation via the Fenton reaction [115, 116]. If hydroxyl radicals from 
iron were the cause of the oxidative stress, then a significant increase in intracellular iron in CAT-
Fe treated cells would be expected relative to ferrous iron treated cells. However, there was no 
significant differences in intracellular iron content for cells grown in CDM or cells grown in CAT-
Fe (Figure 4E), although only cells grown in CDM with CAT-Fe showed significant up-regulation of 
oxidative stress genes, catalase activity, and had a significant increase in survival in the presence 
of H2O2 stress. Therefore, the increase in genes associated with oxidative stress does not appear 
to be caused by iron toxicity. Consistent with this, the up-regulation of ferritin suggests that iron 
is being safely sequestered by iron storage proteins where it is less likely to cause damage to the 
cell via radical formation.  Catecholamines have been shown to induce oxidative stress in 
eukaryotic cells via their breakdown by monoamine oxidase.  A search of the A. 
actinomycetemcomitans genome did not identify a gene with homology to this enzyme but the 
metabolomics results did identify putative breakdown products of norepinephrine in A. 
actinomycetemcomitans. The mechanism of catecholamine degradation in A. 
actinomycetemcomitans is not currently known, but this may represent another possible 
mechanism for inducing oxidative stress and genes involved in the oxidative stress response.  It 
has also been previously reported that catecholamines can induce oxidative stress genes in P. 
gingivalis and Burkoholderia pseudomallei, although the mechanisms behind the induction are 
not clear.  
An additional group of genes that were differentially expressed upon exposure to CAT-
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Fe encoded iron acquisition transporters.  In general, these operons were significantly down-
regulated, suggesting that CDM supplemented with CAT-Fe represented an iron replete medium 
and that under these conditions, A. actinomycetemcomitans does not require high affinity iron 
uptake systems.  Interestingly, expression of the putative enterobactin transport/receptor 
operon was unchanged when cells were exposed to CAT-Fe, suggesting that it may be the main 
iron uptake system that is present in cells grown in CAT-Fe supplemented medium.  In contrast 
to iron transport operons, ferritin was significantly up-regulated by 10-fold, suggesting that the 
bacteria required an increase in iron storage.  This is consistent with cellular growth in an iron 
replete environment and the need to safely sequester high levels of intracellular iron.   
Lastly, CAT-Fe exposure dramatically changed the lipid profile of A. 
actinomycetemcomitans and resulted in down-regulation of genes involved in fatty acid, and 
lipid and LPS biosynthesis. Since LPS is an endotoxin and one of the pathogen associated 
molecular patterns (PAMP), the down-regulation of LPS synthesis may aid in the persistence of 
the pathogen and evasion of killing by immune cells. In addition, the significant decrease in 
several fatty acids, most notably stearic and myristic acid is interesting since these fatty acids 
are often used to modify leukotoxin, and important virulence factor.  Interestingly, leukotoxin 
expression was also significantly down-regulated.  The functional outcomes of the changes in 
the lipid profile of the cell are still unknown. In cells exposed to CAT-Fe, there appeared to be a 
decrease in long-chained fatty acids (Table 8). This may result in greater fluidity in the plasma 
membrane.  Interestingly, a change in membrane fluidity has been shown to act a mechanism of 
regulation of TCS and specifically, temperature dependent membrane fluidity regulates the 
activation status of the DesK sensor kinase of Bacillus subtilis.  We can speculate that QseBC-




Figure 6: Leukotoxin expression in response to Ne/FeCl2. Whole cell extract from cells grown in triplicate 
from two independent experiments was run on a PAGE gel and stained to visualize proteins.  A representative gel is 
shown in Figure 6. The lanes on the representative gel were as follows: 1) the soluble fraction of A. 
actinomycetemcomitans grown in CDM, 2) ladder, 3) the soluble fraction of cells grown with ferrous iron 
supplementation, 4) the soluble fraction of cells grown with Ne supplementation, 5) the soluble fraction of cells grown 
with Ne/FeCl2 supplementation, 6) the insoluble fraction of cells grown in CDM 7) the insoluble fraction of cells grown 
with ferrous iron supplementation, 8) the insoluble fraction of cells grown with Ne supplementation, 9) the soluble 




Figure 7: Extracellular concentration of formate. Supernatant from A. actinomycetemcomitans was collected 
from cultures grown in CDM or with Ne/Fe2+ supplementation and analyzed for extracellular formate. Formate 
concentrations were determined from two independent experiments performed in triplicate. Statistical significance is 




Figure 8: Changes in metabolic flux in A. actinomycetemcomitans in response to CAT-Fe exposure as suggested by 
metabolomics and microarray data. Metabolites and enzymes in red are increased or up-regulated, ones in green are 




Figure 9: Oxidative stress response resulting from exposure to Ne/FeCl2. A) A. actinomycetemcomitans was grown for 
16 hours in CDM with or without Fe2+, Ne, or both and then stressed for 15 minutes with H2O2 or rested. Growth was 
measured by O.D.600NM 5 hours afterwards and inhibition of growth in response to H2O2 was calculated and subtracted 
from 100 to get percent survival. B) A. actinomcyetemcomitans grown in CDM with or without Fe2+, Ne, or both was 
lysed after 24 hours and analyzed for catalase activity. C) The intracellular iron content for cells cultured in CDM with 
Fe2+ or Ne/Fe2+ as measured by O.D.540nm by the reaction of free iron from cell lysate with Ferene S. All experiments 





Table 4 Genes Associated with Anaerobic Metabolism   




D11S_0205 cytochrome c-type protein TorC 3.05 3.52E-06 
D11S_0206 periplasmic nitrate reductase, diheme cytochrome 2.94 2.25E-06 
D11S_0207 ferredoxin-type protein NapH 3.36 1.20E-05 
D11S_0208 quinol dehydrogenase periplasmic component 2.74 1.28E-05 
D11S_0209 periplasmic nitrate reductase, large subunit 4.92 7.68E-06 
D11S_0210 NapD protein 6.69 7.91E-07 
D11S_0303 anaerobic C4-dicarboxylate membrane transporter 2.41 5.75E-05 
D11S_0493 anaerobic dimethyl sulfoxide reductase chain A 2.26 1.52E-04 
D11S_0494 anaerobic dimethyl sulfoxide reductase chain B 2.23 9.61E-06 
D11S_0495 anaerobic dimethyl sulfoxide reductase chain C 1.85 2.10E-03 
D11S_0809 fumarate reductase subunit D 1.95 6.12E-04 
D11S_0810 fumarate reductase subunit C (Fumarate reductase 2.39                              1.51E-05 
D11S_0811 fumarate reductase iron-sulfur subunit 2.39 2.15E-05 
D11S_0982 glycerate dehydrogenase 1.66 1.76E-03 
D11S_1092 hydrogenase accessory protein HypB 1.80 3.50E-05 
D11S_1093 hydrogenase expression/formation protein HypD 1.57 1.16E-03 
D11S_1094 hydrogenase expression/formation protein HypE 1.40 2.01E-03 
D11S_1256 cytochrome c-type biogenesis protein CcdA 1.56 2.29E-03 
D11S_1257 peptide methionine sulfoxide reductase 1.72 6.12E-04 
D11S_1264 glycerol-3-phosphate dehydrogenase, (gpd-m) 1.95 1.75E-02 
D11S_1376 hydrogenase assembly chaperone HypC/HupF 1.88 6.28E-05 
D11S_1379 oxaloacetate decarboxylase gamma chain 3 4.74 3.30E-07 
D11S_1380 oxaloacetate decarboxylase alpha subunit 4.44 3.21E-07 
D11S_1381 oxaloacetate decarboxylase beta chain 4.31 2.69E-06 





    
 
D11S_1413 trimethylamine-n-oxide reductase 2 4.67 1.16E-03 
D11S_1735 [NiFe] hydrogenase maturation protein HypF 2.58 8.83E-04 
D11S_1736 electron transport protein HydN 18.44 5.00E-09 
D11S_1737 hydrogenase-4 component B 14.93 1.54E-08 
D11S_1738 hydrogenase-4 component B 15.02 1.42E-09 
D11S_1739 hydrogenase-4 component C 10.68 1.60E-07 
D11S_1740 hydrogenase-4 component D 10.59 3.57E-08 
D11S_1741 hydrogenase-4 component E 7.95 5.22E-07 
D11S_1742 hydrogenase-4 component F 7.76 4.85E-08 
D11S_1743 hydrogenase-4 component G 5.89 1.38E-07 
D11S_1744 hydrogenase-4 component H 5.87 3.07E-07 
D11S_1745 hydrogenase-4 component I 5.40 5.18E-07 
D11S_1746 hydrogenase-4 component J 4.62 8.70E-08 
D11S_1747 hydrogenase maturation peptidase HycI 4.79 1.03E-06 
D11S_1748 formate dehydrogenase H 10.42 5.29E-09 
D11S_1749 formate dehydrogenase, alpha subunit 10.01 5.95E-08 
D11S_1771 C4-dicarboxylate membrane transporter 1.73 1.02E-05 
D11S_1811 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 2.72 1.04E-06 
D11S_1888 TorCAD operon transcriptional regulatory protein 1.86 1.62E-04 
D11S_1982 cytochrome C-type biogenesis protein 1.95 5.63E-04 
D11S_1984 cytochrome c-type biogenesis protein CcmF 3.87 1.84E-05 
D11S_1986 NrfD protein 11.60 1.14E-07 
D11S_1987 cytochrome c nitrite reductase, Fe-S protein 13.63 4.20E-07 
D11S_1988 cytochrome c nitrite reductase, pentaheme 17.09 2.38E-09 









    
 
D11S_1995 cytochrome c-type biogenesis protein CcmF 2.39 5.05E-05 
D11S_1996 cytochrome c-type biogenesis protein CcmE 2.45 3.65E-06 
D11S_1997 Heme exporter protein D (CcmD) 2.66 5.69E-07 
D11S_1998 CcmC 3.16 7.34E-06 
D11S_1999 heme exporter protein CcmB 2.69 1.88E-06 
D11S_2000 heme ABC exporter, ATP-binding protein CcmA 3.30 1.80E-05 













Table 5: Water Soluble Metabolites    
Metabolite 
Fold 
Change P-value Confirmed with Standard 
























d-Mannose; d(+)-Mannose (Y) 1.56 1.68E-
02 
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Table 6: Genes Involved in Iron Acquisition 
ID Tag Product 
Fold 
Change P-value 
D11S_0236 heme utilization protein 0.55 3.28E-02 
D11S_0237 heme-utilization protein Hup 0.62 4.07E-03 
D11S_0620 ferric cations import ATP-binding protein FbpC 0.57 3.49E-02 
D11S_0621 iron(III)-transport system permease protein FbpB 0.18 1.94E-05 
D11S_0622 ferric iron binding protein 0.19 1.30E-07 
D11S_0815 iron(III) dicitrate transport ATP-binding 0.12 2.42E-05 
D11S_0816 ABC transporter, iron chelate uptake transporter 0.11 1.72E-04 
D11S_0817 iron(III) dicitrate transport system permease 0.17 6.78E-06 
D11S_0818 iron(III) dicitrate-binding periplasmic protein 0.16 1.05E-06 
D11S_0842 hemoglobin binding protein A 0.58 2.67E-02 
D11S_1128 iron(III) dicitrate transport ATP-binding 0.22 3.94E-05 
D11S_1129 iron(III) transport system permease protein 0.33 1.98E-03 
D11S_1130 putative iron/heme permease 0.23 4.24E-04 
D11S_1131 putative periplasmic siderophore binding protein 0.14 5.47E-05 
D11S_1557 high-affinity Fe2+/Pb2+ permease 0.25 3.03E-04 
D11S_1558 high affinity Fe2+ transporter 0.12 1.28E-05 
D11S_1559 putative Fe2+ permease 0.14 4.81E-05 
D11S_1560 FtsX-like permease 0.16 3.33E-04 











Genes Involved in Fatty Acid, Lipid and LPS 
Synthesis   




D11S_0011 phosphatidylserine decarboxylase 0.71 2.80E-03 
D11S_0033 phospholipase/carboxylesterase 0.63 3.49E-03 
D11S_0077 acetyl-CoA:acetoacetyl-CoA transferase subunit 0.51 1.76E-02 
D11S_0079 short chain fatty acids transporter 0.51 1.53E-02 
D11S_0144 lipoprotein VacJ 0.50 5.55E-03 
D11S_0166 PgaA 0.53 6.91E-03 
D11S_0167 biofilm PGA synthesis lipoprotein PgaB 0.47 3.95E-06 
D11S_0168 biofilm PGA synthesis N-glycosyltransferase 0.56 7.22E-03 
D11S_0203 lipopolysaccharide heptosyltransferase II 0.70 1.03E-02 
D11S_0250 UDP-3-O-[3-hydroxymyristoyl] glucosamine 0.67 1.71E-03 
D11S_0253 lipid-A-disaccharide synthase 0.77                             1.95E-02 
D11S_0257 CDP-alcohol phosphatidyltransferase 0.72 5.28E-03 
D11S_0259 phosphatidate cytidylyltransferase 0.67 1.59E-03 
D11S_0284 N-acetylmuramic acid 6-phosphate etherase 0.41 4.20E-05 
D11S_0352 CDP-diacylglycerol--serine 0.52 1.74E-03 
D11S_0359 RfaL protein 0.42 1.20E-03 
D11S_0381 3-deoxy-D-manno-octulosonic acid kinase (KDO 0.78 1.95E-02 
D11S_0394 glycerophosphoryl diester phosphodiesterase 0.59 1.12E-02 
D11S_0525 beta-ketoacyl-ACP synthase IV 0.61 6.46E-04 
D11S_0526 3-oxoacyl-(acyl-carrier-protein) reductase, 0.79 1.11E-02 
D11S_0533 glycosyl transferase, family 2 0.54 3.33E-03 
D11s_0534 glycosyl transferase, group 2 family protein 0.57 2.86E-02 
D11S_0631 lipoprotein 0.65 1.83E-03 







    
D11S_0829 monofunctional biosynthetic peptidoglycan 0.51 2.75E-04 
D11S_0833 hypothetical protein; acyl-CoA thioesterase YciA 0.58 8.78E-04 
D11S_0916 CDP-diacylglycerol--glycerol-3-phosphate 0.50 5.96E-04 
D11S_0994 phosphatidylglycerophosphatase A 0.45 6.65E-03 
D11S_1076 enoyl-[acyl-carrier-protein] reductase 0.75 4.95E-03 
D11S_1181 acetyl-CoA carboxylase, carboxyl transferase, 0.80 9.47E-03 
D11S_1219 3-deoxy-D-manno-octulosonate 0.49 2.82E-03 
D11S_1221 tetraacyldisaccharide 4'-kinase 0.54 6.65E-03 
D11S_1260 phosphoheptose isomerase (Sedoheptulose 0.79 1.94E-02 
D11S_1320 2-acyl-glycerophospho-ethanolamine 0.82 3.25E-02 
D11S_1369 3-deoxy-D-manno-octulosonate 8-phosphate 0.78 7.95E-03 
D11S_1578 N-acetylglucosamine-6-phosphate deacetylase 0.66 3.58E-03 
D11S_1610 lipid A biosynthesis (KDO)2-(lauroyl)-lipid IVA 0.62 4.48E-03 
D11S_1612 peptidoglycan amidase MepA 0.78 3.13E-02 
D11S_1667 HldE 0.59 4.36E-03 
D11S_1668 lipid A biosynthesis lauroyl acyltransferase 0.36 3.73E-03 
D11S_1704 lipopolysaccharide biosynthesis protein 0.63 1.59E-03 
D11S_1944 UDP-2,3-diacylglucosamine hydrolase 0.72 8.05E-03 
D11S_1945 1-acyl-sn-glycerol-3-phosphate acyltransferase 0.73 4.92E-03 
D11S_1952 lipoprotein, putative 0.63 6.99E-03 
D11S_2089 acetyl-CoA carboxylase, biotin carboxylase 0.80 4.04E-02 
D11S_2104 prolipoprotein diacylglyceryl transferase 0.57 3.04E-03 
D11S_2137 lipoic acid synthetase 0.52 3.00E-03 





Table 8: Lipid Soluble Metabolites in Ne/FeCl2    
MetSign_ID m/z Fold_change (C/NF) Class of molecule 
C37H72O5 579.53 41.31 Diacylglyerol 
C52H100N1O8P1 897.72 2.18 Diacylglycerolphosphocholine 
C22H30O6 432.24 0.61 Isoprenoid 
C20H26O6 404.21 0.60 Flavanoid 
C37H70N1O8P1 686.48 0.61 Glycerophospholipid 
C68H112O6 1024.85 16.65 Triacylglycerol 
C42H78N1O10P1 786.53 0.45 Diacylglycerolphosphoserine 
C39H76O5 642.60 11.71 Diacylglycerol 
C37H72N1O8P1 688.49 0.59 Diacylglycerolphosphocholine 
C18H34N1O10P1 438.19 1.77 Diacylglyerolphosphoserine 
C39H76O5 647.56 2.81 Diacylglycerol 
C64H112O6 977.85 3.73 Triacylglycerol 
C18H28O11 438.20 1.24 Isoprenoid 
C19H22O6 410.16 1.50 Isoprenoid 
C30H42O6 516.33 3.46 Sterol 
C30H56N1O8P1 588.37 0.25 Glucuronide 
C16H30O2 253.22 0.50 Branched Fatty Acid 
C42H70O5 689.49 0.69 Diacylglyerol 
C35H68O5 591.50 2.26 Diaclyglycerol 
C21H36O5 391.24 0.41 Prostaglandin 
C37H72O5 631.51 11.51 Diacylglyerol 
C21H42N1O7P1 450.26 0.44 Glycerophosphocholine 
C39H47N1O14 795.34 0.65 Polyketide 
    
C57H108O6 906.85 14.04 Triaclyglycerol 




C40H76N1O10P1 760.51 0.25 Glycerophosphoserine 
C24H24O6; C24H26O7 409.16 2.01 Polyketide 
C35H67N1O8S1 660.45 0.59 Sphingolipid 
C39H74N1O8P1 714.51 0.57 Glycerophosphoethanolamine 
C59H112O6 934.88 5.28 Triacylglycerol 
C37H74N1O8P1 714.50 0.29 Diacylglycerophosphocholine 
C37H71O8P1; C39H74N1O8P1 738.50 0.12 Glycerophosphoethanolamine 






CHAPTER FIVE: CAT-FE EXPOSURE STIMULATES BIOFILM FORMATION AND PLANKTONIC 
GROWTH OF A. ACTINOMYCETEMCOMITANS 
Introduction: 
 Work done on E. coli and other bacteria has shown that catecholamines can stimulate 
planktonic growth and biofilm formation [119, 103, 58, 94]. This stimulation of planktonic 
growth is independent of a functional QseC [92], but biofilm formation is attenuated for a QseC 
mutant in the presence of catecholamines [119]. In addition, the stimulation of planktonic 
growth in E. coli can be blocked by the addition of adrenergic receptor antagonists [80, 55]. 
 For A. actinomycetemcomitans,  QseC is essential for biofilm formation [44,53]. A strain 
lacking qseC has a significant decrease in biofilm depth and mass compared to Wt, but no defect 
in planktonic growth is observed [44, 53]. It is unknown as to whether activation of QseC by CAT-
Fe would result in any changes in planktonic growth or biofilm formation. 
 The microarray data in Chapter 4 showed a significant up-regulation 2.7 fold of 
the anaerobic ribonucleoside triphosphate reductase (D11S_2128) of fold. In addition, the 
metabolomics showed significant increases in every ribonucleoside (Table 5). The increase of flux 
to pyruvate and energy producing pathways (Figure 9) as well as the significant up-regulation of 
the ribonucleoside triphosphate and increase in the pool of available ribonucleosides suggested 
that CAT-Fe was priming the cell for rapid growth. Therefore, the effect of CAT-Fe exposure on 
planktonic growth and biofilm formation was explored. 
Results: 
A. actinomycetemcomitans QseC has been shown to be essential for biofilm formation 
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since a strain lacking qseC exhibited a significant reduction in biofilm depth and biomass [44, 
53]. To determine if CAT-Fe influenced biofilm growth in a QseBC-mediated manner, the ability 
of the bacteria to form biofilms in the presence of CAT-Fe, ferrous iron or Ne was examined. A. 
actinomycetemcomitans was grown for 62 hours in CDM (Figure 10) and analyzed by confocal 
microscopy.  As shown in Figure 9, the Wt strain grown in CDM supplemented with Ne/FeCl2 
resulted in a significant increase in biomass compared to CDM alone. In contrast, the qseCΔp 
mutant did not exhibit a significant increase in biofilm formation in the presence of CAT-Fe 
(Figure 11A) relative to ferrous iron (Figure 11B) supplementation, suggesting that stimulation of 
biofilm growth required a functional QseC sensor. 
In E.coli, catecholamine mediated stimulation of growth was dependent on having a 
functional enterobactin biosynthesis and uptake system.  As previously discussed, A. 
actinomycetemcomitans does not have the capability to synthesize enterobactin or other 
siderophores, but does code for a putative enterobactin receptor and transport system 
(D11S_1357-1352; Figure 12). The potential role of this putative enterobactin transport system 
was explored by making an in-frame deletion of the beta-barrel region of the TonB dependent 
receptor (D11S_1352) and comparing biofilm formation of this mutant strain and wt cells.  As 
shown in Figure 13A & B, biofilm growth of the mutant strain was similar when cultured in CDM 
supplemented either with FeCl2 or CAT-Fe, respectively, and was significantly less than the Wt 
strain cultured in CDM supplemented with CAT-Fe (see Figure 10D). The wt biofilm phenotype 
was restored in the TonB dependent receptor mutant by complementing the strain with a full 
length copy of the gene (Figure 13D).     
Freestone et al previously showed that catecholamines act as pseudosiderophores by 
scavenging iron from holo-transferrin and the concentration of catecholamine (50uM) used in 
81 
 
these experiments also resulted in increased planktonic growth of E.coli [57, 80].  This suggests 
that catecholamines may function as siderophores.  To determine if exposure to CAT-Fe also 
induces A. actinomycetemcomitans growth, cells were cultured in CDM supplemented with 
either 100µM of ferrous iron, 50µM of Ep or Ne, or a combination of the both (CAT-Fe). There 
were no significant changes in growth when A. actinomycetemcomitans was cultured in CDM or 
in CDM/Ne, but growth was significantly increased with the supplementation of ferrous iron 
(Figure 14A). Growth of the bacteria was further increased significantly upon supplementation 
with Ne/FeCl2 (Figure 14A). Ep/FeCl2 also resulted in significant induction of growth over 
bacteria grown in just CDM (Figure 14B). However, in contrast to biofilm growth (see above), the 
increase in planktonic growth was not contingent on a functional QseC since the mutant strain 
lacking the periplasmic domain of QseC (qseCΔp) still showed a significant increase of growth 
with Ne/FeCl2 supplementation over ferrous iron supplementation (Figure 14C).    
CAT-Fe stimulation of planktonic growth was also tested for the TonB dependent 
mutant and the complemented strain. This mutant strain still exhibited significant activation of 
QseC in the presence of Ne/FeCl2 compared to the control CDM (Figure 15A), indicating the 
QseC function in unaffected by inactivating the siderophore receptor. The TonB dependent 
receptor mutant strain exhibited no significant changes in planktonic growth under these 
conditions, suggesting that a functional TonB receptor is required for growth stimulation by 
CAT-Fe (Figure 15B). When the mutant strain was complemented with an intact copy of the 
TonB receptor gene, the Wt growth phenotype was restored (Figure 15C).  
Adrenergic Receptor Antagonists Fail to Block CAT-Fe Growth Stimulation and Inhibit Overall 
Growth of A. actinomycetemcomitans 
In Chapter 3, it was shown that the alpha and beta adrenergic receptor antagonists failed 
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to block QseC activation by CAT-Fe and at a concentration of 400µM appeared to stimulate 
QseBC.  Therefore, the effect of these drugs on CAT-Fe stimulation of planktonic growth of A. 
actinomycetemcomitans was tested to confirm that the growth phenotype is independent of 
QseC.  At a concentration of 200µM, both adrenergic receptor antagonists failed to block CAT-Fe 
stimulation of growth (Figure 16A), consistent with the previous β-galactosidase results obtained 
with these drugs. At 400µM of propranolol or phentolamine, there was an overall inhibition of 
growth compared to Wt when grown in CDM (Figure 16B) or BHI.  The growth inhibition was 
independent from QseC signaling since the mutant lacking the periplasmic domain of QseC still 
showed significant growth inhibition in response to 400µM of propranolol or phentolamine 
(Figure 16C).  
Discussion: 
Catecholamines have been shown to lead to a stimulation of planktonic growth and 
biofilm formation in a wide variety of species such as E.coli, Salmonella, P. burkholderia, A. 
pleuropenumoniae, and a variety of dental pathogens [58, 57, 66, 103, 93]. In addition, 
catecholamines also lead to an increase in biofilm formation in E. coli [119]. For A. 
actinomycetemcomitans, exposure to CAT-Fe and the resulting QseBC activation resulted in an 
increase in the nucleoside pool and up-regulation of the anaerobic ribonucleoside triphosphate 
reducatase (D11S_2128) which converts nucleosides to deoxyribonucleosides (Chapter 4). 
Together with the metabolomics and microarray data suggested that energy production was 
increased (Chapter 4), this data suggested that CAT-Fe primed the cell for increase growth, 
which was confirmed when analyzing planktonic growth and biofilm formation. 
Exposure to ferrous iron resulted in a significant increase of planktonic growth, but 
growth was further significantly stimulated with the addition of CAT-Fe. For the biofilms, 
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although one of the lipoproteins associated with biofilm formation, pgaB, was down-regulated 
in response to CAT-Fe exposure, biofilm formation was significantly increased during exposure 
to CAT-Fe. 
 For E.coli, Salmonella,  and A. pleuropneumoniae, it was found that the stimulation of 
planktonic growth was independent of QseC since a mutant strain still underwent 
catecholamine mediated planktonic growth stimulation [57, 80, 92]. This is consistent with the 
results of the CAT-Fe mediated planktonic growth stimulation in A. actinomycetemcomitans, 
which was also independent of a functional QseC. However, for both E.coli and A. 
actinomycetemcomitans, a functional QseC was required for the biofilm phenotype in response 
to catecholamines [119] or CAT-Fe, respectively.  
One possible explanation for the planktonic growth stimulation in the presence of CAT-
Fe but in the absence of qseC is that there exists the possibility of another sensor that is 
responsive to CAT-Fe. Several other putative receptors (QseE, BasS and CpxA) have been 
reported to function as catecholamine sensors [102]. The other explanation is that QseC has not 
been shown to be essential for planktonic growth, but has been for biofilm formation. It has 
already been shown that the loss of qseC resulted in significant biofilm reduction [44, 53]. The 
significant increase in biofilm formation during QseC activation by CAT-Fe is consistent with 
these previous results. In addition, the role of QseC as a regulator of anaerobic metabolism fits 
within this narrative (Chapter 4). Since QseC activation results in an up-regulation of anaerobic 
respiration and metabolism, this response might assist A. actinomycetemcomitans during 
growth in the biofilm where oxygen levels may be decreased. 
The planktonic growth stimulation and biofilm stimulation in response to CAT-Fe was 
found to be dependent on the TonB dependent receptor. This is consistent with the reports that 
84 
 
E.coli requires a functional enterobactin transport and synthesis operon [58]. A. 
actinomycetemcomitans does not encode for enterobactin, nor any other siderophore. 
Therefore, one potential reason for A. actinomycetemcomitans encoding the enterobactin 
transporter and receptor could be for acquiring iron via catecholamine mediated scavenging. It 
is also possible that this operon functions to scavenge enterobactin made by other oral species, 
or that the operon can be used for both functions. 
Interestingly, the TonB dependent receptor mutant still underwent CAT-Fe mediated 
activation of QseC. This suggests that the enterobactin transport and receptor operon may lay 
downstream of QseC activation. The enterobactin transport and receptor operon was not one of 
the high affinity iron acquisition genes that was down-regulated in the microarray. One possible 
reason for this could be that the operon is required for A. actinomycetemcomitans to respond to 
CAT-Fe.  
As reported in Chapter 3, the growth stimulation in response to catecholamines could 
be blocked in the presence of adrenergic receptor antagonists in E.coli [80], but in A. 
actinomycetemcomitans, the activation of QseC was not blocked by these drugs. Instead, at high 
concentrations, they appeared to act as QseC agonists. Therefore, the effect of the adrenergic 
receptor antagonists was analyzed in A. actinomycetemcomitans to see if the activation of QseC 
at high levels of antagonist resulted in a growth phenotype. The reason for this is that QseC has 
been proposed as a potential target for therapeutics since it plays such a vital role in regulating 
virulence, metabolism, and biofilm formation [107]. 
At concentrations that were sufficient to block catecholamine stimulation of growth (i.e. 
50µM), there was no significant effect on CAT-Fe stimulation of planktonic growth in A. 
actinomycetemcomitans. However, the addition of 400µM of adrenergic receptor antagonist, 
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the same concentration that resulted in QseC activation in Chapter 3, resulting in a significant 
inhibition of growth in either CDM or BHI. This inhibition of growth was independent of QseC, 
therefore it appears these drugs have an overall toxic effect on the cell at high concentrations. 
Interestingly, this inhibition of growth was not reported in E.coli or Salmonella. It is unlikely that 
these drugs can be used as a therapeutic against A. actinomycetemcomitans, since it was only at 
high concentrations this effect was observed, and this same concentration is well outside the 










Figure 10: Biofilm formation in A. actinomycetemcomitans grown in CDM with iron and/or catecholamines. 
Representative photos of A. actinomycetemcomitans grown in a biofilm in CDM (A), or with supplementation of FeCl2 
(B) Ne (C), or Ne/FeCl2 (D). All biofilm experiments were performed independently in triplicate with 5 to 10 pictures 




Figure 11: Biofilm formation in qseCΔp strain. Representative photos of the qseCΔp strain of A. 
actinomycetemcomitans grown in CDM with ferrous iron (A) or Ne/FeCl2 (B). All biofilm experiments were performed 




Figure 12: The enterobactin transport and receptor operon of A. actinomycetemcomitans serotype c D11S. 
The TonB receptor was originally annotated as D11S_1354 with D11S_1353 being an outer membrane receptor and 
D11S_1352 annotated as either fepA or a pseudogene. However, based on sequence similarity from E.coli and the D7S 
strain of A. actinomycetemcomitans and the data from this study, it is most likely that D11S_1354-1352 together 







Figure 13: Biofilm formation in ΔTonB dependent receptor strain. Representative photos of the ΔTonB 
dependent receptor mutant strain of A. actinomycetemcomitans grown in CDM with ferrous iron (A) or Ne/FeCl2 (B) or 
of the TonB dependent receptor complement strain grown in CDM with ferrous iron (C) or Ne/FeCl2 (D). All biofilm 




Figure 14: Planktonic growth response in the presence of CAT-Fe. A) Aliquots were taken at various time points of A. 
actinomycetemcomitans grown in triplicate for two independent experiments in CDM with or without 
supplementation with Ne, ferrous iron, or both and measured for the O.D. 600nm. B) Growth was followed using the 
same methods but for A. actinomycetemcomitans grown in CDM with or without supplementation with ferrous iron, 
Ep, or both. C) Growth of wild type bacteria or a strain lacking the periplasmic domain of Qsec (qseCΔp) was measured 
using OD600 for cultures grown in CDM with either ferrous iron or Ne/FeCl2+ supplementation. All experiments were 





Figure 15: The response of the ΔTonB dependent receptor strain to CAT-Fe. A) Expression of ygiW-qseBC was 
measured in a β-galactosidase assay after 24 hours for the ΔTonB dependent receptor strain of A. 
actinomycetemcomtians grown in CDM or with Ne/Fe2+. Each condition was tested in triplicate in two independent 
assays. B) Growth was measured using the O.D.600NM of the Wt strain or the ΔTonB dependent receptor strain grown in 
CDM with either ferrous iron supplementation or Ne/FeCl2. C) Growth of the ΔTonB dependent receptor complement 
strain in CDM with Fe2+ or Ne/Fe2+ supplementation. All growth curves were performed in triplicate with two 




Figure 16: The growth response of A. actinomycetemcomitans to the alpha adrenergic receptor antagonist 
phentolamine or the beta adrenergic receptor antagonist propranolol. A) Growth was measured by O.D.600NM for A. 
actinomycetemcomitans was grown in CDM with supplementation of either Fe2+, Ne/Fe2+,  and 200µM propranolol. B) 
Growth was measured for A. actinomycetemcomitans grown in CDM with of supplementation either Fe2+, Ne/Fe2+, 
400µM of propranolol or 400µM of phentolamine. C) Growth was measured for the qseCΔp strain of A. 
actinomycetemcomtians grown in BHI with or without 400µM of propranolol. All experiments were done in triplicate 








CHAPTER SIX: THE IRON-RESPONSIVE TOXIN/ANTI-TOXIN (TA) SYSTEM D11S_2133-2134 AND ITS 
ROLE IN YGIW-QSEBC REGULATION 
Introduction:  
The oral cavity is a harsh environment due to fluctuations in pH, nutrients, temperature, 
exposure to antibiotics, competition from other resident microbes and the shear force arising 
from the flow of saliva [129]. In order to compete and thrive, bacteria need to tightly regulate 
gene expression and adapt quickly to changes that occur in the local environment. Inter- and 
intra- species communication allows bacteria to sense changes in population sizes and adapt 
accordingly through quorum sensing. A. actinomycetemcomitans is able to quorum sense via the 
production of AI-2 by LuxS and its subsequent detection by the receptors LsrB and RbsB [44]. 
The qseBC TCS is downstream of AI-2 detection, but its activation is not directly controlled by AI-
2 detection [44]. In E. coli, AI-2 detection leads to the activation of MqsR, which positively 
regulates expression of qseBC [71] and it is possible that a similar mechanism occurs in A. 
actinomycetemcomitans.  In E. coli, MqsR is the toxin in the MqsRA TA system that acts as a CGU-
specific mRNA interferase [108].  
TA systems are mechanisms that allow bacteria to respond to stress [84]. They comprise 
an anti-toxin that is co-transcribed with its cognate toxin [81]. In type II TA systems, both the 
toxin and the anti-toxin are proteins with the anti-toxin being more labile and therefore more 
easily degraded by proteases such as Clp [83] and Lon [82]. Normally, the anti-toxin protein 
binds to the toxin protein to neutralize its effects. Many anti-toxins also bind to their own 
promoter to auto-regulate expression of the operon. Toxin activity can vary but most toxins 
function as either ribosome dependent or independent mRNA endoribonucleases that cleave 
mRNA at certain specific sequences [81, 109, 110]. Some cleave mRNA promiscuously such as 
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the RelE of E.coli which cleaves between the second and third position of an upstream purine 
[111]. TA systems are also thought to play a vital role in the development of the persister 
phenotype that allows the cell to survive environmental stress [81].  
In bacterial populations there exists phenotypic heterogeneity meaning that there can 
be distinct populations within a community of the same species. This often happens during 
persister cell formation where a small percentage of the population represents the slow-growing 
persister phenotype [86]. This phenotype is thought to be the result of activation of TA systems. 
In these cells, there may be a stochastic switch to the persister phenotype that activates the Lon 
protease, which then degrades the anti-toxin to activate the toxin [85]. This mechanism of TA 
activation is dependent on the accumulation of (p)ppGpp [85] which is produced by RelA/SpoT 
and accumulates in cells and inhibits exopolyphosphatase (PPX) [85]. PPX degrades poly-
phosphate (polyP), which is synthesized by polyphosphate kinase (PPK) [85]. At high levels, polyP 
activates the Lon protease, which will in turn degrade the anti-toxins and release the toxin [85].  
A. actinomycetemcomitans contains 10 putative type II TA systems and previous work identified 
various environmental stressors that induced expression of these TA systems and showed that 
one TA system (D11S_2133-2134) was highly up-regulated under iron limited growth conditions 
(i.e., the presence of the iron chelator 2,2′-bipyridyl [DIP]). 
In this Chapter, we show that QseB plays a role in the stress response of A. 
actinomycetemcomitans and influences expression of the Lon protease and the iron-responsive 
TA system D11S_2133-2134. We also show that over-expression of D11S_2133 inhibits growth in 
E. coli while D11S_2134 over-expression had no significant effect on growth, suggesting that 
D11S_2133 is the toxin and D11S_2134 is the anti-toxin. In addition, over-expression of 





Deletion of qseB Results in an Up-regulation of Stress Response Genes  
QseB is the DNA binding response regulator of the QseBC TCS that is activated by QseC 
in response to CAT-Fe. In Chapter 3, we identified changes in the transcriptome of Wt A. 
actinomycetemcomitans when QseC was activated by CAT-Fe. To further define the QseBC 
regulon, a genomic microarray was used to identify differentially expressed genes in a ΔqseB 
strain of A. actinomycetemcomitans.  A total of 250 genes were differentially regulated 2 fold or 
greater in ΔqseB compared to Wt (Appendix Table 2). Of the 250 genes, 89 were up-regulated 
and 161 were down-regulated.  
Of the 89 genes that were up-regulated, 16 were genes involved in the stress response 
(Table 9). These genes were highly up-regulated with 6 of the top 10 results being genes 
associated with the stress response, e.g., the ATP-dependent ClpB protease (D11S_0551), the 
chaperonin groS-groEL (D11S_599-600), the universal stress protein A (D11S_0656), molecular 
chaperone dnaK (D11S_D11S_0922), and lon (D11S_1522). In order to confirm the role of QseBC 
in the stress response, qRT-PCR was performed to measure the expression of lon in ΔygiW, 
ΔqseB, ΔqseC, and a ΔqseC complemented strain (Figure 17). While the ΔygiW did not show a 
significant change in lon expression, ΔqseC and ΔqseB exhibited up-regulation of lon and the 
QseC complemented strain was able to restore lon expression back to Wt levels (Figure 17). 
Interestingly, the activation of QseC by CAT-Fe also resulted in an up-regulation of several genes 
involved in the stress response: the universal stress protein A (D11S_0656), clpB (D11S_0551), 
groS-groEL (D11S_0599-0600), two putative relEB TA systems (D11S_1194-1195 & D11S_1798-
1799), and the molecular chaperone dnaK (D11S_0922).
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Ectopic Expression of lon Induces ygiW-qseBC and Results in Significant Decrease in 
Growth 
 The Lon protease (D11S_1522) degrades the labile anti-toxins of TA systems 
thereby releasing the toxin during the stress response [82]. Since deletion of qseB and 
qseC resulted in an up-regulation of lon, we next determined the effect of ectopic 
expression of lon on expression of qseBC.  The lon gene was ectopically expressed using 
the Trc inducible promoter of plasmid pWAW17. A. actinomycetemcomitans harboring 
pWAW17 was confirmed to exhibit up-regulation of lon (Figure 18A). The 
A.actinomycetemcomitans strain carrying pWAW17 also showed significant up-
regulation of ygiW suggesting that Lon may play a role in regulating ygiW-qseBC (Figure 
18B). 
Activation of Lon results in the activation of TA systems by degrading the anti-
toxin and release of the toxin. The toxins are hypothesized to inhibit cellular processes 
like translation and inhibit growth.  In part, this mechanism may allow the cell to 
transition to a slow-growing persister cell. In E.coli transformed with pWAW17, no 
significant growth difference was observed with or without 1mM IPTG until late log 
phase (Figure 19A). At late exponential and stationary phase, induction of the Lon 
protease resulted in significant reduction of cell density in E. coli (Figure 19A).  A similar 
result occurred with A. actinomycetemcomitans transformed with pWAW17 (Figure 
19B). 
D11S_2133-2134 is Up-regulated during Iron Starvation and in ΔqseC and ΔqseBC 
Different stress conditions, including iron stress, were used to determine under 
which condition each of the 10 putative TA systems were activated. D11S_2133-2134, a 
putative RelE- like type II TA system, was highly up-regulated during iron starvation 
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(Figure 21A). Consistent with this, the D11S_2133-2134 TA system was significantly up-
regulated when cells were cultured in CDM without any iron supplementation relative 
to iron replete cultures grown in BHI.  In addition, there was no significant change in 
expression of the TA system in the Wt strain when cultured in CDM supplemented with 
CAT-Fe (Figure 20B).  Finally, D11S_2133-2134 was up-regulated in the ΔTonB receptor 
strain, a strain that did not have a growth response to CAT-Fe and therefore may have a 
defect in acquiring iron (Figure 20C).  
Real-time PCR was also used to determine expression of D11S_2133-2134 in 
both ΔqseC and ΔqseBC strains relative to Wt. Consistent with the previous microarray 
results using the ΔqseB mutant, the TA system was significantly upregulated in both 
ΔqseBC and ΔqseC (Figure 20D). Together with the data showing that this TA system is 
activated during iron starvation, it is possible that this system may be involved in 
regulating qseBC and fine-tuning the response of A. actinomycetemcomitans to changes 
in environmental iron content. 
D11S_2133 and D11S_2134 are Co-transcribed and Ectopic Expression of D11S_2133 
but Not D11S_2134 Results in Inhibition of Growth in E. coli 
 We next confirmed the identities of the putative toxin and anti-toxin. In Type II 
TA systems, the toxin and the anti-toxin are co-transcribed [81, 118].  To confirm that 
D11S_2133 and D11S_2134 were co-transcribed, primers were designed to amplify the 
intergenic region between D11S_2133 and D11S_2134. The positive control genomic 
DNA and the cDNA resulted in a fragment for the intergenic region (Figure 21A). In 
contrast, primers amplifying an intergenic region between D11S_2134 and the unrelated 
D11S_2135 gene gave a product only for the genomic DNA, but not the cDNA confirming 
that D11S_2133 and D11S_2134 are co-transcribed.  In addition, the promoter which 
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transcribes D11S_2133-2134 was identified by 5' cDNA RACE as being within the 
intergenic region between D11S_2134 and D11S_2135.  The transcriptional start site was 
mapped to nucleotide -36 as shown in Figure 21B. 
Conventionally, the anti-toxin is transcribed first followed by the toxin [118], but 
there have also been reports of this operon structure order being reversed. In order to 
confirm their functional identities, both D11S_2133 and D11S_2134 were ectopically 
expressed using the Trc inducible promoter to generate pWAW20 (Trc-D11S_2133) and 
pWAW19 (Trc-D11S_2134). Confirmation of ectopic expression in both strains was 
performed by qRT-PCR. The growth of E.coli and A. actinomycetemcomitans strains 
transformed with these plasmids was then determined.  When the E.coli strain carrying 
pWAW19 (D11S_2134) was grown in LB or LB with 1mM IPTG, there was no significant 
difference in cell density (Figure 22A). In contrast, the E.coli strain carrying pWAW20 
(D11S_2133) showed significant reduction of cell density when IPTG was added to 
induce expression of D11S_2133 (Figure 22C). The reduction in cell density of the strain 
carrying D11S_2133, but not D11S_2134 suggests that the organization of the operon is 
similar to the normal convention for type II TA systems in that the anti-toxin 
(D11S_2134) is transcribed first followed by the toxin (D11S_2133). 
In A. actinomycetemcomitans, the strains carrying pWAW20 or pWAW19 
showed no difference in cell density in the presence or absence of IPTG. In addition, 
there were no changes in cell density of the Wt strain in the presence of absence of IPTG 
(Figure 23A).  However, there was a significant reduction of cell density for both the 
pWAW19 and pWAW20 strains versus the Wt strain (Figure 23A &B). The reduction of 
growth due to the ectopic expression of D11S_2134 could also be seen in E.coli when 
high levels (2mM) of IPTG was added to the media to induce higher levels of expression 
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from the pTRC promoter (Figure 22B).  
Ectopic Expression of D11S_2134 Induces the Expression of the ygiW-qseBC Operon 
 In order to test the hypothesis that D11S_2133-2134 regulates expression of the 
ygiW-qseBC operon, qRT-PCR was performed with Wt A. actinomycetemcomitans and 
each of the ectopic expression strains.  Since ectopic expression of lon resulted in an up-
regulation of ygiW-qseBC mRNA, we hypothesized that ectopic expression of the 
putative toxin, D11S_2133, would result in the up-regulation of ygiW-qseBC mRNA.  
Both strains for the ectopic expression of either D11S_2133 (pWAW20) or 
D11S_2134 (pWAW19) were confirmed by qRT-PCR to exhibit increased mRNA 
expression (Figure 24A & B). Using qRT-PCR, induction of pWAW19 resulted in a 5000 
fold increased expression of the ygiW-qseBC operon, whereas induction of pWAW20 
resulted in only a 4 fold increase (Figure 24C). These results were also confirmed using 
the inducible lsrA promoter to generate plasmids pWAW14 (D11S_2133) and pWAW16 
(D11S_2134). The lsrA promoter contains a crp binding site and in the absence of 
glucose, expression is induced. Again, ectopic expression was confirmed by qRT-PCR 
(Figure 25A & B). In agreement with the results seen with pWAW19 and pWAW20, 
ectopic expression of D11S_2134 (pWAW16) still resulted in a significant increase in 
mRNA expression of ygiW-qseBC while expression of D11S_2133 (pWAW14) did not 
(Figure 26B). There was no significant difference in ygiW-qseBC expression in Wt cells 
grown in LB or LB with glucose (Figure 26A). 
Discussion: 
QseBC appears to be involved in sensing iron via CAT-Fe which activates the TCS 
and results in regulation of iron acquisition genes. However, as shown in Chapter 3, this 
TCS is not highly activated during times of iron-limitation (i.e. CDM), and there is a basal 
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level of activity under iron limiting conditions.  In addition, our previous results and 
studies of QseBC in other species suggest that QseB may be activated by non-cognate 
sensor kinases [60, 101]. This suggests that a minimal level of QseB activity is essential 
for A. actinomycetemcomitans and the absence of functional QseB triggers a stress 
response. As seen in the microarray data and confirmed with qRT-PCR data performed 
with ΔqseC, the absence of this TCS elicits the up-regulation of several stress response 
genes, including lon.  
Lon is involved in activating TA systems by degrading the labile anti-toxin and 
releasing the toxin. Most of these toxins act as endoribonucleases allowing them to 
post-transcriptionally regulate a variety of mRNA’s in the cell. The ectopic expression of 
lon in A. actinomycetemcomitans was shown to result in an up-regulation of ygiW-qseBC 
mRNA, suggesting that it may regulate the expression of this TCS and our hypothesis is 
that the activation of an iron responsive TA system by Lon regulates the expression of 
qseBC under iron limitation.  Only one TA system in A. actinomycetemcomitans, 
D11S_2133-2134, was found to be highly up-regulated during iron starvation, suggesting 
that it may be the TA system involved in qseBC regulation.  The proposed regulatory 
circuit involving QseBC, Lon and the TA system is illustrated in Figure 27.  We propose 
that these component function in concert to fine tune the response of A. 
actinomycetemcomitans to changes in environmental iron content.  
D11S_2133-2134 was significantly up-regulated in the ΔqseC and ΔqseBC strains, 
yet the consensus binding sequence for QseB, CTTAA-N6-CTTAA, does not exist the 
putative promoter of D11S_2133-2134 [49].  This suggests that QseBC might regulate 
expression of the TA system through indirect means, possibly through the stimulation of 
lon expression.    
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Based on the growth kinetics in E. coli from the ectopic expression strains, 
D11S_2133 encodes for the toxin and D11S_2134 for the anti-toxin. Based on the qRT-
PCR results to confirm expression of D11S_2133/2134, the Trc promoter appears to be 
“leaky” in A. actinomycetemcomitans and this could explain the less robust growth 
phenotypes seen in A. actinomycetemcomitans. In addition, high level induction of 
D11S_2134 led to significant growth inhibition even in E. coli suggesting that at high 
levels, the product encoded by this gene may be toxic to the cell. 
Since ectopic expression of lon resulted in a significant increase in expression of 
ygiW-qseBC mRNA, we hypothesized that ectopic expression of the putative toxin 
(D11S_2133), would result in a significant increase in expression of ygiW-qseBC.  
Therefore, it was unexpected that ectopic expression of the putative anti-toxin 
(D11S_2134) resulted in significant up-regulation of ygiW-qseBC.  There are several 
explanations for this result.  First, the functional assignment of the toxin and anti-toxin 
based on the growth phenotypes may be misleading and clearly there are examples 
where the toxin gene precedes the anti-toxin [120, 121]   Second, since D11S_2133-
2134 is a RelE-like TA system and presumably functions as an endoribonuclease, the use 
qRT-PCR to measure changes in qseBC expression using only one housekeeping gene as 
reference may be misleading. These results could be confirmed by using additional 
internal controls or alternatively by determining the levels of QseBC proteins.   
 The data from this chapter suggests then that Lon and the D11S_2133-2134 TA 
system are involved in regulating expression of the ygiW-qseBC operon (Figure 27) and 
co-ordinating the response of the bacteria to iron-limiting conditions. In addition, 
appropriate expression and activation of QseB appears to be essential for the cell since 
the absence of qseB results in a significant up-regulation of the stress response. 
102 
 
Therefore, QseBC may play a vital role in adapting to the host environment by regulating 
metabolism, iron uptake, virulence and biofilm formation in response to activation by 
CAT-Fe (Figure 27) and loss of that function results in an attenuation of virulence [44]. 
Since QseBC appears to play such a vital role, it may represent a target for potential 
therapeutics. In order to develop these potential treatments, more information is 
needed about the regulation of QseBC by D11S_2133-2134 and other mechanisms as 










Figure 17: Expression of lon. Real-time expression of the Lon protease compared to the Wt strain of A. 
actinomycetemcomitans grown in BHI compared to ΔygiW, ΔqseB, ΔqseC, and ΔqseC complement. RT-PCR 






Figure 18: Regulation of ygiW expression by Lon. A) Real-time expression of lon in Wt A. 
actinomycetemcomitans compared to strains harboring pWAW17 grown in BHI or BHI with IPTG. B)Real-time 
expression of ygiW in Wt A. actinomycetemcomitans grown in BHI compared to a strain carrying a plasmid 
for the ectopic expression of Lon (pWAW17) grown in BHI with or without 1mM IPTG. All experiments were 





Figure 19: Growth response of E.coli and A. actinomycetemcomitans to ectopic expression of Lon. A) Growth 
of E.coli carrying the plasmid for ectopic expression of Lon (pWAW17) grown in LB or with 1mM IPTG. B) 
Growth of Wt A. actinomycetemcomitans with the empty vector pJT3 or strain carrying pWAW17 in BHI. All 





Figure 20: Response of TA systems to iron starvation. A) Real-time expression of putative TA systems in A. 
actinomycetemcomitans grown in CDM with 2,2'-dipyridyl (DIP) 4. B) Real-time expression of D11S_2133-
2134 grown in BHI, CDM and CDM with Ne/Fe2+. C) Real-time expression of D11S_2133-2134 in Wt A. 
actinomycetemcomitans or ΔTonB dependent receptor mutant grown in BHI. D) Real-time expression of 
D11S_2133-2134 in Wt A. actinomycetemcomitans, ΔqseC, or ΔqseBC grown in BHI. . All experiments were 
done in triplicate with two independent trials. P < 0.05. 
 
                                                 




Figure 21: The D11S_2133-2134 Operon. A) DNA gel showing 1) 5000kb ladder, 2) PCR product from 
chromosomal DNA amplified with primers specific for the intergenic region between D11S_2134-2135, 3) 
PCR product from cDNA amplified with primers specific for the intergenic region between D11S_2134-2135, 
4) PCR product from chromosomal DNA amplified with primers specific for the intergenic region between 
D11S_2134-2133, 5) PCR product from cDNA amplified with primers specific for the intergenic region 
between D11S_2134-2133, 6) 1kb ladder. B) The sequence for the upstream and coding region for 
D11S_2133-2134, including the transcriptional start site (purple and italic), ribosome binding site (green) 
and start codon (red). The transcriptional start site was determined by cDNA RACE using 10 transformed 





Figure 22: Growth response of E.coli to ectopic expression of D11S_2133 and D11S_2134. A) Growth of 
E.coli strain carrying plasmid for ectopic expression of D11S_2134 (pWAW19) grown in LB or with 1mM IPTG 
supplementation. B) Growth of E.coli strain carrying pWAW19 grown in LB or with 2mM IPTG 
supplementation. C) Growth of E.coli strain carrying plasmid for ectopic expression of D11S_2133 
(pWAW20) grown in LB or with 1mM IPTG supplementation. All experiments were done in triplicate with 





Figure 23: Growth of A. actinomycetemcomitans in response to ectopic expression of D11S_2133 or 
D11S_2134. A) Growth of Wt strain of A. actinomycetemcomitans with the empty vector pJT3 or a strain 
carrying pWAW20 grown in BHI or BHI with 1mM IPTG. B) Growth of Wt of a strain carrying pWAW19 grown 






Figure 24: Real-time expression of D11S_2133, D11S_2134, and ygiW. A) Real-time expression of 
D11S_2133 in Wt A. actinomycetemcomitans compared to a strain carrying a plasmid for ectopic expression 
of D11S_2133 (pWAW20) grown in BHI with or without 1mM IPTG. B) Real-time expression of D11S_2133 in 
Wt A. actinomycetemcomitans compared to a strain carrying a plasmid for ectopic expression of D11S_2134 
(pWAW19) grown in BHI with or without 1mM IPTG. C) Real-time expression of ygiW in Wt A. 
actinomycetemcomitans compared to a strain carrying the plasmid for ectopic expression of D11S_2134 
(pWAW19) or D11S_2133 (pWAW20) grown in BHI with or without 1mM IPTG . All experiments were done 





Figure 25: Real-time Expression of D11S_2133 or D11S_2134. A) Real-time expression of D11S_2133 in Wt 
A. actinomycetemcomitans grown in LB compared to Wt grown in LB with 0.2% glucose or a strain carrying 
plasmid for ectopic expression of D11S_2133 (pWAW14) grown in LB or LB with 0.2% glucose. B) Real-time 
expression of D11S_2134 in Wt A. actinomycetemcomitans grown in LB compared to Wt grown in LB with 
0.2% glucose or a strain carrying plasmid for ectopic expression of D11S_2134 (pWAW16) grown in LB or LB 





Figure 26: Regulation of ygiW expression by D11S_2133-2134. A) Real-time expression of ygiW in Wt A. 
actinomycetemcomitans grown in LB compared to grown in LB with 0.2% glucose. B) Real-time expression of 
ygiW in Wt A. actinomycetemcomitans grown in LB compared to A. actinomycetemcomitans carrying 
pWAW16 (D11S_2134) or pWAW14 (D11S_2133) grown in LB or LB with 0.2% glucose.  All experiments were 





Figure 27: Schematic of QseBC activation by CAT-Fe and regulation by D11S_2133-2134. Activated 
polymorphonuclear cells release catecholamines and lactoferrin. The holo-lactoferrin is bound by 
catecholamines that scavenge the iron from them. The CAT-Fe complex is recognized by QseC (with or 
without the help of YgiW) and activates QseC, in turn activating QseB. QseB regulates genes involved in iron 
uptake, virulence and biofilm formation. Increased levels of the anti-toxin encoded for by D11S_2134 results 



























heat shock protein HslVU, ATPase 
subunit HslU 8.24 8.79E-03 
D11S_0147 
ATP-dependent protease peptidase 
subunit 8.15 7.00E-03 
D11S_0551 ATP-dependent chaperone ClpB 14.5 9.08E-03 
D11S_0599 chaperonin GroS 5.36 7.96E-03 
D11S_0656 universal stress protein A 2.17 3.35E-04 
D11S_0739 RNA polymerase sigma factor RpoE 4.3 4.10E-02 
D11S_0795 heat shock protein 90 11.32 1.97E-02 
D11S_0838 RecN protein 1.77 1.09E-02 
D11S_0841 heat shock protein GrpE 6.96 3.77E-02 
D11S_0922 molecular chaperone DnaK 8.91 7.63E-03 
D11S_1074 
DNA protection during starvation 
protein 1.74 1.72E-02 
D11S_1431 cold shock domain protein CspD 1.8 2.05E-02 
D11S_1480 DNA mismatch repair protein 2.16 1.28E-02 
D11S_1522 ATP-dependent protease La 4.51 6.74E-03 
D11S_1798 Stability protein StbD 2.41 3.07E-02 




CHAPTER SEVEN: SUMMARY 
QseBC is a conserved TCS in the Enterobacteriaceae and Pasteurellaceae that 
has been shown previously to play a role in regulating several complex phenotypes 
including virulence [44, 112], biofilm formation [44, 53, 71, 113], and metabolism [50, 
69]. Interestingly, the activating signal varies from species to species. In E. coli and 
Salmonella, QseC was shown to be activated by AI-3 and by catecholamines [54-56]. In 
H. influenzae, QseBC (FirRS) did not respond to catecholamines but was activated by 
ferrous iron, cold temperatures and zinc [62]. The activating signal for the QseC in A. 
actinomycetemcomitans was found to be the combination of both catecholamines and 
iron (either ferrous or ferric), and the activation was dependent on having a functional 
YgiW, QseB and QseC. The exact role of YgiW is still unclear as to whether it binds to 
catecholamine and/or iron in the periplasm and perhaps shuttles the complex to the 
QseC sensor or if perhaps YgiW interacts with QseC. In addition, questions still remain as 
to the nature of the binding pocket(s) of CAT-Fe: whether there are two different pockets 
for each component, or if CAT-Fe binds one pocket as a complex. 
Although it was previously shown that QseC is vital for virulence and biofilm 
formation, the complete regulon and downstream functional outcomes of QseC 
activation via CAT-Fe was unknown. Interestingly, the largest group of genes that were 
differentially transcribed in A. actinomycetemcomitans were genes involved in anaerobic 
respiration and metabolism. There was a significant up-regulation of genes involved in 
formate, fumarate, mannose, succinate, and aspartate metabolism as well as an up-
regulation of components of the electron transport chain. Metabolomics performed 
with samples treated with Ne/FeCl2 confirmed the outcomes suggested by changes in 
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gene transcription. The up-regulation of genes and increase in metabolites associated 
with anaerobic respiration and metabolism is consistent with the findings of Jorth et al 
that showed that the same genes and pathways were highly up-regulated in vivo and 
therefore might be essential for the ability of A. actinomycetemcomitans to colonize the 
host [52]. 
In contrast, genes involved in the metabolism of fatty acids, lipid and LPS 
biosynthesis were consistently down-regulated. The down-regulation of these genes 
translated into significant decreases in the amount of several fatty acids such as palmitic 
acid, myristic acid, and palmitelaidic acid and significant changes in the lipid profile of 
the plasma membrane. Most notable was that several long-chained fatty acids were 
decreased in cells treated with Ne/FeCl2 compared to CDM. The decrease in length of 
fatty acid chains suggests that there is a change in membrane fluidity, specifically an 
increase in fluidity with Ne/FeCl2 treatment. 
Ne/FeCl2 represents an iron-rich environment, which is confirmed by the fact 
that ferritin was highly up-regulated while iron acquisition genes were down-regulated. 
The genes involved in iron acquisition were most likely down-regulated as a mechanism 
to maintain iron homeostasis. In addition, there was an up-regulation of genes involved 
in oxidative stress with exposure to Ne/FeCl2, but this up-regulation was most likely not 
due to iron toxicity. The up-regulation of oxidative stress genes was confirmed by a 
significant increase in catalase activity and a protective effect against H2O2 stress. This 
suggests that the ability to detect Ne/FeCl2 might prepare A. actinomycetemcomitans for 
growth in the oral cavity, an environment where H2O2 exposure is common either from 
host cells like the respiratory burst from neutrophils or other oral bacteria.  
Other functional outcomes due to Ne/FeCl2 exposure included increase in 
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planktonic growth and biofilm formation. The increase in planktonic growth was not 
dependent on a functional QseC as a strain lacking the periplasmic domain of QseC still 
saw a significant increase in growth with Ne/FeCl2 supplementation. However, the 
increase in biofilm formation in response to Ne/FeCl2 was dependent on QseC. The 
presence of a planktonic growth phenotype despite the absence of a functional QseC 
suggests that there might be other receptors that might respond to catecholamines or 
CAT-Fe, as has been suggested for other bacteria [102], or that QseC isn’t as vital to 
planktonic growth as biofilm formation. The dependence on QseC for biofilm formation 
has been previously shown [44], so the lack of a biofilm phenotype in response to CAT-Fe 
may be due to the overall important of QseC on the ability of A. actinomycetemcomitans 
to form biofilms. 
 In contrast, the TonB dependent receptor was found to be essential for both the 
planktonic growth and biofilm phenotype, but not for the ability of QseC to respond to 
catecholamines. The TonB dependent receptor is part of the putative enterobactin 
receptor of A. actinomycetemcomitans. Enterobactin biosynthesis and uptake was 
shown to be essential for catecholamine mediated growth enhancements in E. coli [58]. 
Since it was shown to also be essential for catecholamine mediated growth phenotypes, 
but not for QseC activation, the TonB dependent receptor likely lies downstream of QseC 
activation and plays a role in allowing A. actinomycetemcomitans to take advantage of 
catecholamine mediated iron acquisition. This also suggests there is some other uptake 
system that is responsible for bringing catecholamines or CAT-Fe into the periplasm to be 
sensed by QseC.  
The impact of both alpha and beta adrenergic receptor antagonists to block CAT-
Fe activation of QseC and the downstream effect on planktonic growth was also 
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explored. Surprisingly, both adrenergic receptor antagonists resulted in a significant 
activation of QseC at 400µM. At this same concentration the activation of QseC in the 
presence of just the receptor antagonists was not significantly different than the 
activation of QseC in the presence of the antagonists and Ne/FeCl2. The adrenergic 
receptor antagonists could still be potential therapeutics since the addition of them to 
the media resulted in significant inhibition of growth suggesting that it has some overall 
toxic effect to the cell that is not dependent on QseC. 
The role that QseBC plays on a variety of complex and essential processes in A. 
actinomycetemcomitans means that its presence is essential for the cell to sense the 
environment and adapt to any changes. Therefore, the lack of QseB results in an up-
regulation of the stress response, either due to a direct role of QseB on regulating the 
stress response or an indirect role of the lack of regulating genes via QseB causing stress 
to the bacteria. Several of the genes that were up-regulated in the ΔqseB strain include 
the TA response system: the Lon protease and two putative RelE TA systems 
(D11S_1194-1195 & D11S_1798-1799). Lon was also up-regulated in the ΔqseC strain 
showing that both components of this two-component system play a role in the stress 
response. 
One of the putative RelE TA systems was shown to be highly up-regulated during 
iron starvation suggesting that it might play a role in regulating the response of A. 
actinomycetemcomitans to variations in environmental iron, particularly in regulating 
expression of ygiW-qseBC. Ectopic expression of the anti-toxin encoded for by 
D11S_2134 resulted in a significant up-regulation of expression of the ygiW-qseBC 
operon as did the Lon protease suggesting that these systems function together to 
regulate ygiW-qseBC expression to fine tune it depending on the concentration of iron in 
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CHAPTER EIGHT: FUTURE DIRECTIONS 
Determining the Structure and the Binding Pocket(s) for CAT-Fe: 
The QseC of E. coli and Salmonella can be activated by catecholamines in iron-
limiting conditions, but the QseC of A. actinomycetemcomitans is only activated in the 
presence of both catecholamines and iron. In addition, unlike the QseC of E. coli, the 
QseC of A. actinomycetemcomitans was activated by adrenergic receptor antagonists. 
There is a 70% sequence similarity between the QseC of E. coli and A. 
actinomycetemcomitans and no strong similarity has been shown between QseC and the 
eukaryotic adrenergic receptors.  
Since the QseC of A. actinomycetemcomitans functions uniquely, it suggests that the 
structure and binding pocket of QseC might also be unique. In order to understand more 
about how QseC recognizes the activating signal or why adrenergic receptor antagonists 
activate QseC, the structure of the binding pocket still needs to be elucidated. 
Particularly, it is unknown as to whether CAT-Fe binds in the same pocket or if there are 
separate binding pockets for catecholamine and iron. Since QseC plays an essential role 
in virulence, it offers a good target for therapeutics. Understanding more about the 
binding pocket may be essential for the development of therapeutics for targeting A. 
actinomycetemcomitans mediated periodontitis. 
In order to answer this question, equilibrium dialysis using purified QseC and 
either catecholamine, iron or both will be used to determine if QseC binds to the CAT-Fe 
complex or to each individual component.  Furthermore, if catecholamine and iron bind 
separately, the question remains as to whether there are two binding independent 
binding pockets or one. Each component could bind separately, but based on the β-
galactosidase assay, both are needed for QseC to become activated. In order to answer 
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this, further structural and functional analysis of QseC would need to be done, 
particularly of the periplasmic domain. One possible approach is to crystallize this 
domain for 3-dimensional structural determination.  
Determining the Potential Role of YgiW in Binding CAT-Fe 
YgiW is a putative solute binding protein of the OB-fold family. It is also co-
transcribed with qseBC in A. actinomycetemcomitans and closely associated with the TCS 
in E. coli on the chromosome. Since the ΔygiW strain showed no activation of QseC in 
the presence of CAT-Fe, this suggests that it is essential for QseC mediated CAT-Fe 
binding.  However, whether it directly binds either component is unknown. This question 
could also be addressed by equilibrium dialysis. Further structural analysis of YgiW can 
be done by introducing mutations in the putative solute binding loops. 
CAT-Fe Mediated Changes to Virulence: 
Stress is one of the risk factors for the development and worsening of 
periodontitis [130]. One possible explanation for this link is that stress causes an 
increase in catecholamine stress hormones which can be exploited by the bacteria in 
order to acquire iron. The link between stress and worsening of infection has been 
demonstrated previously and the exposure of E. coli, P. gingivalis, and Salmonella to 
catecholamines has been shown to increase virulence and expression of various 
virulence factors.   It remains unknown if exposure to CAT-Fe results in increased 
virulence. CAT-Fe did result in the down-regulation of several well-characterized 
virulence factors in the microarray, e.g. leukotoxin, cytolethal distending toxin, and pgaB. 
Interestingly, pgaB was down-regulated, but CAT-Fe exposure resulted in a significant 
increase in biofilm formation. The ability of bacteria to form biofilms has been linked to 
disease and persistence of infection, so it is possible that although many well-
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characterized virulence factors were down-regulated, there could be an increase in 
virulence in a mouse model of periodontitis.  Further, there was a large overlap between 
the genes that were up-regulated in the microarray to those that were up-regulated 
when A. actinomycetemcomitans was grown in vivo in an abscess model. This suggests 
that the ability of the bacteria to detect catecholamines is essential for its ability to 
respond and adapt to the host environment.  
In addition, the inflamed gingiva is most likely an environment high in 
catecholamines and lactoferrin due to their release by activated neutrophils. The 
exposure to CAT-Fe would lead to an activation of QseC, which has been shown to be an 
important regulator of virulence in A.actinomycetemcomitans. The previous work 
showing that QseC is vital for virulence in A. actinomycetemcomitans was performed 
using a mouse model of periodontitis [44]. Any changes to bone loss levels is correlated 
to changes in virulence. Mice could be given exogenous catecholamines in their water 
prior to infection with A. actinomycetemcomitans or alternatively, the C.129-
Chgatm1Gnh/J strain of mice (https://www.jax.org/strain/023514) with high systemic 
levels of catecholamines can be used for these studies. 
Determine if QseC can be Activated by Catecholamines and Holo-Transferrin 
Catecholamines have been shown to act as pseudosiderophores by being able to 
scavenge iron from holo-transferrin or holo-lactoferrin [57]. QseC is activated by the 
combination of catecholamines and ferrous iron, but there is little free iron in the host. 
Most iron is bound by a host iron binding protein like lactoferrin or transferrin. In order 
to confirm that A. actinomycetemcomitans is responding to CAT-Fe in the host by 
recognizing catecholamines that have scavenged iron from lactoferrin, catecholamines 
and holo-lactoferrin, instead of ferrous iron, can be added to the media to determine if it 
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results in the same phenotype of QseC activation in response to CAT-Fe. Similarly, the 
addition of apo-lactoferrin and catecholamines should not result in any QseC activation 
since there would be no iron for the catecholamine to scavenge. 
Determining the effect of A. actinomycetemcomitans on Neutrophils in Terms of 
Catecholamine Release 
Activated neutrophils have been reported to release catecholamines up to 
millimolar amounts in response to inflammatory signals [25]. Based on this information, 
we hypothesized that the CAT-Fe activating signal for QseC is from activated neutrophils 
that are releasing catecholamines in response to being activated by A. 
actinomycetemcomitans. However, the degree to which A. actinomycetemcomitans can 
stimulate neutrophils to release catecholamines has not been extensively examined. 
Therefore, it is important to demonstrate that A. actinomycetemcomitans induces 
catecholamine release and at what multiplicity of infection (MOI) the release occurs at. 
For this experiment, different MOI’s for A. actinomycetemcomitans will be tested against 
isolated neutrophil.   The mechanisms of catecholamine release by neutrophils can also 
be studied. 
Determining the Mechanism of Action for the D11S_2133-2134 TA system 
The toxins from most type II TA systems work as endoribonucleases, either 
ribosome dependent or ribosome independent [84]. D11S_2133-2134 is a putative RelE-
like type II TA system.  Based on the growth results in E. coli with the ectopic expression 
of D11S_2133 and D11S_2134, D11S_2133 is correctly annotated as a putative toxin and 
D11S_2134 is the anti-toxin, but in order to confirm these labels, functional assays will 
need to be performed. RelE toxins have been shown to act as endoribonucleases that 
cleave between the second and third position of an upstream purine [111]. In order to 
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confirm that D11S_2133 acts as endoribonuclease, then different mRNA’s with known 
sequences will be incubated together with the purified toxin and then ran on a gel to 
look for RNA degradation. Since some of the toxins act as ribosome dependent 
nucleases then the experiment would also need to be repeated using isolated ribosomes 
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Table 1 Genes Differentially Regulated by Ne/FeCl2     
ID Tag Product 
Fold 
Change Direction P-value rtPCR 
D11S_0087 asparagine synthetase AsnA 2.9 up 5.61E-07  
D11S_0159 pts system mannose-specific eiiab component 2.99 up 7.69E-06  
D11S_0160 fructose permease iic component 2.39 up 4.84E-06  
D11S_0161 mannose permease iid component 2.1 up 5.71E-06  
D11S_0205 cytochrome c-type protein TorC 3.05 up 3.52E-06  
D11S_0206 periplasmic nitrate reductase, diheme cytochrome 2.94 up 2.25E-06 1.9 ± 0.06 
D11S_0207 ferredoxin-type protein NapH 3.36 up 1.20E-05  
D11S_0208 quinol dehydrogenase periplasmic component 2.74 up 1.28E-05  
D11S_0209 periplasmic nitrate reductase, large subunit 4.92 up 7.68E-06  
D11S_0210 NapD protein 6.69 up 7.91E-07  
D11S_0270 regulatory protein RecX 2.32 up 9.40E-06 
 
D11S_0271 protein RecA 2.35 up 5.87E-05  
D11S_0281 transporter 2.41 up 1.11E-06  
D11S_0303 anaerobic C4-dicarboxylate membrane transporter 2.41 up 5.75E-05  
D11S_0310 fructose-1,6-bisphosphatase, class II 2.65 up 2.19E-06  
D11S_0383 alkylhydroperoxidase AhpD core 4.03 up 4.31E-06 5.9 ± 0.13 
D11S_0493 anaerobic dimethyl sulfoxide reductase chain A 2.26 up 1.52E-04  
D11S_0494 anaerobic dimethyl sulfoxide reductase chain B 2.23 up 9.61E-06  
D11S_0551 ATP-dependent chaperone ClpB 2.03 up 1.37E-04  
D11S_0597 aspartate ammonia-lyase 6.86 up 7.29E-06 12.4 ± 0.16 
D11S_0670 conserved ATP-binding protein 2.89 up 0.021983  





D11S_0811 fumarate reductase iron-sulfur subunit 2.39 up 2.15E-05  
D11S_0812 fumarate reductase flavoprotein subunit 3.86 up 4.10E-05  
D11S_0838 RecN protein 2.38 up 1.28E-06  
D11S_0887 cystathionine beta-lyase 2.28 up 1.56E-04  
D11S_0922 chaperone protein DnaK 2.1 up 0.001914 3.1 ± 0.1 
D11S_0939 ImpA 2.41 up 4.03E-04  
D11S_1049 probable L-ascorbate-6-phosphate lactonase UlaG 2.1 up 8.44E-04  
D11S_1061 fumarate hydratase, class II 2.43 up 4.66E-06 4.18 ± 0.12 
D11S_1092 hydrogenase accessory protein HypB 1.81 up 3.50E-05  
D11S_1093 hydrogenase expression/formation protein HypD 1.57 up 0.001163 
 
D11S_1135 protein YgiW 17.3 up 4.67E-07 13.4 ± 0.29 
D11S_1136 protein QseB 4.63 up 4.22E-04 4.0 ± 0.21 
D11S_1137 protein QseC 3.63 up 7.24E-04 3.4 ± 0.18 
D11S_1269 fructosamine kinase 3.46 up 7.19E-07  
D11S_1299 hypothetical protein 2.6 up 5.83E-05  
D11S_1305 MacA macrolide exporter 2.15 up 0.006983  
D11S_1317 lipoprotein HlpB 2.48 up 3.43E-04  
D11S_1330 nonheme iron-containing ferritin 9.87 up 5.47E-05  
D11S_1331 ferritin 10.59 up 2.38E-04 5.5 ± 0.07 
D11S_1343 AcrA protein 5.52 up 5.47E-05  
D11S_1344 CcmA protein 3.73 up 3.83E-04  
D11S_1345 ABC-type multidrug transport 3.21 up 0.019619  
D11S_1346 ABC-2 type transporter 4.77 up 0.005669  
D11S_1347 TolC protein 2.5 up 8.83E-04  
D11S_1376 hydrogenase assembly chaperone HypC/HupF 1.88 up 6.28E-05  





D11S_1380 oxaloacetate decarboxylase alpha subunit 4.44 up 3.21E-07  
D11S_1381 oxaloacetate decarboxylase beta chain 4.31 up 2.69E-06  
D11S_1387 hypothetical protein 2.17 up 7.16E-04  
D11S_1399 dethiobiotin synthase 4.08 up 2.98E-07  
D11S_1412 cytochrome c-type protein TorY 7.68 up 6.78E-09  
D11S_1413 trimethylamine-n-oxide reductase 2 4.67 up 1.97E-07  
D11S_1431 cold shock domain protein CspD 2.1 up 0.005718  
D11S_1631 PqqL peptidase 2 up 0.028597  
D11S_1676 cytochrome c peroxidase 5.05 up 5.12E-07  
D11S_1735 [NiFe] hydrogenase maturation protein HypF 2.58 up 8.83E-04 3.6 ± 0.07 
D11S_1736 electron transport protein HydN 18.44 up 5.00E-09 
 
D11S_1737 hydrogenase-4 component B 14.93 up 1.54E-08  
D11S_1738 hydrogenase-4 component B 15.02 up 1.42E-09  
D11S_1739 hydrogenase-4 component C 10.68 up 1.60E-07  
D11S_1740 hydrogenase-4 component D 10.59 up 3.57E-08  
D11S_1741 hydrogenase-4 component E 7.95 up 5.22E-07  
D11S_1742 hydrogenase-4 component F 7.76 up 4.85E-08  
D11S_1743 hydrogenase-4 component G 5.88 up 1.38E-07  
D11S_1744 hydrogenase-4 component H 5.87 up 3.07E-07  
D11S_1745 hydrogenase-4 component I 5.41 up 5.18E-07  
D11S_1746 hydrogenase-4 component J 4.62 up 8.70E-08  
D11S_1747 hydrogenase maturation peptidase HycI 4.79 up 1.03E-06  
D11S_1748 formate dehydrogenase H 10.42 up 5.29E-09  
D11S_1749 formate dehydrogenase, alpha subunit 10.01 up 5.95E-08 3.83 ± 0.36 




D11S_1771 C4-dicarboxylate membrane transporter 1.73 up 1.02E-05  
D11S_1801 ribosomal protein L11 methyltransferase 2.24 up 2.89E-04  
D11S_1811 bifunctional acetaldehyde-CoA/alcohol dehydrogenase 2.72 up 1.04E-06  
D11S_1888 TorCAD operon transcriptional regulatory protein 1.86 up 1.62E-04  
D11S_1981 hypothetical protein 2.08 up 3.86E-04  
D11S_1983 thiol-disulfide interchange protein 3.19 up 1.08E-04  
D11S_1984 cytochrome c-type biogenesis protein CcmF 3.87 up 1.84E-05 8.59 ± 0.5 
D11S_1986 NrfD protein 11.59 up 1.14E-07 2.1 ± 0.02 
D11S_1987 cytochrome c nitrite reductase, Fe-S protein 13.63 up 4.20E-07  
D11S_1988 cytochrome c nitrite reductase, pentaheme 17.09 up 2.38E-09 
 
D11S_1989 nitrite reductase (cytochrome; ammonia-forming) 18.44 up 5.00E-09  
D11S_1992 TPR-repeat-containing protein 1.51 up 0.003085  
D11S_1993 cytochrome c-type biogenesis protein CcmH 1.57 up 0.001409  
D11S_1994 thiol-disulfide interchange protein 2.04 up 1.71E-05  
D11S_1995 cytochrome c-type biogenesis protein CcmF 2.39 up 5.05E-05  
D11S_1996 cytochrome c-type biogenesis protein CcmE 2.45 up 3.65E-06  
D11S_1997 Heme exporter protein D (CcmD) 2.66 up 5.69E-07  
D11S_1998 CcmC 3.16 up 7.34E-06  
D11S_1999 heme exporter protein CcmB 2.69 up 1.88E-06  
D11S_2000 heme ABC exporter, ATP-binding protein CcmA 3.31 up 1.80E-05  
D11S_2007 lipoprotein GNA1870 6.73 up 3.00E-07  
D11S_2125 putative long-chain-fatty-acid--CoA ligase-like 2.15 up 0.0183  
D11S_2128 anaerobic ribonucleoside-triphosphate reductase 2.7 up 5.42E-04  





D11S_2165 hypothetical protein 1.87 up 0.007808  
D11S_2171 hypothetical protein 1.63 up 0.01497  
        
D11S_0016 YjjP 0.277 down 1.58E-06  
D11S_0017 YjjB 0.195 down 1.42E-07  
D11S_0018 hypothetical protein 0.332 down 8.55E-04  
D11S_0046 multiphosphoryl transfer protein 0.498 down 5.13E-05  
D11S_0052 LysR family transcriptional regulator 0.49 down 0.003419  
D11S_0083 carbamate kinase 0.493 down 5.91E-04  
D11S_0084 ornithine carbamoyltransferase 0.469 down 5.07E-04 
 
D11S_0085 EriC protein 0.469 down 8.86E-05  
D11S_0117 LapB 0.356 down 7.35E-04  
D11S_0144 lipoprotein VacJ 0.495 down 0.005554  
D11S_0152 Low affinity tryptophan permease 0.394 down 0.021582  
D11S_0167 biofilm PGA synthesis lipoprotein PgaB 0.469 down 3.95E-06  
D11S_0216 DNA transformation protein TfoX (Competence 0.493 down 1.99E-05  
D11S_0231 hypothetical protein 0.459 down 1.19E-04  
D11S_0260 molybdopterin biosynthesis mog protein 0.418 down 0.004003  
D11S_0283 anhydro-N-acetylmuramic acid kinase 0.413 down 0.005207  
D11S_0284 N-acetylmuramic acid 6-phosphate etherase 0.411 down 4.20E-05  
D11S_0292 sulfur relay protein TusB/DsrH 0.407 down 0.002779  
D11S_0301 shikimate 5-dehydrogenase 0.208 down 4.22E-06  
D11S_0302 CydD 0.375 down 1.56E-06  
D11S_0341 Na+/H+ antiporter NhaC 0.463 down 0.014605  





D11S_0343 monosaccharide-transporting ATPase 0.472 down 0.003003  
D11S_0344 possible xylose ABC superfamily ATP binding 0.485 down 3.87E-05  
D11S_0359 RfaL protein 0.422 down 1.15E-04  
D11S_0360 CrcB protein 0.373 down 3.08E-04  
D11S_0397 RNA methyltransferase, TrmH family, group 3 0.465 down 2.63E-06  
D11S_0415 excinuclease ABC subunit B 0.357 down 0.00117  
D11S_0487 TonB-system energizer ExbB 0.208 down 1.30E-05  
D11S_0488 TonB system transport protein ExbD 0.223 down 4.29E-06  
D11S_0489 protein TonB 0.229 down 6.56E-06  
D11S_0621 iron(III)-transport system permease protein FbpB 0.182 down 1.94E-05 
 
D11S_0622 ferric iron binding protein 0.195 down 1.30E-07  
D11S_0664 CpxA two component sensor 0.442 down 0.003331  
D11S_0671 O-methyltransferase N-terminus family protein 0.341 down 0.001208  
D11S_0694 adenylate cyclase, class I 0.426 down 1.43E-04  
D11S_0785 cell division protein FtsW 0.422 down 0.007201  
D11S_0815 iron(III) dicitrate transport ATP-binding 0.123 down 2.42E-05  
D11S_0816 ABC transporter, iron chelate uptake transporter 0.108 down 1.72E-04  
D11S_0817 iron(III) dicitrate transport system permease 0.166 down 6.78E-06  
D11S_0818 iron(III) dicitrate-binding periplasmic protein 0.157 down 1.05E-06  
D11S_0858 citrate lyase, alpha subunit 0.498 down 2.92E-04  
D11S_0859 citrate lyase beta chain 0.375 down 0.009593  
D11S_0860 citrate lyase acyl carrier protein 0.448 down 0.001633  
D11S_0861 [citrate (pro-3S)-lyase] ligase 0.474 down 3.56E-05  
D11S_0867 peptidase B (Aminopeptidase B) 0.167 down 2.69E-05  
D11S_0868 nucleoside diphosphate kinase 0.325 down 1.15E-05  




D11S_0873 FeS assembly protein IscX 0.284 down 6.02E-07  
D11S_0874 ferredoxin, 2Fe-2S type, ISC system 0.282 down 2.33E-05  
D11S_0875 Fe-S protein assembly chaperone HscA 0.325 down 2.88E-06  
D11S_0876 Fe-S protein assembly co-chaperone HscB 0.326 down 3.42E-05  
D11S_0877 iron-sulfur cluster assembly protein IscA 0.345 down 1.45E-05 0.59 ± 0.02 
D11S_0878 FeS cluster assembly scaffold IscU 0.417 down 7.31E-05  
D11S_0879 cysteine desulfurase IscS 0.444 down 1.03E-04  
D11S_0890 sugar efflux transporter 0.481 down 0.003058  
D11S_0902 relaxase 0.448 down 8.83E-04  
D11S_0916 CDP-diacylglycerol--glycerol-3-phosphate 0.5 down 5.96E-04  
D11S_0930 NlpC cell wall peptidase 0.378 down 4.21E-04  
D11S_0977 hypothetical protein 0.216 down 9.38E-04 
 
D11S_0993 thiamine-monophosphate kinase 0.5 down 0.001987  
D11S_0994 phosphatidylglycerophosphatase A 0.448 down 0.006652  
D11S_0995 threonine efflux protein 0.449 down 1.64E-04  
D11S_0999 hypothetical protein 0.425 down 0.01952  
D11S_1067 hypothetical protein 0.268 down 9.22E-04  
D11S_1097 5,10-methylenetetrahydrofolate reductase 0.5 down 4.21E-04  
D11S_1125 high-affinity zinc uptake system membrane 0.37 down 0.001867  
D11S_1128 iron(III) dicitrate transport ATP-binding 0.215 down 3.94E-05  
D11S_1129 iron(III) transport system permease protein 0.331 down 0.001976  
D11S_1130 putative iron/heme permease 0.23 down 4.24E-04  
D11S_1131 putative periplasmic siderophore binding protein 0.143 down 5.47E-05  
D11S_1147 CRISPR-associated helicase Cas3 0.418 down 0.027601  
D11S_1179 tRNA(Ile)-lysidine synthase 0.398 down 0.002894  




D11S_1226 hypothetical protein 0.332 down 3.75E-04  
D11S_1227 phosphate acetyltransferase 0.417 down 0.003227  
D11S_1235 tellurite resistance protein TehB 0.439 down 0.010619  
D11S_1238 dihydrolipoyl dehydrogenase 0.465 down 2.09E-04  
D11S_1265 Ndh NADH dehydrogenase 0.379 down 2.17E-04  
D11S_1322 chromosome partition protein MukE (Protein 0.402 down 0.002735  
D11S_1324 cell division protein MukB 0.412 down 0.005851  
D11S_1325 exodeoxyribonuclease I 0.446 down 2.55E-04  
D11S_1332 hypothetical protein 0.486 down 0.00174  
D11S_1334 UspA universal stress protein 0.476 down 7.38E-04 
 
D11S_1360 DoxX family protein 0.405 down 4.67E-04  
D11S_1370 anthranilate synthase component I 0.436 down 0.017378  
D11S_1457 ATP-dependent DNA helicase RecG 0.417 down 4.29E-04  
D11S_1519 RhaT permease 0.385 down 0.026275  
D11S_1557 high-affinity Fe2+/Pb2+ permease 0.245 down 3.03E-04  
D11S_1558 high affinity Fe2+ transporter 0.122 down 1.28E-05  
D11S_1559 putative Fe2+ permease 0.138 down 4.81E-05  
D11S_1560 FtsX-like permease 0.156 down 3.33E-04  
D11S_1561 membrane permease component 0.165 down 2.62E-05  
D11S_1562 macrolide export ATP-binding/permease protein 0.069 down 0.001665  
D11S_1563 ResA 0.183 down 4.38E-04  
D11S_1564 cytochrome c-553 0.157 down 3.79E-05  
D11S_1601 hypothetical protein 0.443 down 5.93E-04  
D11S_1602 putative translation initiation inhibitor, YjgF 0.357 down 1.23E-04  
D11S_1604 hypothetical protein 0.515 down 1.73E-05  
D11S_1630 putative TonB-dependent iron receptor 0.48 down 0.008308  





D11S_1636 5-methyltetrahydropteroyltriglutamate-- 0.5 down 0.001143  
D11S_1643 AfeC periplasmic iron binding protein 0.403 down 8.22E-04  
D11S_1644 acyl phosphatase 0.404 down 8.62E-05  
D11S_1652 protein-(glutamine-N5) methyltransferase, 0.481 down 0.003915  
D11S_1668 lipid A biosynthesis lauroyl acyltransferase 0.362 down 0.003732  
D11S_1685 cysteine/glutathione ABC transporter 0.435 down 8.63E-04  
D11S_1686 ABC transporter, CydDC cysteine exporter 0.41 down 0.002955  
D11S_1694 hypothetical protein 0.213 down 3.94E-05  
D11S_1729 formate dehydrogenase, alpha subunit 0.287 down 0.001835 
 
D11S_1730 formate dehydrogenase, alpha subunit 0.467 down 0.001382  
D11S_1731 formate dehydrogenase, alpha subunit 0.524 down 0.007025  
D11S_1769 Hypothetical protein 0.413 down 0.01957  
D11S_1792 histidinol-phosphate aminotransferase 0.319 down 0.004321  
D11S_1793 3-phosphoshikimate 1-carboxyvinyltransferase 0.355 down 8.83E-04  
D11S_1800 cupin 2, conserved barrel 0.459 down 0.002002  
D11S_1809 heme acquisition system receptor 0.463 down 1.04E-04  
D11S_1819 LtxA 0.482 down 0.020787  
D11s_1820 LtxC 0.48 down 3.43E-04  
D11S_1827 ribosomal-protein-alanine acetyltransferase 0.472 down 1.05E-04  
D11S_1843 cytochrome D ubiquinol oxidase, subunit II 0.341 down 8.53E-05  
D11S_1844 cytochrome D ubiquinol oxidase subunit 1 0.4 down 6.65E-04  
D11S_1864 outer membrane protein 64 0.106 down 2.40E-05  
D11S_1954 23S rRNA (uracil-5-)-methyltransferase RumB 0.5 down 0.001068  
D11S_1973 DNA polymerase III, beta subunit 0.48 down 1.38E-04  





D11S_1975 methyltransferase domain family 0.305 down 2.48E-04  
D11S_2018 menaquinone-specific isochorismate synthase 0.457 down 0.01013  
D11S_2029 hypothetical protein 0.471 down 0.004366  
D11S_2050 type I modification enzyme 0.442 down 5.17E-06  
D11S_2052 YaeB 0.5 down 4.17E-04  
D11S_2056 conserved transporter, NadC family 0.271 down 5.47E-05  
D11S_2060 glycerate kinase 0.461 down 7.80E-04  
D11S_2061 transporter, gluconate:H+ symporter 0.426 down 6.44E-04  
D11S_2118 glycosyltransferase sugar-binding region 0.424 down 0.005345  
D11S_2154 fatty acid/phospholipid synthesis protein PlsX 0.429 down 2.01E-04  
     
     
     
     












    




 Appendix Table 2: Genes Differentially Regulated in ΔqseB    
ID Tag Product Fold Change Direction 
D11S_0016 YjjP 3.07 up 
D11S_0136 Putative transposase 2.95 up 
D11S_0146 heat shock protein HslVU, ATPase subunit HslU 8.24 up 
D11S_0147 ATP-dependent protease peptidase subunit 8.15 up 
D11S_0171 regulatory protein UhpC 2.29 up 
D11S_0204 bifunctional glutathionylspermidine 2.71 up 
D11S_0278 transposase 2.88 up 
D11S_0279 deoxyribose-phosphate aldolase 2.53 up 
D11S_0281 transporter 2.22 up 
D11S_0297 hypothetical 2.04 up 
D11S_0298 hybrid peroxiredoxin hyPrx5 (Thioredoxin 2.58 up 
D11S_0310 fructose-1,6-bisphosphatase, class II 2.43 up 
D11S_0361 protein cof 2.16 up 
D11S_0420 methyltransferase domain family 2.06 up 
D11S_0460 hypothetical 2.23 up 
D11S_0461 preprotein translocase subunit SecA 2.15 up 
D11S_0480 MerR family transcriptional regulator 2.28 up 
D11S_0551 ATP-dependent chaperone ClpB 14.5 up 
D11S_0578 hypothetical 2.33 up 
D11S_0599 chaperonin GroS 5.36 up 
D11S_0600 chaperonin GroEL 7.15 up 





D11S_0656 universal stress protein A 2.17 up 
D11S_0687 putative outer membrane protein 2.04 up 
D11S_0689 phosphoenolpyruvate carboxykinase 2.49 up 
D11S_0738 MclA 4.8 up 
D11S_0739 RNA polymerase sigma factor RpoE 4.3 up 
D11S_0795 heat shock protein 90 11.32 up 
D11S_0812 fumarate reductase 2.14 up 
D11S_0824 preprotein translocase subunit SecG 2.15 up 
D11S_0840 hypothetical 3.47 up 
D11S_0841 heat shock protein GrpE 6.96 up 
D11S_0843 5-methylaminomethyl-2-thiouridine methyltransferase 2.28 up  
D11S_0893 curved DNA-binding protein 3.48 up 
D11S_0894 MerR family regulatory protein 2.9 up 
D11S_0922 molecular chaperone DnaK 8.91 up 
D11S_1049 putative L-ascorbate 6-phosphate lactonase 4.03 up 
D11S_1050 transcriptional repressor UlaR 2.45 up 
D11S_1051 putative L-xylulose 5-phosphate 3-epimerase 2.01 up 
D11S_1061 fumarate hydratase 2.12 up 
D11S_1070 HTH-type transcriptional regulator HipB 2.27 up 
D11S_1087 putative periplasmic binding protein CbiK 2.2 up 
D11S_1104 ModE 2.14 up 
D11S_1114 malate dehydrogenase 2.21 up 
D11S_1132 bifunctional 2',3'-cyclic nucleotide 2'-phosphodiesterase/3'-nucleotidase periplasmic protein 2.12 up 




D11S_1163 PTS system maltose and glucose-specific transporter subunit IIBC 2.53 up 
D11S_1192 putative integrase 2.4 up 
D11S_1269 fructosamine kinase 2.18 up 
D11S_1331 ferritin 2.52 up 
D11S_1387 tryptophan synthase subunit alpha 2.61 up 
D11S_1412 cytochrome c-type protein TorY 2.14 up 
D11S_1414 MmcQ protein 2.03 up 
D11S_1415 CitT protein 2.5 up 
D11S_1443 MsmK 2.15 up 
D11S_1444 ATP-dependent metallopeptidase HflB 3.1 up 
D11S_1445 ribosomal RNA large subunit methyltransferase J 3.37 up 
D11S_1447 H-NS histone family 2.82 up 
D11S_1480 DNA mismatch repair protein 2.16 up 
D11S_1522 ATP-dependent protease La 4.51 up 
D11S_1662 hypothetical 2.23 up 
D11S_1674 hypothetical 3.12 up 
D11S_1676 cytochrome c peroxidase 4.57 up 
D11S_1735 hydrogenase maturation protein HypF 2.11 up 
D11S_1763 peptidase T 3.94 up 
D11S_1770 seryl-tRNA synthetase 2.16 up 
D11S_1771 C4-dicarboxylate membrane transporter 2.15 up 
D11S_1789 hypothetical 2.04 up 
D11S_1798 Stability protein StbD 2.41 up 
D11S_1799 putative relE protein 2.13 up 
D11S_1800 cupin 2 3.08 up 





D11S_1822 lipoprotein 2.32 up 
D11S_1870 hypothetical 2.19 up 
D11S_1888 TorCAD operon transcriptional regulatory protein 3.43 up 
D11S_1911 fructose-1,6-bisphosphatase 2.81 up 
D11S_1949 formate acetyltransferase 2.47 up 
D11S_1989 nitrite reductase (cytochrome; ammonia-forming) 2.18 up 
D11S_2007 lipoprotein 3.28 up 
D11S_2022 S-adenosylmethionine synthetase 2.67 up 
D11S_2024 serine transporter 2.12 up 
D11S_2047 copper-translocating P-type ATPase 2.36 up 
D11S_2067 EbgC protein 2.35 up 
D11S_2078 sigma 54 modulation protein/ribosomal protein S30EA 3.49 up 
D11S_2165 hypothetical 3.39 up 
D11S_2175 hypothetical 2.58 up 
D11S_2183 I protein 2.71 up 
D11S_2184 Mu-like phage G protein 1 2.74 up 
D11S_2185 f protein 3.47 up 
D11S_0039 DNA Polymerase I 0.327 down 
D11S_0040 tRNA (uracil-5-)-methyltransferase 0.435 down 
D11S_0046 multiphosphoryl transfer protein 0.278 down 
D11S_0047 1-phosphofructokinase 0.354 down 
D11S_0060 hypothetical 0.381 down 
D11S_0064 DNA-directed RNA polymerase, beta subunit 0.477 down 
D11S_0101 Trk system potassium uptake protein TrkA 0.428 down 





D11S_0167 biofilm PGA synthesis lipoprotein PgaB 0.404 down 
D11S_0180 PnuC transporter 0.478 down 
D11S_0192 ATP-dependent DNA helicase Rep 0.344 down 
D11S_0250 UDP-3-O-[3-hydroxymyristoyl] glucosamine 0.495 down 
D11s_0283 anhydro-N-acetylmuramic acid kinase 0.406 down 
D11S_0284 N-acetylmuramic acid 6-phosphate etherase 0.396 down 
D11S_0292 sulfur relay protein TusB/DsrH 0.332 down 
D11S_0293 sulfur relay protein TusC/DsrF 0.452 down 
D11S_0306 glycerol-3-phosphate dehydrogenase (NAD(P)+) 0.402 down 
D11S_0323 F0F1 ATP synthase subunit gamma 0.466 down 
D11S_0324 F0F1 ATP synthase subunit beta 0.463 down 
D11S_0325 ATP synthase F1, epsilon subunit 0.48 down 
D11S_0370 2-C-methyl-D-erythritol 4-phosphate 0.355 down 
D11S_0372 tRNA pseudouridine synthase D 0.366 down 
D11S_0415 excinuclease ABC subunit B 0.247 down 
D11S_0422 acriflavine resistance protein 0.338 down 
D11S_0423 AcrA protein 0.296 down 
D11S_0424 AcrR protein 0.254 down 
D11S_0434 formamidopyrimidine-DNA glycosylase 0.294 down 
D11S_0444 cAMP-regulatory protein 0.494 down 
D11S_0455 DNA adenine methylase 0.45 down 
D11S_0520 aspartate racemase 0.452 down 
D11S_0530 hypothetical 0.362 down 
D11S_0531 outer membrane lipoprotein carrier protein LolA 0.485 down 





D11S_0533 glycosyl transferase, family 2 0.25 down 
D11S_0534 glycosyl transferase, group 2 family protein 0.242 down 
D11S_0535 AMP-binding enzyme family protein 0.286 down 
D11S_0536 integral membrane protein 0.402 down 
D11S_0588 drug/metabolite exporter family transporter 0.376 down 
D11S_0589 drug/metabolite exporter family transporter 0.358 down 
D11S_0594 hypothetical 0.487 down 
D11S_0607 diacylglycerol kinase 0.433 down 
D11S_0608 GTP pyrophosphokinase 0.492 down 
D11S_0609 23S rRNA 5-methyluridine methyltransferase 0.121 down 
D11S_0619 tRNA-dihydrouridine synthase C 0.358 down 
D11S_0623 hypothetical 0.5 down 
D11S_0652 UTP-glucose-1-phosphate uridylyltransferase 0.329 down 
D11S_0751 hypothetical 0.314 down 
D11S_0815 iron-dicitrate transporter ATP-binding subunit 0.177 down 
D11S_0816 subunit FecD 0.229 down 
D11S_0817 iron-dicitrate transporter permease subunit 0.267 down 
D11S_0822 DNA topoisomerase III 0.487 down 
D11S_0823 hypothetical 0.418 down 
D11S_0831 intracellular septation protein A 0.41 down 
D11S_0856 inner membrane protein YbhI 0.248 down 
D11S_0857 citrate lyase subunit alpha 0.257 down 
D11S_0858 citrate lyase subunit beta 0.259 down 
D11S_0859 gamma 0.176 down 
D11S_0891 sugar efflux transporter 0.478 down 





D11S_0910 cytolethal distending toxin protein C 0.462 down 
D11S_0916 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase 0.35 down 
D11S_0928 protein-(glutamine-N5) methyltransferase 0.386 down 
D11S_0951 dipeptide transport system permease DppC 0.442 down 
D11S_0960 tRNA delta(2)-isopentenylpyrophosphate transferase 0.478 down 
D11S_0964 hypothetical 0.433 down 
D11S_0965 hypothetical 0.202 down 
D11S_0966 glycosyl transferase, family 2 0.215 down 
D11S_0967 putative inner membrane protein 0.197 down 
D11S_0968 integral membrane protein 0.13 down 
D11S_0985 outer membrane-specific lipoprotein transporter subunit LolE 0.447 down 
D11S_0993 thiamine-monophosphate kinase 0.408 down 
D11S_0994 phosphatidylglycerophosphatase A 0.341 down 
D11S_0995 threonine efflux protein 0.335 down 
D11S_1039 sulfate/thiosulfate import ATP-binding protein CysA 0.397 down 
D11S_1066 valyl-tRNA synthetase 0.465 down 
D11S_1067 hypothetical 0.227 down 
D11s_1075 exoribonuclease II 0.418 down 
D11S_1096 shikimate 5-dehydrogenase 0.412 down 
D11S_1123 endonuclease III 0.486 down 
D11S_1128 iron(III) dicitrate transport ATP-binding protein FecE 0.315 down 
D11S_1136 QseB 0.059 down 
D11S_1179 tRNA(Ile)-lysidine synthase 0.473 down 
D11S_1191 putative tail fiber assembly protein 0.465 down 
D11S_1210 putative DNA repair ATPase 0.462 down 




D11S_1219 3-deoxy-manno-octulosonate cytidylyltransferase 0.38 down 
D11S_1220 hypothetical 0.447 down 
D11S_1221 tetraacyldisaccharide 4'-kinase 0.378 down 
D11S_1225 poly A polymerase 0.362 down 
D11S_1227 phosphate acetyltransferase 0.219 down 
D11S_1232 4-alpha-glucanotransferase 0.054 down 
D11S_1261 hypothetical 0.493 down 
D11S_1304 ABC transporter-like protein 0.393 down 
D11S_1307 hypothetical 0.376 down 
D11S_1324 cell division protein MukB 0.332 down 
D11s_1338 dihydroorotate dehydrogenase 2 0.337 down 
D11S_1353 TonB dependent outer membrane siderophore receptor protein 0.471 down 
D11S_1389 ribonucleoside-diphosphate reductase subunit beta 0.421 down 
D11S_1419 tRNA pseudouridine synthase A 0.303 down 
D11S_1423 tellurite resistance protein TehB 0.372 down 
D11S_1424 exodeoxyribonuclease V subunit alpha 0.31 down 
D11S_1437 two component Fis family transcriptional regulator 0.376 down 
D11S_1455 glutamate racemase 0.442 down 
D11S_1456 chorismate--pyruvate lyase 0.376 down 
D11S_1457 ATP-dependent DNA helicase RecG 0.492 down 
D11S_1479 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 0.46 down 
D11S_1500 threonine synthase 0.387 down 
D11S_1501 putative 4'-phosphopantetheinyl transferase 0.277 down 
D11S_1524 DNA primase 0.496 down 
D11S_1530 NAD-dependent DNA ligase LigA 0.398 down 





D11S_1574 FAD linked oxidase 0.398 down 
D11S_1575 esterase YdiI 0.288 down 
D11S_1598 DNA topoisomerase IV subunit A 0.335 down 
D11S_1606 hypothetical 0.389 down 
D11S_1607 DNA polymerase III subunit tau 0.342 down 
D11S_1608 hypothetical 0.454 down 
D11S_1611 inner membrane protein YfcA 0.497 down 
D11S_1640 sulfurtransferase TusE 0.398 down 
D11S_1653 transketolase, central region 0.363 down 
D11S_1654 transketolase, N- subunit 0.36 down 
D11S_1664 protein ParB 0.624 down 
D11S_1686 cysteine/glutathione ABC transporter membrane/ATP-binding protein 0.395 down 
D11S_1700 hypothetical 0.451 down 
D11S_1701 glycosyltransferase 0.273 down 
D11S_1702 exopolysaccharide production protein EXOZ 0.479 down 
D11S_1704 lipopolysaccharide biosynthesis protein 0.417 down 
D11S_1709 hypothetical 0.427 down 
D11S_1749 formate dehydrogenase subunit alpha 0.44 down 
D11S_1758 periplasmic protein 0.455 down 
D11S_1780 SH3 domain-containing protein 0.339 down 
D11S_1781 
multifunctional tRNA nucleotidyl transferase/2'3'-cyclic 
phosphodiesterase/2'nucleotidase/phosphatase 0.257 down 
D11S_1782 outer membrane lipoprotein LolB 0.26 down 
D11S_1783 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase 0.231 down 
D11S_1809 heme acquisition system receptor 0.387 down 





D11S_1862 hypothetical 0.448 down 
D11S_1915 ThiF family protein 0.465 down 
D11S_1954 23S rRNA (uracil-5-)-methyltransferase RumB 0.492 down 
D11S_1955 23S rRNA methyluridine methyltransferase 0.272 down 
D11S_1969 ribonuclease P protein component 0.5 down 
D11S_1981 hypothetical 0.431 down 
D11S_1982 thiol-disulfide interchange protein 0.498 down 
D11S_1983 cytochrome c-type biogenesis protein CcmF 0.443 down 
D11S_1992 TPR-repeat-containing protein 0.497 down 
D11S_2020 acyl-CoA thioester hydrolase YfbB 0.339 down 
D11S_2030 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase 0.372 down 
D11S_2031 histidyl-tRNA synthetase 0.331 down 
D11S_2072 PilC 0.44 down 
D11S_2082 ribosomal protein L11 methyltransferase 0.459 down 
D11S_2083 sodium/panthothenate symporter 0.366 down 
D11S_2084 sodium/panthothenate symporter 0.402 down 
D11S_2085 acetyl-CoA carboxylase biotin carboxylase subunit 0.448 down 
D11S_2086 chromosomal replication initiation protein 0.409 down 
D11S_2093 O-succinylbenzoate synthase 0.411 down 
D11S_2094 DNA polymerase, beta domain-containing protein 0.468 down 
D11S_2102 tRNA-specific adenosine deaminase 0.402 down 
D11S_2112 cold-shock DNA-binding domain-containing protein 0.475 down 
D11S_2131 anaerobic ribonucleotide reductase-activating protein 0.463 down 
D11S_2147 transcription termination factor Rho 0.368 down 
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